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ABSTRACT 
The aim of the project was to optimize cell cycle co-ordination in murine 
embryos reconstructed by nuclear transfer. The project also involved studies of 
oocyte activation, cell cycle length and synchronization, evaluation of MPF, and 
DNA replication in early embryos. 
Embryos were successfully arrested at mitosis by culturing them up to 16 
hours with 2.5 mM 6-dimethylaminopurine (DMAP). However, the reversibility 
and the development after release was affected when exposed for more than 9 
hours. A comparative study of different concentrations of 6-DMAP and 10 tM 
nocodazole for holding the embryos at mitosis for 12 hours showed a greater 
effectiveness of nocodazole. Treatment of embryos for synchronization with 
different concentrations of Taxol for different time periods was not successful 
because of its toxicity affects. Nocodazole was used as a method of synchronization 
in subsequent studies. 
In most of the experiments 25 mM strontium chloride was used as the 
method for the artificial activation of cytoplasts and reconstituted embryos. Later 
on, a new method for parthenogenetic activation of metaphase II oocytes or 
recipient cytoplasts was established. The later method involved the exposure of 
metaphase II oocytes or recipient cytoplast to 25 mM strontium chloride for 60 
minutes with subsequent exposure to 2.0 mM 6-DMAP for 3 hours. The proportion 
of parthenogenetically activated metaphase II oocytes that reached blastocyst stage 
was greater (P< 0.001) than using strontium chloride alone. The new protocol was 
better than the protocol using 5 pM lonomycin for 5 minutes with subsequent 
exposure to 2.0 mM 6-DMAP. Moreover, when embryos were produced by 
transfer of 4-cell donor nuclei into recipient cytoplasts which were pre-activated 
with strontium chloride and 6-DMAP (25 mM strontium chloride (1 hour) + 2.0 
mM 6-DMAP (3 hours)), an enhanced development to morulalblastocyst was 
achieved compared to the use of strontium alone. 
The effect of meiosis/mitosis/maturation promotion factor (MPF) on the 
development of embryos reconstructed at different times in relation to activation 
was investigated and its level was studied by looking at nuclear envelope 
breakdown (NEBD) and nuclear envelope breakdown and premature chromatin 
condensation (NEBD&PCC). The first cell cycle length of the enucleated and non-
enucleated parthenotes was also studied. In the absence of nuclear material, the cell 
II 
cycle in parthenotes was reduced by 5 hours. The lower development of the 
embryos reconstituted at different time in relation to activation by using 4-cell donor 
nuclei at GI or GUS to blastocyst suggested the need to re-investigate the duration 
of Gi-phase because it was suggested that cell cycle stage was incorrectly 
classified. 
After determining the timing of Gi duration and S-phase initiation of 3rd 
and 4th cell cycle, nuclear transfer experiments were performed to investigate the 
effect of nuclear donor cell cycle stage and its interaction with recipient cell cycle 
stage. Two methods for determining the duration of GI and start of DNA 
replication in 3rd and 4th cell cycle were established. The start of DNA replication 
was detected by the technique of pulse labeling for proliferating cell nuclear antigen 
PCNA or by incorporating 5-bromodeoxyuridine (BrdU) by rapid pulsing. 
Embryos were then reconstructed either by using 2-cell donor nuclei at G2I1\4 phase 
or 4-cell donor nuclei at Gi, S and G2/M stage of cell cycle with MIII cytoplasts or 
pre-activated cytoplasts. Further more, the embryos were reconstructed by 
transferring 2-cell donor nuclei at G21M stage and 4-cell donor nuclei at GuS, S 
and G2/1\4 phases of cell cycle into metaphase II cytoplasts and then delaying 
activation by 4 hours. Delayed activation in embryos reconstructed using G2IM 
stage of cell cycle improved development to morula/blastocyst stage to the same 
proportion achieved with Gi donor nuclei transferred to Mil cytoplasts. 
The studies confirm the importance of cell cycle co-ordination in the 
development of reconstructed embryos. By appropriate co-ordination of cell cycle 
stages it has been possible for the first time to obtain similar development with 4-
cell blastomeres with donor cell nuclei at any stage of the cell cycle . Moreover, the 
use of strontium chloride + 6-DMAP activated cytoplasts with 4-cell donor nuclei 
from different cell cycle can produce embryos that will develop with a higher 
frequency to morula/blastocyst than strontium chloride alone. 
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Historically, animal scientists have been quick in taking up the advantages of 
new biotechnological techniques for the propagation of economically superior animals. 
In the past few decades, the spread of superior germ plasm of carefully selected proven 
bulls by artificial insemination has played a vital role in rapid genetic improvement. 
This technique allows each bull to have its genetic contribution to thousands of 
offspring but each cow can only produce 5 or 6 calves in her lifetime. In later years, 
the use of multiple ovulation embryo transfer (MOET) and cloning by embryo splitting 
have been developed which partially compensated this imbalance. 
During recent years, the establishment of nuclear transfer procedures has 
provided new opportunities, at least in principal, to multiply large number of 
genetically superior animals. Previous experience with artificial insemination and 
multiple ovulation/embryo transfer suggest that it may be at least 10-20 years before 
this could become a routine procedure in livestock production. The techniques of 
nuclear transfer can be used in cattle and pigs because it is probably only in these 
species that the benefits are likely to justify the cost. Non surgical procedures of 
transferring embryos would need to be developed to keep the procedure simple on the 
farm and success rate has to efficiently improved. 
In recent years since the introduction of techniques for cloning in domestic 
animal (Willadsen, 1986; Prather et al., 1987), embryo cloning has moved from 
experimental tool to its commercial application. Nicholas and Smith (1983) evaluated 
the genetic value from breeding, selection, and large scale commercial use of cloned 
dairy cattle and demonstrated its considerable potential to increase genetic gain. The 
cloned animals are expected to be more uniform than the random-bred animals and 
provide greater opportunity for investigating genotype-treatment interactions in 
research. For traits such as milk production, one monozygotic twin could replace more 
than 20 random-bred animals in the experiment. However, the study of Wilson et al., 
(1995), on the comparison of birth weight and growth characteristics of bovine calves 
produced by nuclear transfer (cloning), embryo transfer and natural mating suggested 
1 
that the variability in the birth weight for CLONE calves was four to 12-fold greater 
than for ET or AT/NM calves. The cause of this variability is not known. 
In animal breeding, genetic progress is dependent on exploiting genetic 
variation and cloning has it's limited use within breeding programsns. Some traits of 
economical importance are greatly influenced by environment and it is often difficult to 
assess the genetic merit of an individual animal. In cases like mastitis in dairy cattle , it 
might be beneficial to clone several copies of elite animal to accurately assess her 
susceptibility to these kinds of conditions. Cloning could also be integrated into 
breeding strategies aimed at multiplying endangered indigenous breeds of livestock, in 
order to conserve the genetic diversity of animals adapted to specific environments. 
The ability to produce large numbers of genetically identical animals would also have 
important benefits in experimental design. Genetic variations between individuals often 
alter the responses to test the diet and drugs. In those experiments, which require the 
slaughtering of animals to assess the carcass traits, the multiple number of genetically 
identical animals would be helpful. In addition to decreasing the number of animals 
required for an experiment, it is possible to investigate the interactions between 
genotype and various treatments for the first time (Biggers, 1986). Individuals 
reconstructed with identical nuclear genomes, but with different cytoplasmic 
environments also provide greater opportunities for evaluating the cytoplasmic 
inheritance and nuclear-cytoplasmic communication. 
The ultimate aim for most of the commercial embryo cloning projects is the 
production of a large number of genetically identical animals from a superior embryo. 
One way to achieve this goal might be the implementation of multiple generational 
cloning. This procedure assumes that the success rate for each generation of cloning 
remains constant. However, very little information has been reported on the success 
rate of cloning in mammals. Stice and Keefer, (1993) reported the production of 54 
genetically identical embryos that developed to morula stage from one parent embryo 
by recloning. Another way to get large number of genetically superior identical animals 
is the use of different cell lines as source of nuclei for transfer. In the mouse, it is 
possible to establish cell lines by the culture of embryonic cells in such a way that they 
divide but do not differentiate (Evans and Kaufman, 1981). 
The production of live lamb "Megan and Morag" by nuclear transfer from cells 
of early embryos that had been cultured for several generations laid down a mile stone 
in history of nuclear transfer (Campbell et al., 1995). This major breakthrough came 
because of the induction of quiescence in the donor cells. Later on the birth of Dolly 
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from an adult cell (Wilmut et al., 1997) has opened a new era in developmental 
biology. The ability of nuclear transfer procedures to derive live animals from cultured 
cells provides an alternate way of producing transgenic farm animals. Moreover, the 
ability to manipulate millions of cells at once opens up the possibility of much more 
specific genetic modifications, including the deletion or substitution of specific genes 
or the introduction of the single letter changes in the whole genetic code that are typical 
of many human genetic diseases. At present transgenic sheep, goat and cattle are 
already being used to produce human proteins in milk. The technique of nuclear 
transfer will provide a more reliable way of producing transgenic animals, reducing the 
number of animals needed to establish each transgenic line. By using donor cells from 
established cell cultures with specific genetic modifications, this technique provides its 
future applications in the successful production of xenotransplants and nutrichemicals. 
At present, mice in which specific mutations have been deliberately introduced have 
often provided very useful model for studying human genetic diseases such as cystic 
fibrosis and obesity. The differences between mice and humans mean the effects of 
introduced mutation are not the same as in the human genetic disease. Nuclear transfer 
will extend the range of species in which gene targeting will be possible and thereby 
provide better models to test treatments for human diseases. In diseases like 
Parkinson's and leukemia, intact cells are used to treat the patients. These cells have to 
be obtained from the close relatives to avoid the problems to immune rejection. As the 
research will advance in the understanding of the process of reprogramming of the 
differentiated cells into all the cell types, the patient's own cells would be removed 
converted into the desirable cell type in the laboratory and reintroduced into the patient 
for treatments. The technique of cloning using cultured cell also provides tools for 
future research in the fields of ageing & cancer. 
During recent years significant progress has been made in understanding the 
interaction of cell cycle stages of donor nuclei and recipient cytoplasm in reconstructed 
embryos by nuclear transfer. This understanding has led to an increase in the 
frequency of development and also to development from later developmental stages. In 
reconstituted embryos the transplanted nucleus must fulfill a number of roles; 
* firstly the nucleus must be able to respond to the new cytoplasmic environment 
in such a way that its genetic material remains undamaged, 
* secondly the genetic information present must be able to redirect development of the 
reconstituted embryo. 
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The present project was thus planned to optimize cell cycle co-ordination in the 
development of murine embryos reconstructed by nuclear transfer. In the start of this 
project (1994), the hypothesis was that there is cytoplasmic state in Mil cytoplasts after 
activation which could support development of embryos reconstructed with donor 
nuclei from any stage of cell cycle. The hypothesis of higher development after nuclear 
transfer from GI donor was also tested. The efficiency of lower development in 
embryos reconstructed using different cytoplasmic environments of cytoplasts, 
suggested the need to re-investigate the length of the cell cycle and to map the 
cytoplasmic activity of MPF(Chapter 6). 
To conduct experiments for evaluating the cell cycle co-ordination in the 
development of reconstructed embryos, there was need to synchronize the donor cell 
cycle. The experiments were also conducted to establish proper method for the 
synchronization of cell cycle (Chapter 4). The experiments in chapter 7 were conducted 
to test the hypothesis of a window of opportunity in the donor cell cycle; the DNA 
synthesis initiation timings were investigated. In chapter 8, the experiments were 
conducted using three nuclear transfer protocols to study their effect on reprogramming 
of donor nuclei. In the end of this project it was felt that activation stimuli used in 
previous experiments was not enough to create a cytoplast as "universal recipient". The 




REVIEW OF LITERATURE 
The idea of nuclear transfer as a tool to investigate the potential of nuclei from 
differentiated cells was first proposed by Spemann (1938). He proposed nuclear 
transfer experiments by transferring nuclei from embryos more advanced in 
development into cytoplasts to study their ability to direct development. Briggs and 
King (1952) adopted this idea of performing nuclear transfer experiments after 
Spemann' s death in 1941. They performed nuclear transfer experiments in 
amphibians in which donor nuclei were injected into cytoplasts of enucleated 
parthenogenones of Rana pipiens. It was demonstrated that the embryonic nuclei 
could replace the nuclei of fertilized ova and result in development. The cloning 
procedure as described by Briggs and King (1952) is as follows: 
activation of the recipient oocyte, the process of initiating in the absence 
of fertilization 
enucleation of the recipient ovum; and 
transfer of a nucleus intact, lysed blastomere to the enucleated ovum. 
The detailed procedure has been described by Elsdale et al., (1960) and Gurdon and 
Laskey (1970). By using slightly different methods of nuclear transplantation in 
Xenopus, Gurdon and his colleagues have obtained results suggesting that the 
nuclei of some differentiated cells may retain totipotency which progressively loss 
during increased development. Using the procedure of serial transplantation (which 
involved placing an intestinal nucleus into an egg and, when the egg had become a 
blastula, transferring the nuclei of the blastula cells into several more eggs), 
increased rate of development (7%) to the feeding tadpole stage was demonstrated 
(Gurdon, 1962). Moreover, seven of these tadpoles metamorphosed into fertile 
adult frogs (Gurdon and Uehlinger, 1966); these nuclei were totipotent. Kings and 
his colleagues, however, criticized these experiments, pointing out that (1) not 
enough precautions were taken to make certain that primordial germ cells-which 
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migrate through and often stay in the gut - were not used as source of nuclei, and 
(2) the intestinal epithelial cell of such a young tadpole may not qualify as a truly 
differentiated cell type. Such cells of tadpole still contain yolk platelets (DiBerardino 
and king, 1967; Mckinnell, 1978; Briggs, 1979). To answer these criticisms, 
Gurdon and his colleague cultured epithelial cells from adult frog foot webbing. 
When nuclei from these cells were transferred into activated, enucleated Xenopus 
oocytes, none of the first generation transfers progressed further than the formation 
of the neural tube shortly after gastrulation. By serial nuclear transplantation, 
however, numerous tadpole were generated (Gurdon et at., 1975). Although these 
tadpole died prior to feeding, a single differentiated cell still retained incredible 
potencies. A single nucleus derived from an adult frog red blood cell (which neither 
replicate nor synthesizes mRNA) can undergo over 100 divisions after being 
transplanted into an activated oocyte and still retain the ability to generate swimming 
tadpoles (On et al., 1986; DiBerardino, 1989). Although DiBerardino (1987) has 
observed that " to date, no nucleus of a documented specialized cell nor of an adult 
cell has been shown to be totipotent," such a nucleus can still instruct the formation 
of all the organs of a swimming tadpole. 
In principle the procedure of Briggs and King (1952) is similar to that used 
today in mammals. The method of non-invasive ovum enucleation and use of 
fusogenic agent for blastomere fusion by McGrath and Solter (1983a) has created 
the revolutionary opportunities in animal breeding and research. The nuclear 
transfer procedure involves pre-treatment of recipient ova with Cytochalasin. This 
compound causes the recipient plasma membrane to become more elastic, making 
the recipient ovum more conducive to manipulation without lysis. The zona 
pellucida can be circumvented, either by making a cut with a glass knife to allow the 
insertion of a blunt enucleation pipette (Willadsen, 1986); or a sharpened bevelled 
pipette can be used to puncture it and subsequently enucleate the ovum (McGrath 
and Solter, 1983a). 
2.1-PROCEDURES OF NUCLEAR TRANSFER 
IN MAMMALIAN SPECIES 
In mammalian species there are two predominant methods of nuclear 
transfer which varies upon the point at which the recipient cell is enucleated. Both 
metaphase II (Mil) oocytes and one cell zygote have been considered as recipients 
for nuclear transfer. Metaphase II (MU) oocytes which are to be enucleated are 
cultured in medium containing the microfflament inhibitor Cytochalasin D or B and 
specific fluorochrome Hoechst 33342. The metaphase plate is removed by 
aspirating a small amount of cytoplasm from directly beneath the 1st polar body. 
The enucleation is confirmed by exposing the aspirated portion of cytoplasm to UV 
light for the presence of both polar body and the metaphase plate. Similarly, zygotes 
are cultured in medium containing Cytochalasin D or B with the addition of 
microtubule inhibitor colchicine. In mouse the pronuclei are visible under DIC 
optics and can be removed by aspiration. However, in ungulate species the zygotes 
have to be centrifuged to visualized the pronuclei. After enucleation the recipient cell 
is then ready to receive the donor cell (karyoplast). Donor cells (karyoplasts) can be 
derived from a variety of embryonic cell stages ranging from the 2-cell stage to the 
blastocyst stage (McGrath and Solter, 1983b; Robi et al., 1986; Robi et al., 1987; 
Prather et al., 1987; Willadsen, 1986; Tsunoda et al., 1988; Smith and Wilmut, 
1989; Stice and Robi, 1989; Prather et at., 1989; Bondioli et al., 1990). Now a 
donor cell (karyoplast) is aspirated into the enucleation pipette, the pipette is inserted 
through the hole previously created in the zona pellucida and the karyoplast expelled 
into the perivitelline space. The karyoplast is then placed in close contact with the 
recipient cell or cytoplast. The karyoplast (donor cell) and recipient cell or cytoplast 
are ready for fusion. Fusion may be performed in two ways. Sendai virus ranging 
from 1000 to 9000 hemagglutination units (HAU) successfully fuses blastomeres 
and enucleated ova in sheep and mice (Graham, 1969; McGrath and Solter, 1983a; 
RobI et al., 1986; Willadsen, 1986). Fusion may be induced by electroporation in 
cattle, pigs and rabbits as well as in sheep and mice. This is performed in a non 
ionic solution such as 0.3 M mannitol in distilled water and a fusion chamber 
consisting of two electrodes, ranging from 200 pm to 1 mm apart (Kubiak et al., 
1985; RobI et al., 1987; Willadsen, 1986; Smith and Wilmut, 1989). The use of 
electric pulse for fusion also induces activation of Mil oocytes (cytoplast) in most of 
the situations. 
The establishment of these procedures have played a very important role in 
successful production of embryo clones in cattle, sheep, rabbit, pigs and mice 
(Prather et at., 1987; Willadsen, 1986; Stice and RobI, 1989 ; Prather, 1989 
Tsunoda et at., 1987 ). Similar procedures of nuclear transfer have been used 
during that period to investigate the regulation of early development in mice (e.g. 
S urani et al., 1987) and in livestock species for fundamental research (for review 
see Barnes et al., 1990). 
Amphibian eggs and embryos have , for a long time , been favoured 
material for analysis of problems in embryology primarily because of their large size 
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makes manipulation seem easier, and external fertilization and development makes 
observation straightforward. Wilson (1896) studied the early cell lineage's and 
proposed that nucleo-cytoplasmic interactions were important in inducing gradual 
changes in cell function. The most obvious change in cell activity between oocyte 
and early embryo is the resumption of the cell cycle. 
2.2 THE CELL CYCLE 
The cell cycle is the period during which events required for successful 
reproduction are completed. Two major events considered to be common to all cell 
cycles are S-phase (Laskey et at., 1989), when chromosomes are replicated (DNA 
synthesis) and M-phase (McIntosh and Koonce, 1989), when the replicated 
chromosomes are segregated into two daughter cells (Mitosis). These two easily 
detectable components of nuclear activity are divided by a post-mitotic gap (G I) and 
a second gap (G2) between DNA synthesis and mitosis. Prescott (1976), and Smith 
and Martin (1973) studied the duration of these phases and reported that though all 
phases vary in length, but post embryonic cells show greatest variation in the length 
of G1, both between cell type and within one population. In amphibians, the first 
embryonic cell cycle lasts 75 minutes and is followed by 11 synchronous cell 
cycles, each about 30 minutes. The early embryonic cell cycle of amphibians during 
cleavage is dramatically different in many ways. 
Firstly, during early synchronous cleavage, G  and G2 are largely 
suppressed (Graham and Morgan, 1966) which reflects the absence of growth in 
early embryos. 
Secondly, the cell cycle is extremely rapid with cleavage recurring every 
35 minutes (Newport and Kirschner, 1982). 
Somatic cells are born small and must import nutrients so that they can grow 
and duplicate all the contents of the cell. On the other hand , eggs, however, are 
large and inherit with them a stock of nutrients from their mother, all the structural 
components of cells, and almost all the enzymes that catalysis the processes of DNA 
synthesis and mitosis (e.g. histones, Woodland and Adamson, 1977; DNA 
polymerase, Benbow et at., 1975; tublin, Pestell 1975). 
Thirdly, the recurrence of surface contraction wave in each cell cycle (Hera 
et al., 1980). These waves have been interpreted as the autonomous cytoplasmic 
oscillator which directs the orderly repetition of DNA synthesis and mitosis. The 
same type of cytoplasmic oscillators are also found in adult cell cycle (Klevecz, 
1976). 
2.2.1- REGULATION OF CELL CYCLE 
Xenopus and starfish have been the main species whose oocytes were 
widely used to study the regulation of cell cycles (Mailer, 1990; Meijer and 
Guerrier, 1984). These immature oocytes undergo meiotic maturation following the 
stimulation of harmones. Newport and Kirschner, (1982) have reported that the cell 
cycles of these embryos after fertilization were composed of S and M phases 
without any detectable G  and G2 phases. However, the regulation of the cell cycle 
in mammalian oocytes seems to be different from that in Xenopus and starfish 
oocyte. The mitotic cell cycle of mammalian oocytes after fertilization is composed 
of all the four phases i.e. Gi,  S, G2 and M (Abramzuk and Sawichi, 1975). The 
progression of cell cycle in these phases depends on the "checkpoint" control 
(Hartwell and Weinert, 1989) operating at the two principal decision points of the 
cell cycle: Gi => S (DNA synthesis initiation) and G2 => M (mitotic induction). 
Van't Hof (1985) illustrated the design features of cell cycle control system to 
describe the progression and points of control in the mitotic cell cycle (Fig. 2.1). 
These transitions are regulated by a combination of transcriptional, post 
translational, and quaternary protein association mechanisms. The transcriptional 
controls are more prominent in the Gi = S than in the G2 => M transition. 
During last 20 years, extensive biochemical and genetic studies have 
provided a better understanding of the regulation and control of the normal cell cycle 
in eukaryotes. The frog oocyte and eggs have been widely used in these studies to 
identify the key regulator of the cell cycle. The fully grown frog oocyte is arrested at 
GV, preceding the first meiotic division. It is induced by the release of progesterone 
from the follicle cells to proceed rapidly through meiosis 1 and prophase of meiosis 
II before its arrest at metaphase of meiosis II. Fertilization relieves the metaphase 
arrest and initiates a series of rapid, nearly synchronous cell cycles that proceed 
without any detectable Gi and G2 phases until there is an abrupt change to a more 
complex and asynchronous cell cycle after 12 division (Newport and Kirschner 
1982). 
Although the initial studies of meiotic maturation were focused on extra 
cellular signals like progesterone, a major innovation was the use of cytoplasmic 
transfer by microinjection to identify the intracellular regulators of meiosis. Studies 
of Masui and Markert (197 1) and Reynhout and Smith (1974) revealed the presence 
of cytoplasmic activity (not progesterone) that could induce the meiotic maturation 
in immature oocytes. They named this activity maturation promotion factor or MPF. 
























Fig. 2.1 Points of control in the mitotic cell cycle. Cells monitor essential 
conditions, primarily in late Gi and G2, but also elsewhere in the cell cycle before 
entering the next phase of the cycle. Labelled check marks indicate six points at 
which control systems operate to prevent cell cycle progress in the absence of a 
positive response to the questions posed in the boxes. Large asterisks within the 
circle indicate principal control points of the plant cell cycle(Van't Hof, 1985). 
MPF also stand for mitosis and meiosis promoting factor, a name that more 
generally describes its widespread role in cell cycle. Oocytes can be induced to 
mature by injecting cytoplasm from mitotically arrested mammalian cells, suggests 
MPF existence in wide range of cell types. After meiosis 1 MPF activity 
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disappeared, but reappeared and was maintained at high levels as the oocyte entered 
and was stably arrested at, second meiotic metaphase in the unfertilized egg 
(Gerhart and Kirschner, 1984), suggesting that MPF is associated with the 
metaphase state. The discovery that MPF activity rises and falls in the meiotic and 
mitotic cell cycles of frog eggs strengthened the suggestion that MPF plays a key 
role in regulating the cell cycle. Further, experiments with enucleated oocytes 
proved that both the appearance of MPF and its disappearance during activation 
were purely cytoplasmic events independent of GV. 
Maturation Promotion Factor (MPF) is central to cell cycle regulation. 
During meiosis the activity of MPF increases sharply before germinal vesicle 
breakdown (GVBD), remains high throughout first metaphase, declines slightly 
during anaphase and telophase and increases again at metaphase II. After activation 
of the egg by the fertilizing sperm MPF activity falls to basal levels (Fulka et al., 
1992). High levels of MPF, seem to be needed around the time of sperm 
penetration in order to remove the sperm nuclear membrane (Peter et al., 1990) and 
the breakdown of sperm nuclear envelope is required for the formation of male 
pronucleus. Recently Naito et al. (1992) reported that a high Hi kinase (MPF) 
activity of pig oocyte at the end of in vitro maturation was followed by a high 
incidence of male pronuclear formation (73.5%) after in vitro fertilization as 
compared with that (10.6%) of oocytes with low-level activity. So the elevated level 
of MPF at the time of sperm entry plays an important role in the formation of the 
pronuclei while the subsequent decline of MPF allows the progression of the zygote 
into the G 1-phase of the first mitotic cell cycle. 
MPF has been identified as a complex of two sets of proteins, cyclins 
(Swenson et al., 1986; Labbe et al., 1989) and p34Cdc2  (Dunphy et al., 1988; 
Labbe et al., 1989). p34cdc2  is a protein kinase whose activity is measured by 
using exogenous histone Hi as a substrate. p34cdc2  is essential for the transition 
from Gi to S and G2 to M phase in the cell cycle. Activation of the p34cdC2  kinase 
requires cyclin (Murray et al., 1989), and the kinase activity of p34cdc2  cydin 
complexes is regulated by the phosphorylation state of both components (reviewed 
by Clarke and Karsenti, 1991). 
There are now known to be a number of proteins whose activity varies 
according to the phase of cell cycle. The first to be identified is cyclin. Cycin is a 
prominent protein of 56 kD, which accumulates until the first mitotic division and 
then disappear at the end of mitosis. This protein accumulates in the next interphase 
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and again disappear at mitosis. Because of its cyclic appearance, this protein was 
named as cyclin. In the late interphase, p34cdc 2  makes complex with cycin and at 
G2JM transition, dephosphorylation of the complex provides p34cdc2  with histone 
Hi kinase activity, generating active MPF. Similarly, p34cdc2  is kept in the 
dephosphorylated active form during metaphase II arrest in oocytes. The kinase 
activity of MPF is believed to trigger a cascade of reactions leading to nuclear 
envelope breakdown, chromosome condensation, spindle formation (reviewed by 
Lewin, 1990), and, thereby, entry into and maintenance of second meiotic arrest. 
In mouse as in most of other vertebrates, oocytes are arrested at the second 
meiotic metaphase by cytostatic factors (CSF) (Masui and Markert, 1971). CSF 
prevents ubiquitin-dependent degradation of mitotic cyclins and thus inactivation of 
MPF (Glotzer et al., 1991; Murray et al., 1989). Two components of CSF have 
been identified so far: Mos, the product of c-mos proto oncogene (Sagata et al., 
1989), and cycin dependent kinase 2 (Cdk2) (Gabrielli et at., 1993). The product 
of the oncogene mos is expressed early in oocyte maturation and disappears 
immediately after fertilization (Sagata et al., 1989; Watanabe et at., 1989). The Mos 
protein has the same effect as CSF in arresting mitosis at metaphase with high 
p34cdc2 activity. It is believed that CSF is, in part or entirely, Mos and the second 
meiotic arrest is due to the transcription of mos as the oocyte matures. Mos will 
also trigger frog oocyte maturation (Sagata et at., 1988). These observations 
suggest that it is Mos that need to be synthesized to take the oocyte through the 
G2IM transition (Minshull, 1993). However, in mouse oocytes that lack Mos, 
GVBD occurs normally (B. Maro, unpublished). Mos may be activating MAP 
kinase (Nebreda and Hunt, 1993). MAP kinase itself has CSF activity. MAP kinase 
is a serine / threonine kinase activated early in mitogenesis in response to growth 
factors (Thomas, 1992, Ruderman, 1993, Marshall, 1995). Originally called MAP 
kinase because it phosphorylated a MAP (microtubule-associated protein), it now 
represents mitogen-activated protein kinase. The study of Whitaker, (1996) 
indicates that MAP kinase is activated during oocyte maturation and that it regulate 
meiosis. In mouse oocytes it is activated at first meiosis, its activity remains high 
throughout oocyte maturation and during the second meiotic arrest at metaphase II 
(Kubiak et al., 1993). Its activity falls after fertilization during the first mitotic cycle 
as the pronucleus forms. In mouse oocytes, It has been suggested that MAP kinase 
is responsible for maintaining condensed chromatin and suppressing S phase during 
the second meiotic division, taking over from p34 2, the content of which 
decreases in the interval between meiosis I and meiosis H (Verlhac et at., 1994). 
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In general, the calcium signalling system is responsible for breaking meiotic 
arrest, although there are some exceptions. The fertilization calcium signal is 
sufficient to trigger release from the metaphase II block in mature oocytes. Mollusc 
and ascidian oocytes arrest in metaphase I and frog and mammalian oocytes pause 
in metaphase U. In all these oocytes, fertilization sets off a calcium transient that is 
the trigger that releases meiotic arrest (Igusa and Miyazaki, 1983; Busa and 
Nuccitelli, 1985; Speksnijder, 1992; Galione et at., 1993; Whitaker and Swann, 
1993). The Ca2 transients stimulated at fertilization continue until the formation of 
pronuclei in the one-cell mouse embryo (Jones et at., 1995). The fertilization 
calcium transient activates calmodulin, which activates CaMKinase II, which 
activates cyclin destruction and degradation of Mos (CSF). There are three points to 
note, however. First, no link has been established between CaMKinase and cycin 
destruction machinery. Second, cyclin content falls before Mos content declines 
(Watanabe et at., 1991; Lorca et at., 1993). Third, it is still unclear how the 
fertilizing sperm starts the Ce transient. 
Cyclin are destroyed by controlled proteolysis. They are tagged with 
ubiquitin and presented to the proteasome, a large multifunctional protease. Cyclins 
have their own ubiquitin-conjugating enzymes in oocytes (Hershko et at., 1994; 
King et al., 1995) and so the most regulatory pathway would involve activating 
these enzymes. However, the proteasome itself is also regulated and peaks of 
activity coincide spatially and temporally with mitosis in the ascidian oocyte 
(Kawahara et at., 1992). So the proteasome may also be a direct or indirect target of 
CaMKinase II (Whitaker, 1993). 
In Xenopus, cyclin has disappeared long before Mos, although the loss of 
both seems to be due to activation of CaMKinase (Lorca et at., 1993). Cyclin falls 
before Mos in mouse, too (Kubiak et at., 1993). The calcium transient seem to 
override the effect of Mos. Despite the fact that calcium increases explosively in the 
oocytes at fertilization, its effect are subtle and depend on the integrity of the mitotic 
spindle. This behaviour may be related to the fact that calmodulin and CaMKinase II 
are localized to mitotic (and presumably, meiotic) spindle. 
The calcium-calmodulin signalling pathway is a candidate for the role of 
controlling anaphase onset and cyclin destruction in both oocyte and somatic cells 
(Whitaker and Patel, 1990; Lorca et al., 1993; Lu and Means, 1993). One possible 
effect of Mos/MAP kinase may be to suppress the endogenous mechanism that 
generates Ca2 transient (Ciapa et at., 1994), forcing the oocyte to wait for large 
13 
C2 transient triggered by the sperm. It is also hypothesized that p34 2 activates 
the cyclin proteolysis pathway directly (Felix et at., 1990). 
Repeated calcium pulses are thought to be essential for normal development 
in mammalian oocytes (Ozil and Swann, 1995). There is correlation between p34c1c2 
activity and Ca2 oscillations in mouse oocytes. InsP 3 induces repetitive Ca"  
pulses in metaphase oocytes but only a single Ca 21  transient in oocytes when 
injected between meiosis I and II (Jones et at., 1995). The correlation between 
p34cdc2 and C2 oscillations may be explained by the observations of Kono et at., 
(1995), that transplanting an interphase nucleus from the zygote generates Ca 2 
oscillations in unfertilized mature oocytes. The Ca 2 transients begin when the 
nuclear envelope of the transplanted nucleus breaks down under the influence of the 
high p34cdc2  activity in the unfertilized oocytes. This may be due to the an oscillogen 
which is sequestered into the nucleus during interphase and is released when the 
nuclear envelope dissolves during mitosis. 
Oocytes arrested at both first and second meiotic metaphase all show a 
calcium wave at fertilization (Whitaker, 1996). The wave is carried across the egg 
by calcium-induced calcium release (CICR) mediated by InsP 3 (Galione et at., 
1993; Miyazaki et al., 1993) and ryanodine (Swann, 1992; Galione et al., 1993; 
Ayabe et al., 1995) receptors. 
Upon fertilization, a diffusible, activating messenger may pass from sperm 
to egg after sperm-egg fusion. It has not been identified and could be any, or a 
mixture, of InsP3 , calcium, cGMP and cADP ribose (Whitaker and Swann, 1993). 
Or it could be a protein. Swann, (1993) has identified a cytoplasmic protein found 
in the equatorial segment of the sperm head that will trigger Ca" transients when 
rnicroinjected into mature mouse and hamster oocytes. 
From the above review, it is concluded that oocytes need p34 2 activation 
to go into meiotic metaphase and p34cdc1  inactivation to procede through anaphase 
into the next cycle. They need Mos/MAP kinase activation to induce second meiotic 
arrest. But the connection at molecular level between Mos/MAP kinase and p34' th2 
is unclear. In mature oocytes, the evidence for calcium signal that breaks the second 
meiotic arrest is strong. Fertilization or artificial activation releases the oocyte from 
meiotic arrest by inactivation of MPF (Newport and Kirschner, 1984; Murray and 
Kirschner, 1989; Murray et at., 1989). Studies by Jaffe, (1983) and Berridge, 
(1993) shows that at fertilization, the sperm triggers a transient increase in the 
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cytoplasmic free Ca++  which inactivates both MPF and CSF in a reaction mediated 
by calmodulin-dependent protein kinase II (Lorca et al., 1993). This reaction first 
overcome the ability of CSF to prevent ubiquitin-dependent degradation of cycin 
and thus inactivates MPF. This is then followed by a slower disappearance of CSF 
(Lorca et al., 1991; Lorca et al., 1993). 
The purpose of this review is to gather informations regarding the role of 
cell cycle co-ordination in the development of embryos after nuclear transfer, 
particularly with reference to studies for DNA synthesis, chromatin structure and 
development after transferring of donor nuclei from different cell cycle stages of 
mouse preimplantation embryos including nuclei from some cultured cell lines. 
2.3-NUCLEAR-CYTOPLASMIC EFFECTS ON 
TRANSFERRED NUCLEUS 
Oocytes of amphibians and mammals represents particularly interesting 
experimental system for studying the behaviour of transfer nuclei. Following 
ovulation , mammalian oocytes remain blocked at the metaphase of second 
maturation division (metaphase II). Fertilization resumes the second meiotic 
division and the second polar body is extruded. This is followed by the 
decondensation of male and female chromatin and two pronuclei are formed. 
Shortly after the formation of pronuclei, DNA replication is initiated. 
The level of MPF activity during oocyte maturation is maximal at metaphase 
of both the first and second meiotic division. MPF level remained high during 
metaphase II arrest and then its activity declines rapidly upon fertilization or artificial 
activation . This indicates the different states of cytoplasmic environments when 
using Ivifi oocytes or pronuclear zygotes as cytoplast. Nuclei introduced into 
nonactivated (metaphase II) oocytes with high levels of MPF undergo premature 
chromosome condensation (PCC) and nuclear envelop breakdown (NEBD). The 
transplantation of interphase nucleus into an enucleated, metaphase II (MH) oocyte 
also results in premature chromosome condensation (PCC) in mouse (Czolowska et 
al., 1984, 1986; Balakier and Masui, 1986, Szollosi et al., 1988). In addition, PCC 
results in chromosome damage, the degree of which depends on the cell cycle stage 
of donor cell (Johnson and Rao, 1970; Collas et al., 1992a). It was reported by 
Schwartz et al., (1971) that PCC in 01 and G2 phases results in elongated 
chromosomes with single and double-stranded chromatids, respectively. S-phase 
chromatin, however, condenses less completely and displays extensive 
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fragmentation, a phenomenon also describes as 'pulverization". The extent of 
development of nuclear transfer embryos is also influenced by the position of donor 
nucleus in the cell cycle. Collas et al., (1992b) studied the influence of cell cycle 
stage of the donor nucleus on development of nuclear transfer rabbit embryos and 
reported that the transfer of nuclei in G1 into .Jffl cytoplasm yields high rates of 
development to blastocysts, whereas development is dramatically impaired with S-
phase nuclei. Therefore, the progress of donor nuclei in cell cycle reduces the 
development after transplantation into Ivifi cytoplasm, likely due to the deleterious 
effect of PCC. 
2.3.1-DNA SYNTHESIS IN RECONSTRUCTED 
EMBRYOS 
Donor and recipient cell cycle stage synchrony affects not only chromosome 
structure, but also the regulation .of DNA synthesis in cell hybrids (Johnson and 
Rao, 1970; Rao and Johnson, 1970). During a single cell cycle all chromosomal 
DNA must be replicated once and only once. Experiments in somatic cell hybrids 
(Roeper et al., 1977) and the Xenopus cell free system (Blow and Laskey, 1988) 
have shown that intact G2 nuclei are not induced to re-replicate when transferred to 
an S-phase cytoplasm . However, when the nuclear envelope is permeabilized, 
replicated nuclei undergo a second round of replication. The results of study by 
Campbell et at., (1993) showed that all nuclei, regardless of cell cycle stage, 
undergo DNA replication when transplanted into metaphase II (MIT) cytoplasts in 
which MPF activity was high. However, if the nuclei are transferred after the 
decline of MPF activity, when no NEBD occurred, then the replication was 
dependent upon the cell cycle stage of the transferred nucleus. Nuclei which were in 
GI and S-phase initiate or continued replication respectively, whilst those which 
were in G2 were not induced to re-replicate previously replicated DNA (Campbell et 
al., 1993). The results of this study suggests that when using lviii oocytes as 
cytoplasts, then only nuclei at GI phase of the cell cycle should be transferred. On 
the other hand when the nuclei are transferred after the decline of MPF activity then 
the chromosomal damage induced by PCC is avoided and all nuclei regardless of 
their cell cycle stage undergo co-ordinated DNA replication. 
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2.3.2- STAGE OF DEVELOPMENT OF DONOR CELL 
(KARYOPLAST) 
The development of embryos after nuclear transplantation depends upon the 
cleavage stage of development of the donor embryo, and difference in stages within 
the cell cycle of karyoplasts and cytoplasts. Smith et at., (1988) reported that the 
high incidence of development is observed when nuclei are transferred between 
embryos at exactly the same stage of development. However, when embryo 
reconstruction involves nuclear transfer between different stages of the same cell 
cycle or different cell cycles, a lower development of subsequent developmental 
success is achieved (Smith et at., 1988). Mouse one celled cytoplasts have an 
extremely limited capacity to support development when reconstituted with nuclei 
from embryos in the second or later cleavage cycles (Howlett et at., 1987). These 
studies suggest the need to regulate the cell cycle stage of both the donor and 
recipient and also the development stage of the donor. 
Across species comparison suggests that: 1) the developmental potential of 
reconstituted embryos is influenced by the stage of development of donor embryo 
and II) the latest stage of donor embryo that is consistent with development of the 
reconstituted oocytes of different species to term may coincide with the stage at 
which the transcription of the embryonic genome begins (Table: 2.1). During their 
growth phase, mammalian oocytes synthesize and accumulate protein and mRNA 
(Schultz, 1986). Following fertilization, there is a period of time in which 
transcription from the embryonic genome is essentially absent or very low and these 
proteins and mRNAs, which constitute the maternal contribution to early 
development, direct early development at least up to the time when the embryonic 
genome is activated; this time corresponds to the maternal to zygotic transition. 
Zygotic gene activation (ZGA) is involved in replacing maternal transcripts that are 
common to both the oocyte and embryo, as well as generating new transcripts that 
are unique to the developing embryos. The destruction of these maternal transcripts, 
which frequently initiates during oocyte maturation and continues up to the time of 
ZGA, can result in the loss of greater than 90% of many mRNAs (Schultz, 1993). 
The first cell cycle following fertilization appears to be exclusively regulated by the 
information provided in the maternal cytoplasm (Flach et al., 1982). Fertilization 
induces the synthesis of new proteins from the pool of maternal RNAs (Latham et 
at., 1991) together with post-translational modifications of existing maternal 
proteins (Braude et al., 1979; Howlett and Bolton, 1985; Beffier et at., 1997), and 
these events may be involved in the acquisition of transcriptional permissive state at 
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the G2 phase of the 1-cell embryo and during the minor phase of ZGA (Latham et 
at., 1992). However, no direct molecular has yet been found between maternal 
information and the ZGA (discussed in Forlani and Nicolas, 1996). 
The potential of donor nuclei to retain the ability to support development is 
longest in amphibians. In Xenopus, the transcription of zygotic genes is delayed 
until the mid-blastula transition at the 4,000-cell stage, whereas the potential is lost 
most rapidly in the mouse, a species in which acquisition of transcriptionally 
competent state occurs during the late 1-cell stage (Vemet et at., 1992; Latham et 
at., 1992; Ram and Schultz, 1993) and late 1-cell embryos are capable of 
synthesizing a paternally derived mRNA (Matsumoto et at., 1994). This is the stage 
at which the embryo first begins producing its own RNA, whereas previously the 
embryo relied on maternally produced transcripts (Newport and Kirschner, 1982b). 
The major transcription- dependent expression of endogenous genes begins in 2-cell 
embryos about 2 to 4 hours after completion of the first mitosis (concurrent with 
DNA replication) and then increases significantly 8 to 10 hours later during G2-
phase, concurrent with degradation of maternal RNA (see DePamphilis et at., 
1988). Expression of zygotic genes is controlled by a time-dependent mechanism 
(the "zygotic clock") that delays transcription-dependent gene expression until 
about 20 hours after fertilization, regardless of whether the 1-cell embryo has 
completed S-phase, entered mitosis, and cleaved into 2 cells (Conover et at., 1991; 
Manejwala et at., 1991; Wiekowski et at., 1991). 
Not all mammalian blastomeres are the same, however, and mammalian 
species differ greatly in the time of gene activation (ZGA) or time of transcription 
(Table: 2.1); which occurs early in mammalian development. The early start of 
transcription in mammalian species was thought to be a big barrier to clone 
mammalian species from the later developmental stages of the embryo and it was 
thought that cloning in mammalian species would not be successful despite some 
suggestions that it would work in Xenopus. 
In frog (Rana pipiens), the tale bud-stage is the latest developmental stage 
from which a tadpole has been produced by nuclear transfer of a somatic nucleus, 
whereas 40% of germ cell nuclei of this stage are still totipotent (Smith, 1965). 
LeSimple et al., (1987) obtained normal adults by nuclear transfer of germ cells 
isolated from larva of salamander (Pteurodeles wait ). In amphibians, germ cells 
seem to retain totipotency longer than the somatic differentiated cells (DiBerardino, 
1987). Later experiments with different mammalian species suggests that the loss of 
V. 
developmental potential (totipotency) of donor nuclei is not associated absolutely 
with the initiation of transcription, for normal development has occurred following 
nuclear transfer from cells that have progressed through the stage of activation of 
the embryonic genome, including inner cell mass (1CM) cells in ruminants and 
primordial germ cells in salamander (Smith and Wilmut, 1989 and LeSimple et al., 
1987). The transfer of nucleus from a donor cell that has initiated transcription 
results in the need to reprogram gene expression such that transcription ceases and 
is then re-initiated in a stage specific manner. Any change in the gene expression of 
a nucleus transferred into a different cytoplasmic environment is defined as 
reprogramming of its gene expression. Reprogramming may be complete or 
incomplete. Reprogramming of gene expression of the donor nuclei of early 
cleavage stages is effective in some species. The use of present nuclear transfer 
procedures seems to be less effective in inducing the reprogramming of gene 
expression of donor nuclei more advanced in differentiation and also a lower rate of 
development to term is observed. 
Table 2.1 








8- 16 cell 	8- 16 cell 	4000 
32-cell 	64-cell 	Tadpole 
intestinal 
epithelium 
A comparison between the stage of development at which 
transcription from the embryonic genome begins and the most 
advanced stage of development from which nuclei transferred to 
enucleated oocytes have been able to support development to 
adulthood. Data on nuclear transfer from Kono et al., 1991b; Collas and Robi, 
1991• Bondioli et al., 1990; Smith and Wilmut, 1989; Gurdon, 1986. Data on 
transcription from Bolton et al., 1984; Van Blerkom and Manes, 1974; King et al., 
1985, 1988; Camous et al., 1986; Calarco and McClaren, 1976; Newport and 
Kirschner, 1982. 
The transferred nuclei may be able to support normal development only if 
the nuclei are in an undifferentiated state or the donor cells are differentiated but the 
nuclei are amenable to reprogramming. So it is possible to produce totipotent nuclei 
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from many tissues. However, the plunpotential characteristics of embryonic stem 
(ES) cell have made them suitable candidates for future investigation. Cells are said 
to be totipotent when they are able to contribute to all the tissues of the conceptus 
including the placenta, whereas they are said to be pluripotent if they are able to 
contribute to all tissues of the fetus. Pluripotent embryonic stem (ES) cells or ES-
like cells have been derived from preimplantation embryos of several species, 
including mice (Evan and Kaufman, 1981; Martin, 1981), hamsters (Doetschman et 
at., 1988), cattle (Saito et al., 1992; Streichenko and Stice, 1994). ES cells also 
provide a large population of totipotent nuclei potentially useful for production of 
clonal offspring by nuclear transfer (First and Prather, 1991). The encouraging 
results with nuclear transfer of blastomeres and briefly cultured 1CM (Inner cell 
mass) cells in species other than mouse (Keefer et at., 1994; Sims and First, 1994; 
Stice et at., 1994) opens up the possibility of producing viable animals through 
nuclear transfer of ES cells that retains totipotential properties. 
2.3.3 - The recipient cell (cytoplast) 
The state of cytoplasmic differentiation at transplantation is a major 
determinant governing the integration of a transplanted nucleus into a host cytoplast. 
In nuclear transfer experiments variety of recipients cells (cytoplasts) of different 
stages of development have been used from oocytes at metaphase I through 
metaphase II to pronuclear zygotes and 2-cell embryos. Each recipient cell 
(cytoplast ) has advantages and disadvantages. The use of pronuclear zygote 
ensures the activation while on the other hand parthenogenetic activation is needed 
for the oocytes. The use of cleavage stage recipient cells is favoured in some species 
to the extent that reprogramming of gene expression is required. The 2-cell 
recipients are mainly used in mouse because transcription starts in this species at 
two cell stage (Tsunoda et at., 1987). Studies using nuclear transfer in mouse 
embryos have shown that the ability of a blastomere nucleus to support 
development to the blastocyst stage in vitro and to term depends on the stage of the 
recipient cytoplasm to which it is fused. Recipient cytoplasts from one and two-cell 
embryos were used and it was shown that, while nuclei from four and eight cell 
blastomeres could support development to the blastocyst stage (Robi et at., 1986) 
and on some occasions, to term (Tsunoda et al., 1987) when transferred to two cell 
stage cytoplasm, no development could be obtained after transplantation to the 
cytoplasm of one-cell enucleated zygotes (McGrath and Solter, 1984; Surani et at., 
1987; Smith et at., 1988). In livestock species the use of MIII oocytes have become 
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the method of choice because of technical difficulties and lack of development 
while using the pronuclear zygotes. 
After choosing the suitable recipient cell the enucleation of the chromosome 
material is done. Wiladsen (1986) described the procedure of enucleation by 
splitting the oocyte into two halves, one of which was likely to be enucleated. One 
of the major disadvantage was the reduction of the cytoplasmic volume of the 
oocyte which is believed to accelerate the pattern of differentiation of the new 
embryo (Evsikov et al., 1990). Smith and Wilmut, (1989) used different procedure 
to remove the chromosomes with minimum of cytoplasm. Aspiration of the 1st polar 
body and neighbouring cytoplasm removes the metaphase chromosomes in 67% of 
sheep oocyte. Now it has been proved that the use of DNA specific fluorochrome 
(Hoechst 33342) guaranteed the enucleation with minimum removal of cytoplasm 
(Tsunoda et al., 1988). Although these MU cytoplasts have the proven ability, after 
activation, to induce nuclear remodelling and full subsequent development of nuclei 
obtained even as late as seventh mitotic cycle from ovine and bovine blastocysts, 
nevertheless , it is possible that cytoplasts from early meiotic stages may be superior 
to those from matured eggs (DiBerardino et al., 1984). An alternate approach of 
non- invasive enucleation of the oocytes was used by some workers in mammals, 
whereas in amphibians, irradiation with ultraviolet light is used as a routine 
procedure (Gurdon, 1960). 
2.3.4 - Effects of cell cycle co-ordination on the 
development of reconstructed embryos 
The information gathered above about the effect of cell cycle co-ordination 
on development illustrates that the development after reconstruction is dependent on 
the cytoplasmic state of recipient cytoplasts. The transfer of nuclei at GI stage of 
development into IVifi oocyte cytoplasts at the time of activation, when the MPF 
level is high, gives maximum development compared to the donor nuclei in S or G2 
phase. All nuclei transferred at the time of activation when MPF levels are high, 
undergo nuclear envelope breakdown (NEBD) which is followed by premature 
chromosome condensation (PCC). The nuclear envelope is then reformed and DNA 
synthesis is observed in all nuclei. However, the results of different studies shows 
that in sheep the maximum development (61.3%) is observed (Campbell et al., 
1994) when donor nuclei in 5- phase are transplanted after the decline of MPF i.e. 
in early S-phase cytoplasts. It reduces to 45.7% when the donor nuclei were 
transferred in mid S-phase of the recipient cytoplasts. In cow the transfer of nuclei 
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at S-phase in MIT oocyte cytoplasts at the time of activation at high levels of MPF, 
only 1.25% embryos developed. Studies on development in rabbits by Collas et al., 
(1992) showed that maximum development (7 1%) occurs when the donor nuclei in 
G  stage of cell cycle are transferred in Mil cytoplasts at the time of activation. The 
results of the studies in mouse depicts the same trend of maximum development 
(77.8%) when the nuclei are transferred at Gi stage of development but when the 
donor nuclei are transferred at G2 stage of development in MIT cytoplast showed 
lower rate (20.8%) of development (Cheong et al., 1993). From the above results it 
may be predicted that the only nuclei which are in Gi would promote development 
when using lvii cytoplasts and therefore, the percentage of development reflects the 
percentage of blastomeres in the GI phase. This discrepancy in results also leads to 
another prediction that the recipient cytoplasm were not at Mi at the time of embryo 
reconstruction. 
2.3.5 - EVENTS AFTER NUCLEAR TRANSFER 
After the transfer of a donor nuclei to an enucleated, activated oocyte various 
changes occur to the transferred nucleus. These changes are characterized by a 
remodelling of the nucleus and can be observed as a swelling of the transferred 
nucleus (Gurdon, 1964). This remodelling presumably results in a reprogramming 
of the transferred nucleus such that it behaves developmentally as if it was a one 
celled zygote. 
2.3.5.1 - Nuclear Remodelling 
Nuclear remodelling is a process of changes that occur to a nucleus after 
transfer to an oocyte. These morphological and biochemical changes in the nuclear 
structure are thought to be a result cytoplasmic components from the oocyte acting 
upon the transferred nucleus that result in a reprogramming of genomic expression. 
2.3.5.1.1- Nuclear Remodelling in Amphibians and 
Mammals 
The morphological indication of nuclear remodelling is the disappearance of 
the nucleoli after transfer to an oocyte, as nucleoli are present in Xenopus larval 
stage nuclei, but not in early cleavage stages (Gurdon and Brown, 1965). Another 
indicator is the swelling of the transferred nucleus in amphibians (Gurdon and 
Brown, 1965) as well as in mammals (mouse: Czolowska et al., 1984; rabbit: Stice 
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and Rob!, 1988; pig: Prather et at., 1988) and is dependent upon the time of transfer 
in relation to the time of activation. Swelling does not occur if the recipient cell is an 
enucleated zygote, enucleated 2-cell stage blastomere (Barnes et al., 1987), or an 
enucleated germinal vesicle oocyte (Dettlaff et al., 1964). 
Nuclear remodelling may be the result of exchange of proteins between 
donor nuclei and cytoplasmic compartment. The exchange of protein between the 
nucleus and cytoplasm does not appear to be limited by the nuclear envelope, but by 
selective binding sites within the nucleus (Feldher and Pomerantz, 1978). Some 
proteins appear to migrate out of or into the nucleus at different rates than other. 
Simultaneously, cytoplasmic proteins, both basic and acidic, are acquired by the 
nucleus (Merriam, 1969; Guidon, 1986). This protein intake appears to be an 
inducer of the nuclear swelling and is not a consequence of nuclear swelling 
(Merriam, 1969). 
In amphibians and mammals changes in the distribution of nuclear antigen 
have been observed during early cleavage (Dreyer, 1987; Stricker et at., 1989). 
Changes are also observed in nuclear lamins. The A/C type of nuclear lamin 
becomes undetectable after the transition to zygotic control of development in the 
mouse, pig and cow (Schatten et al., 1985; Prather et at., 1989b). 
2.3.5.1.2 - Chromosomal Abnormalities 
Some of the chromosomal abnormalities which limit development are related to the 
regulation of DNA synthesis (DiBerardino, 1979) that appears to occur in the first 
cell cycle after nuclear transfer (DiBerardino and Hoffner, !970). Serial nuclear 
transfer reveals that these chromosomal abnormalities show stable developmental 
restrictions (Briggs et at., 1964; DiBerardino and King, 1965). One of the other 
changes observed is the reprogramming of the RNA synthesis. There are two 
approaches to illustrate this. One is by evaluating the localization of snRNA protein 
within the nucleus and the other is evaluating the nucleolar morphology. 
2.3.5.2 - DEVELOPMENT AFTER NUCLEAR TRANSFER 
Nuclear transplantation studies with mice and rat have shown that enucleated 
zygotes which receive nuclei from either late 2-cell or more advanced embryos 
exhibited limited preimplantation development (McGrath and Solter, 1984; Robl et 
al., 1986; Tsunoda et at., 1987 and Kono and Tsunoda, 1988). Transplantation of 
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single nuclei from a 4-cell mouse embryo into one of the enucleated blastomeres of 
a 2-cell resulted in the successful production of identical triplet mice (Kono et al., 
1991a), but it is difficult to produce live young by such nuclear transplantation 
between highly asynchronous embryos. Development to term after nuclear transfer 
was achieved in sheep (Willadsen, 1986), cattle (Prather et al., 1987) and rabbits 
(Stice and Robl, 1988). Although the mouse was the mammal species in which 
most of the early work was conducted, it appeared to be rather difficult to clone by 
nuclear transfer. Tsunoda et al., (1987) reported the development of fertile mice 
after transplantation of 8-cell stage nuclei into enucleated 2-cell blastomere. The 
development to term have also been reported when a enucleated oocyte in metaphase 
II stage was used as recipient from late two cell stage nuclei (Kono et al., 1991b) 
and early 8-cell nuclei (Cheong et al., 1993). The production of identical sextuplet 
mice by transferring metaphase nuclei from four-cell embryos have also been 
reported by Kwon and Kono, (1996) by serial nuclear transfer. 
Review of literature depicts very little information about the most advanced 
embryonic stage from which development after nuclear transfer could occur in 
mammals. Development to term has been reported from inner cell mass (1CM) 
nuclei in sheep (Smith and Wilmut, 1989) rabbit (Collas and Robi, 199 1) and cow 
(Collas and Barnes, 1994). There are a few reports of development to blastocysts 
by using the various types of cells as donor nuclei, but no report of development to 
term has been observed until recently. 
Moreover, development to blastocyst stage after nuclear transfer has been 
reported from thymocyte nuclei (Kono et al., 1991c) and embryonic stem cells 
(Tsunoda and Kono, 1993) in mouse; cumulus granulosa cells and primary foetal 
fibroblast in rabbit (cited by Collas and Barnes, 1994); and cumulus granulosa cells 
in cow (Collas and Barnes, 1994). Mouse primordial germ cells lead to implantation 
sites although no development to term (Tsunoda et al., 1989). However,- the recent 
study of Wakayama et al., (1998) has demonstrated the full term development of 
mice from enucleated oocytes injected with cumulus cell nuclei. 
The results of the nuclear transfer experiment suggests progressively 
restricted development after nuclear transfer for nuclei more and more 
developmentally advanced cells. The decline in the development to term may be 
related with the transcriptional activity at different stage of development of the 
different species. Surani et al., (1987) reported that the transcriptional activity of 
reconstituted embryos could affect the development of reconstituted embryo. In the 
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mouse the transcriptional activity of the embryonic genome occurs at the mid 2-cell 
stage (Piko and Clegg, 1982; and Bensaude et al., 1983) but the later reports have 
shown that it starts at the late 1-cell stage (Latham et al., 1992; Ram and Schultz, 
1993). Transferred nuclei from early 2-cell stage embryos have a greater 
developmental potential than nuclei derived from the late 2-cell stage embryos 
(Howlett et al., 1987). However, Smith et al., (1988) have reported better 
development following the transfer of late 2-cell nuclei after activation of embryonic 
genome. These conflicting results suggests that the transcriptional activity is not 
solely responsible for the development of reconstructed embryos. It is now believed 
that the cell cycle stage of the recipient cytoplasm and donor nuclei are critical for 
optimal development of the reconstituted embryos (Smith et al., 1988). 
Early development is controlled by product of maternal genome. These 
products, in the form of mRNA and protein are synthesized and stored within the 
oocyte during growth. The point during early development when genes unique to 
the embryos are first expressed is the maternal/zygotic transition (MZT; reviewed by 
Davidson, 1986; First and Barnes, 1989; Barnes and Eyestone, 1990). 
In mammals the effects of donor nuclei obtained beyond the time of the 
MZT on embryo cloning are mixed. Experiments with mouse, where enucleated 
pronuclear eggs were used as recipients demonstrated that only nuclei obtained 
around the time of the MZT (2 cell stage) resulted in significant development 
(McGrath and Solter, 1984; RobI et al., 1986). In addition to this , it has been 
postulated that development resulting from embryo cloning in mice is due to the 
overlap of developmental periods, (i.e. from the MZT to compaction). The 
transition of which may mark the irreversible points of commitment (Johnson, 
1981; RobI et al., 1986; Barnes et al., 1987; Howlett et al., 1987). Studies on 
embryo cloning of cattle and sheep suggest that the MI!' does not represent an 
irreversible barrier of commitment. In sheep and cattle the Ml!' occurs at the 8- to 
16-cell stage and 4- to 8-cell stage, respectively (Crosby et al., 1988; Camous et al., 
1986; King et al., 1989; Barnes and Eyestone, 1990). Nuclei from inner cell mass 
(1CM) cells of sheep, when transferred to meiosis II cytoplasm, result in substantial 
development to the blastocyst stage (Smith and Wilmut, 1989). In cattle the nuclei 
from 16- to 64-cell stage donor embryo result in blastocyst formation and are 
capable of resulting in offspring (Prather et al., 1987; Bondioli et al., 1990).The 
results of the above experiments demonstrate that the development to the blastocyst 
stage is not totally dependent on reprogramming. 
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There are two ways in which it may be possible to produced larger numbers 
of genetically identical calves : to repeat the transfer of nuclei from embryos derived 
by nuclear transfer or to use various cultured cell lines as donor cells. Serial transfer 
of nuclei which were themselves derived following nuclear transfer is progressively 
less efficient with each passage (Stice, 1992). The development of totipotent 
embryonic cell cultures has great value in producing genetically identical animals. 
One of the first differentiation events in mammalian embryonic development is the 
formation of two cell types, the trophectoderm (TE) and the inner cell mass (1CM). 
Historically, murine embryonic stem (ES) cell lines have been established from the 
inner cell mass (1CM) of blastocyst stage embryos by culture on feeder layers of 
embryonic fibroblast or buffalo rat liver cells. The ability to isolate embryonic cells 
directly from preimplantation mouse embryos and to maintain them in vitro has 
provided a powerful research tool. 
The production of cloned offspring in mammalian species by the transfer of 
nuclei from embryonic stem (ES) cells could provide a useful method for the 
production of large numbers of identical offspring. These cells have the ability to 
differentiate into a wide variety of cell types . They are able to produce all tissues of 
new individual (Nagy et al., 1993). Once isolated, ES cells may be grown in vitro 
for many generations. They produces an unlimited number of identical cells capable 
of developing into fully formed adult chimaeras (Evans and Kaufman, 1981; 
Martin, 1981; Bardley et al., 1984; Robertson, 1987). Now researchers are trying 
to prove the possibilities of embryonic stem (ES) cells as a source of donor nuclei 
for nuclear transfer. Kono et al., (199 1) reported that the mouse embryonic stem 
(ES) cells have the potential to support development to term with present 
procedures, as the cells of the inner cell mass (1CM) do not do so. At the present 
time, the isolation of pluripotent embryonic stem (ES) cells or ES-like cells have 
been derived from preimplantation embryos of several mammals, including mice 
(Evans and Kaufman, 1981; Martin, 1981), hamsters (Doetschman et al., 1988), 
pigs (Notarianni et al., 1990), cattle (Saito et al., 1992; Strelchenko and Stice, 
1994), mink (Sukoyan et al., 1992), rat (lannaccone et al., 1994) and rabbits 
(Graves and Moreadith, 1993). However, neither production of chimeric animals 
nor development to term following nuclear transfer has been shown except for 
mice. 
Primordial germ cells are another stem cell population that has attracted 
particular interest as nuclear donor. Although primordial germ cells in mammals 
acquire pluripotency or totipotency after gametogenesis or fertilization, it is still 
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unknown whether the cells have these characteristic before gametogenesis begins. 
Tsunoda et al., (1989) reported development from the enucleated unfertilized mouse 
oocytes receiving a single male germ cell into blastocysts, but live foetuses were not 
obtained after the transfer of reconstituted eggs into recipients. Observations on 
development after nuclear transfer suggest that primordial germ cells may be a 
suitable source of nuclei. In the mouse, 17% of manipulated eggs developed to 
blastocyst stage following transfer of nuclei to enucleated oocytes, and this 
proportion was increased to 62% by serial transfer from a two-cell egg to normal 
two-cell embryos (Tsunoda et al., 1989). As the methods of nuclear transfer are 
improved, it may be possible to increase these proportions. There is also the 
probability that in other mammals, primordial germ cells will prove to have a greater 
developmental potential, perhaps in species in which genome activation occurs later 
in development. Of the different cell types primary foetal fibroblast cells are another 
candidates which might be used as donor nuclei. 
2.3.5.2.1 - QUIESCENCE USE OF CULTURED CELLS 
In normal cell cycle, a new-born cell while starting out a normal 
prereplicative program begins activating genes and accumulating things which 
commit it to a round of chromosome replication when they reach critical levels. If 
the medium lacks essential factors or contains the transcription inhibitor actinomycin 
D or a protein synthesis inhibitor such as cycloheximide at the time of cell birth, the 
cell cannot accumulate enough components to reach this critical commitment point, 
the so-called restriction point. If the cell is caught before the restriction point, it will 
stop advancing toward the S phase and, bearing marks of its aborted Gl transit, it 
will "park" itself indefinitely in a so-called GO state. This parking state in cell cycle 
is also said to be the GO state of quiescence. This state could occur in cultured cell 
from Gi phase into a quiescent Go state by lack of serum or a critical nutrient. 
The knowledge about different cell lines suggests that most of the cells have 
very short GI and G2 with long S phase. The reduced development or no 
development may be due to the reason that they have already initiated replication 
when transferred into cytoplast. This is confirmed by the results that the donor 
nuclei in Gi phase gives maximum development after nuclear transfer. In the same 
way the study with different cell type i.e. pluripotent embryonic stem (ES) cell have 
showed that the development to blastocysts is possible from ES or ES-like cells in 
different species of livestock but the development to term is still restricted. The 
restricted development by the use of the cells of different cell lines may due to their 
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long S phase. As discussed earlier that the cells in GI can be aborted from the 
normal cell cycle and go to GO state of quiescence, could be used as donor nuclei 
and may support development to term. 
From the information about the transition of G  phase of the cell into GO 
state of quiescence, it is hypothesized that the ES or ES-like cells can enter into GO 
state of quiescence and that can stay there without differentiation. The birth of sheep 
(Dolly) from the quiescent population of cultured cell make it possible to produce 
large number of cloned animals (Campbell et al., 1996). This technique of 
quiescence could provide greater opportunity for the use of cultured cell population 
as donor nuclei for embryo reconstruction by nuclear transplantation in mice. 
CHAPTER 3 
GENERAL MATERIALS AND METHODS 
All the experimental work described in this thesis have been conducted in 
murine preimplantation embryos and oocytes. The general facilities, animals, and 
methodology commonly used in most of the experiment during the project are 
described in this chapter. More details and specific methodology have been provided 
in each of the experimental chapters. The composition of different media, their 
modifications and the procedures followed in their preparation are described in 
appendix 1 (section 1.1 to 1.6). Moreover, the details of stock solutions of chemical 
compounds and antibodies used in this project have been shown in the appendix 
l(section 1.7.1 to 1.7.10). 
3.1-GENERAL MANIPULATION FACILITIES 
All the experimental studies on oocytes or embryo manipulation were 
conducted at the Roslin Institute. The basic equipment in this laboratory included: a 
humidified, 5 % CO2 in air incubator (Flow Laboratories, Rickmansworth, 
Hertfordshire, UK) set a 37 °C; a binocular, dissecting microscope with transmitted 
light illumination system (magnification: X12.5-X80; M3Z, Wild) fitted with 
homemade heated stage for embryo handling and an embryo micromanipulator 
system (see section 3.4.3). 
The sterile disposable plastic ware was mostly used as culturing material. 
The 60 mm (Costar corporation, Cambridge USA) petri dishes were utilized 
through out these experiments. The Gilson Pipetman digital pipettes (Scotlab Ltd. 
Strathclyde, UK) with the adjustable volume, with the capacity of 10 p1 , 20 p1, 200 
p1 and 1000 p1 and universal fit tips (Laser, Laboratory systems Ltd., Southampton 
UK) were used for microvolume measurements of the stock solutions and media. 
Also 30 ml universal tubes (Sterilin, Bibby Sterilin Ltd., Stone, Staffs, UK) and 
1.5 ml Eppendorfs tubes (Sterilin, Bibby Sterilin Ltd., Stone, Staffs, UK) were 
used for storing the stock solutions, media and drugs. The embryological watch 
glass dishes were used. They were thoroughly cleaned and rinsed with water, dried 
and kept in dust free conditions. 
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3.2 IN VITRO CULTURE OF MOUSE 
EMBRYOS. 
3.2.1 - In Vitro Culture Of Embryos. 
The in vitro culture system consisted of a 5% CO2 - 95% air atmosphere 
incubator and a microdrop culture system was set up with a modified M16 medium 
(Whittingham, 1971) in 60 mm disposable plastic dishes. The microdrops of the 
medium (35-40 .tl) were dispensed on the bottom of the Petri dish and then covered 
with paraffin oil (Merck Ltd. Poole, Dorset, UK). The culture dishes were 
incubated 2-3 hours prior to the transfer of embryos into the drops to equilibrate the 
temperature and CO2. 
In the start of this project, M16 was used for the culture of embryos. But 
later on a modified M16 medium i.e. pM16 was used (PJ Otaegui, unpublished 
data, Ph.D. thesis). The pM16 medium was further modified by including L-
glutamine and essential and non-essential amino acids and designated as sMl6 (see 
appendix 1 section 1.1). The embryos cultured in this medium showed no cell block 
at 2-cell stage and reaches to blastocyst stage earlier (S, Ali, data not presented) The 
osmolarity of the modified medium used was around 260 mOsms. The sM16 
medium was used in most of the experiments reported in this thesis. 
A stock solution of the specific compound was made (see appendix section) 
and supplemented with the medium (sM16) 2-3 hours prior to the start of the 
experiment. This supplemented medium was then used to set up the microdrop 
culture and equilibrated for temperature and CO 2 . 
The stock solutions of all the chemicals required for the preparation of media 
(sMl6) were prepared and stored at 4 °C. It was convenient to prepare concentrated 
stock of the component of sM16 (see appendix 1 section 1.3). The bovine serum 
albumin (BSA) was dissolved at the rate of 4% in the end while preparing the sM16 
media from the concentrated stocks. The media were sterilized by pushing it through 
Acrodisc syringe filters of 0.2 gm pore size (Product No. 4652 Gelman Science, 
Ann Arbor, Michigan, USA), aliquoted and stored at 4°C. The first 5 to 10 ml of 
sterilized media were discharged to avoid toxicity effects from the filter (Harrison et 
al., 1990). Each aliquot was used once to minimize the chances of contamination. 
The media were prepared every week from the concentrated stocks and the stock 
solution were refreshed according to the requirements of their sheiflife. 
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3.2.2 - Handling of the Embryos 
The M2, an HEPES buffered medium M2 (Whittingham and Wales, 1969) 
was used during the recovery of embryos and manipulations procedures. The M2 
medium was prepared freshly every week from the concentrated stock solutions (see 
appendix 1 section 1.4 ). It was sterilized through filtration by using the syringe 
filters and stored in 30 ml universals at 4 °C. The media was equilibrated for room 
temperature before use. The embryos were washed 2-3 times with M2 medium into 
an embryological watch glass dishes at room temperature. The microdrops of M2 
media was also used to store the embryos at 4 °C in the refrigerator. 
3.3-PRODUCTION OF OOCYTES AND 
EMBRYOS 
3.3.1 - Animal Management. 
The animals were housed in a small animal unit (S.A.U.) where the 
computerized system had been installed to control the internal environments. The F 1 
females (C57BL/6 x CBA/Ca) were used to recover the oocytes but the embryos 
were recovered from Fl females (C57BL/6 x CBA/Ca) mated to Fl (C57BL16 x 
CBA/Ca) males. 
The photoperiod of 12 hours (08:00 hr to 20:00 hr) light and 12 hours dark (20:00 
hr to 08:00) was practiced under this project to recover the oocytes in the morning 
and to perform the experiments during day time. 
There were 20 air changes per hour. The temperature in the small animal 
unit was maintained at 21 °C ± 2°C and air humidity was kept at 50 % ± 5%. There 
were 20 air changes per hour. The health status of the colony of the animals was 
being specific pathogen free (SPF). They were Staphylococcus aureus positive (an 
human comensal bacteria). The animals had "ad libitum" access to food and water. 
3.3.2 - Superovulation Regime for the production of oocyte 
and embryos. 
To superovulate the mice, two types of hormones were used: the pregnant 
mare's serum gonadotrophin hormone (eCG, Folligon; Intervet) to increase 
ovulatory follicle number and human chorionic gonadotrophin (hCG, Chorulon; 
Intervet) to induce the ovulation. The lyophilized powders of pregnant mare's serum 
gonadotrophin hormone (eCG) and human chorionic gonadotrophin (hCG) were 
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dissolved in sterile molecular water and a concentration of 50 ITJ/ml was achieved. 
The solutions were then aliquoted, stored at - 20 °C and used within two months. 
Four to seven weeks old Fl females were superovulated and used as oocyte 
and embryo donor. Superovulation was induced by intraperitoneal injection of five 
IU of eCG at 20.00 hours, followed by 48 hours later (20.00 hours) five IU of 
hCG injection . When embryos were required, F1 females were mated with F1 
males of the same strain immediately after hCG injection and copulation plugs were 
checked on the following morning. 
3.3.3 - Harvesting of embryos and oocytes. 
The females were killed by cervical dislocation a few minutes prior to 
embryo recovery. The females were laid on their backs on absorbent tissues and 
soaked thoroughly with 70 % ethanol, to reduce the risk of contamination during 
dissection from mouse hair. By holding the abdominal skin firmly upward with the 
forceps, a small cut was made in the midline. By grasping firmly, the both sides of 
the abdominal skin was pulled toward the head and tail until the abdomen was 
completely exposed and the fur was well out of the way. The body walls were then 
cut by using forceps and fine scissors. The coils of the intestines were pushed aside 
to locate the horns of the uterus, the oviducts and the ovaries. 
Ovulated oocytes and early preimplantation embryos were recovered from 
the oviducts. The uterine horns were gently lifted with small forceps away from the 
abdominal cavity and a hole was made in the mesometrium with the tip of a fine 
scissors. The mesometrium was dissected away from the uterine horn, oviduct, 
ovary and fat pad and the oviducts were recovered by applying cut between ovary 
and uterine horn. 
The oviducts were placed in a embryological watch glass containing embryo 
M2 medium at room temperature and transferred to the dissecting microscope under 
low magnification. The embryos were recovered by tearing the near by walls of the 
oviduct where the embryos were located and by gently squeezing the oviduct. 
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Tip of pipette closed from 150 to approx 20 pm. 
Fig 3.2 A diagrammatic representation of an enucleation pipette 




3.4-MICROMANIPULATION OF EMBRYOS 
AND OOCYTES. 
3.4.1 - Preparation of Micro-Tools 
3.4.1.1 - Holding pipettes 
The holding pipettes were prepared by rolling a 10 mm long capillary tube 
(external diameter 1.0 mm; GC100-10, Clark Electromedical Instruments, Reading, 
UK) uniformly over a microburner flame and pulled by hand over a length of 5 to 8 
cm with an external diameter of about 100 Jim. The pulled capillary was mounted 
onto a microforge (MF1-microforge, Research Instruments Ltd. UK) and the first 
bend was made close to the start of the pulled part of the pipette at an angle of 450 
(see fig 3.2) . The second bend was made approximately 1 cm from the first bend, 
making it parallel to the rest of the capillary. The third bend was created 2 cm away 
from the second bend and fourth very near to the third bend. All these bends were 
made by placing the capillary near the hot glass drop bead without touching it, in 
such a way that the heat would melt only the nearest side of the tube wall causing it 
to bend 450  downwards. The tip of the pipette was then cut flat by using the 
diamond pencil to mark the glass 2 mm from the final bend. The flat tip was then 
heat-polished, leaving an opening of approximately 20 p.m diameter. 
3.4.1.2 - Enucleation pipettes. 
The enucleation pipettes were prepared by pulling thin-walled, 1.0 mm 
diameter glass capillary tubes (GC100T-15; Clark Electromedical Instruments, 
Reading, UK) using the moving coil microelectrode horizontal pipette puller (753 
Micropipette Puller, Campden Instruments Ltd., UK). The settings of 
Microelectrode pipette Puller were adjusted to give an initial taper, which reduces 
the diameter of the capillary to slightly greater than the diameter required, with the 
second taper being almost parallel. The capillary was mounted on the microforge 
and the tip of the needle was then broken at right angles to an outside diameter of 15 
to 20 jim, according to the intended use. A particular point of the needle with 
required diameter (determined by a graticular eyepiece) was placed near to the glass 
bead on the platinum wire heating filament. The capillary needle was brought into 
contact with slightly heated glass bead of the microforge resulting into fusion 
together. The filament of the microforge was switched off simultaneously and the 
spring-loaded connecting rod, holding the filament, was depressed causing the 
capillary to break at the point of contact with the glass bead. 
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Fig 3.3 Diagrammatic representation of micromanipulation chamber 
lei 
a) positioning of oocytes/embryos to be enucleated b) position of the enucleated 
oocytes or reconstructed embryos in the chamber c) glass support d) coverslip e) 
paraffin oil f) sliconised glass slide g) holding pipette h) enucleation pipette. 
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The tip of the pipette was then beveled to a 450 angle by positioning it on the 
beveller, built in the workshop of Roslin Institute with 1 micron Aluminum Oxide 
grading surface by passing a continuous flow of air through it, using a 50 ml 
syringe and a length of tubing (fig 3.2). The continuous air flow was applied to 
prevent dirt from entering into the pipette as it was ground. After bevelling, the tip 
was thinned and polished by rinsing with dilute 20%, v/v) hydrofluoric acid 
(Aldrich, USA) for 20-25 seconds by blowing continuos flow of air through it. The 
tip of the capillary needle was rinsed again with distilled water and then with 95% 
(v/v) ethanol. The bevelled capillary was then placed on to the microforge and a 
small point was pulled on the leading edge of the bevel. This was done by touching 
the tip of the pipette to the glass bead which was slightly heated to fuse the bead 
with the tip of the pipette and then drawing the pipette away to from a spike. If the 
tip was too long after being drawn out, the excess length was broken off to leave the 
shorter tip, suitable to pierce the zona pellucida without damaging the cytoplasmic 
membrane. 
The enucleation pipettes were siliconised to prevent cellular contents from 
adhering to the pipette tip during manipulation. The pipette was connected to an 
empty 60 ml syringe and the tip of the pipette was dipped into a silicone solution 
(Sigmacotè Sigma cat no. SL-2) to drawn it up and down 2-3 times. The pipettes 
after siliconization were placed overnight in an oven at 80 C ° for drying. 
3.4.2 - Micromanipulation Chamber. 
The good quality glass slides were washed thoroughly with Decon 
detergent, rinsed at least five times in distilled water and dried overnight in an hot air 
oven. They were sliconised by dipping in "Sigmacote" (Sigma) and drying in oven. 
The micromanipulation chamber was made from a siliconised slide to which two 
rectangular glass supports (20 x 3 x 2 mm) were fixed by applying a line of a 
mixture of 5% sterile wax in Vaseline approximately 2.5 cm in length along both 
edges of the upper surface. The wax mixture was also applied on the top of each 
glass support. The micromanipulation medium was pipetted in the center of the slide 
(300 pJ) in such a way that it was touching both glass supports and a cleaned 
coverslip was placed onto the mixture. The coverslip was pushed down to make a 
water-tight seal. In the end the both sides of the chamber were filled with paraffin 
oil to seal the chamber medium (see fig 3.3). 
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3.4.3 - Micromanipulator Assembly. 
The micromampulator system consist of an inverted microscope 
(magnification up to x400; Diaphot-TMD; Nikon UK Ltd., UK) with condenser and 
objectives for differential interference contrast (Normarski optics); two 
micromampulators (Micromanipulators M; E. Leitz Ltd., UK) with coaxial coarse 
and fine adjustment, tilting top and control for transverse and sagital movement and 
hydraulic system. 
The micromanipulators were raised from the base to the level of the 
microscope stage on either side of the microscope. Each micromanipulator had 
double or single unit instrument holders which held micro tools-holders for the 
micro pipettes. The hydraulic system was controlled by 3x Narishige (IM-188) 
microinjectors that are modified to accept gas-tight micrometer syringes (Agla 
Micrometer Syringe Kit, Welcome Reagents Ltd., UK) which were connected 
through flexible polythene tubing (mod. 21.852-0062; Bel-art Products, UK) to the 
instrument tubes. The whole of the hydraulic system was filled with an inert mineral 
oil (Fluorinert 77, Sigma, cat no. F 4758 UK). 
The holding pipettes were held in the left-hand manipulator, with its 
corresponding micrometer syringes situated on the right-hand side. The reverse 
arrangement was made for the enucleation pipette and its micrometer syringe. 
Before fixing the pipettes into the respective microtool-holders, the tubing was 
purged of air bubbles using a 20 ml syringe filled with Fluorinert, which was 
connected into the hydraulic line via a three-way tap. The pipettes were locked into 
the tool holders and using the reservoir syringes, each pipette was filled with 
Fluorinert. The pipettes were aligned parallel to each other and their tips introduced 
into the manipulation chamber. Medium from the chamber was then drawn a short 
distance into the pipettes using the microsyringes. 
3.4.4 - Micromampulation Procedures. 
3.4.4.1 - Preparation and enucleation of oocytes. 
The oocytes after their recovery from the oviduct were denuded from the 
cumulus cells prior to the start of manipulation procedures. The cumulus cells of the 
oocytes were removed by exposing the oocytes to M2 media containing 
hyaluronidase (300 j.tgIml) for about 5 mm. at room temperature with continuous 
pipetting. The oocytes were then separated from the cumulus cells and washed with 
M2 medium 2-3 times in embryological watch glass dishes. The oocytes were kept 
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Fig: 3.4 - Micromanipulation Procedures 
- holding the oocyte using holding pipette 
- recognition of metaphase plate using UV light 
- gently inserting the enucleation pipette into the oocyte 
- suction of metaphase chromosomes 
- removal of cytoplasm containing metaphase chromosomes from the 
enucleation pipette 
- reconstructed embryo by placing donor nuclei inside the perivitelline space 
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under paraffin oil at room temperature till their use for micromanipulation or some 
other treatments. 
Before the start of enucleation procedure, the oocytes were incubated with 
Hoechst 33342 (0.8 jig/ml) in M2 for 5-6 minutes at room temperature. The oocytes 
were then washed with medium M2 and placed inside the micromanipulation 
chamber. The oocytes were placed in groups (10-1 5)before enucleation and the 
enucleation procedure was performed in the center of the chamber. The oocytes after 
enucleation were placed in the upper right corner of the chamber. The chamber 
medium was consisted of M2 medium supplemented with 10 jig/ml of Cytochalasin 
B, a microfilament inhibitor, which gave elasticity to the cytoskeleton to facilitate 
micromanipulation. Moreover, it also includes 10% FCS to minimize stickiness 
inside the enucleation pipette. 
The oocyte picked up with the holding pipette, was positioned in the center 
of the chamber by moving the chamber. After recognizing the position of metaphase 
complex inside the oocyte by flushing the UV light at x 400 magnification, the 
enucleation pipette was introduced through the zona pellucida and the metaphase 
complex was aspirated into the enucleation pipette. It was possible to identify a 
clearer, non granular zone inside the cytoplasm that would reveal a circular structure 
when pushed gently with the enucleation pipette and enucleation could be performed 
without using the UV light. As the pipette was withdrawn from the oocyte, there 
was a formation of bridge extending between the aspirated cytoplast within the 
pipette and the enucleated oocytes within the zona pellucida. This bridge would 
stretch to a fine thread, pinch off and reseal. After enucleation, the enucleation 
pipette was exposed to the ultraviolet (UV) light for one or two seconds to confirm 
the aspiration of metaphase II complex of the oocyte.(see Micromanipulation 
procedures Fig. 3.4). The study of Tsunoda et at., (1988) demonstrate that the 
cytoplasm of mouse zygote is more resistant to UV irradiation after Hoechst 
staining. Eggs at the second metaphase, from which chromosomes have been 
removed under a fluorescence microscope, can be used as cytoplasm recipients for 
nuclear transplantation of inner cell mass nuclei. In bovine nuclear transfer 
embryos, no detrimental effects of short-term UV exposure and Hoechst dye on the 
development was observed (Betthauser et al., 1993). 
3.4.4.2 - Nuclear Transfer 
All nuclear transfer procedures were performed in the micromanipulation 
chamber. The M2 medium supplemented with inhibitors of both microfilament 
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(Cytochalasin B 10 pg/m1) and microtubule (nocodazole 10pM) polymerization and 
10% FCS was used as chamber medium. The nuclear donor embryos were placed in 
the chamber and nuclear transfer was started 5-10 minutes later after achieving the 
elasticity of the cytoskeleton due to presence of drugs in the chamber. 
The nuclear donor embryos were picked up by holding pipette and were 
positioned tightly by increasing the negative pressure. The enucleation pipette was 
then introduced through the zona pellucida and positioned adjacent to the nucleus to be 
removed. The karyoplast with small amount of cytoplasm surrounded by the cellular 
membrane was then gently sucked inside the enucleation pipette by increasing the 
negative pressure. By moving the pipette outside the zona a complete separation of the 
karyoplast was achieved through the formation, break and reseal of a cytoplasmic 
bridge. 
In Sendai virus mediated fusion, the enucleation pipette was then moved to 
a 5 tl drop of the viral solution near to the main drop of the chamber medium. After 
picking up the small amount of viral suspension in the enucleation pipette, the 
enucleation pipette was moved back into the chamber. 
The slide was then moved to focus the previously enucleated oocytes. The 
cytoplast was then oriented to the previous hole by repeated pushing and picking up 
moves with the holding pipette. This pipette was then introduced inside the 
perivitelline space of the cytoplast and a karyoplast was carefully placed. The 
reconstituted embryos were then washed twice with M2 and shifted into the 
microdrops of M16 at 37°C in the incubator. 
3.4.4.3 - Fusion Procedure 
3.4.4.3.1- Sendai Mediated Fusion 
In most of the experiments unless otherwise mentioned in this thesis, The 
fusion between the transferred karyoplast and the recipient cytoplast was Sendai 
virus mediated. The karyoplast with small amount of inactivated Sendai virus 
suspension was expelled inside the perivitelline space of the zona pellucida of the 
recipient cytoplast for fusion which occurred within 30 minutes at 37°C. 
3.4.4.3.2- Electrofusion of mouse embryos 
Experiment were also performed using Electrofusion technique of fusing 
karyoplast and recipient cytoplast. This was achieved by homemade pulse 
generator. The parameters were set according to information provided by Kubiak 
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and Tarkowski (1985) and J-P. Renard of the Pasteur Institute, Paris, France. The 
pulse generator was capable of producing an AC pulse up to 5 V for 20 sec 
followed by also DC pulse up to 4 pulses of 10-200 Isec duration's and range of 
0.25 to 2.0 kV/cm when it was used, fusion chamber consisting of two electrodes 
of 200 .Im apart. A homemade fusion chamber was used in fusing the couplets. The 
fusion chamber consisted of two platinum wire electrodes of 100 .tm diameter fixed 
parallel and 200 pm apart with glue to the bottom of a 4.5-cm glass pertri dish. The 
couplets were fused by first washing them with 500 Jil of 0.3 M mannitol solution. 
About 200 j.il mannitol solution was placed in the fusion chamber, spanning the 
electrodes and the couplets were placed in the fusion medium at one side. Each 
couplet was then placed between the electrodes and the plane of contact between the 
cytoplast and the karyoplast was oriented parallel to the electrodes with the help of 
the pipette. A 3V of 5 sec duration AC current was also applied to help in alignment 
of the couplet and the fusion was achieved by the following a single pulse of 1.5 
ky/cm DC current of 100 jisec duration. 
3.4.4.4 - Activation. 
3.4.4.4.1- Strontium Activation Media 
In most of the experiments Ca 2 and Mg free strontium activation media was 
used. The recipient cytoplasts and fused couplets were activated by using the 25 
mIVI strontium chloride in Ca +2  and Mg free M16 (Otaegui et al., 1994). The 
strontium chloride stock solution was made by dissolving 0.452 g/lOml of 
strontium chloride in distilled, deionised water. The final concentration of 25 mM 
was achieved by adding 3.67 ml of stock solution to the calcium magnesium free 
M16. Different stock solutions were mixed in a manner that stock B was added last 
to avoid any precipitation of salts and the final calibration of 25 ml was achieved by 
adding cold molecular water at 4°C. (see Appendix 1 table: 1.4). 
In later experiments discussed in chapter 5, different activation protocols 
were used for activating the recipient cytoplasts. The protocol involved the use of 
lonomycin and 6-Dimethylaminopurine. 
3.4.4.4.2- lonomycin Activation Media 
The recipient oocytes were artificially activated by exposing them to 5.0 pM 
concentration of lonomycin in M2 medium for 5-6 mm. The stock solution of 
lonomycin calcium salt (Sigma) was prepared by dissolving ling of lonomycin 
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calcium salt with DMSO to the concentration of 1.0 mM (see Appendix 1 section 
1.7.8). 
3.4.4.4.3 - 6-Dimethylaminopurine (DMAP) treatment. 
The oocytes were subsequently exposed to 6-Dimethylaminopurine 
(DMAP), the protein kinase inhibitor. A stock solution of 6-dimethylaminopurine 
(Sigma) was prepared by dissolving with the distilled, deionised water and 20 pJ 
aliquots were made containing 2.5 mM DMAP (see Appendix section 1.7.5). This 
solution was diluted with M16 or strontium activation media depending upon the 
type of treatment and the final concentration of 2.5mMlrril or 2.0 mM/mi was 
achieved. 
3.5 - PREPARATION OF THE INACTIVATED 
SENDAI VIRUS SOLUTION. 
The viral stock which produce growth in the embryonated chicken egg was a 
generous gift from Dr. Bill Christie (MRC, Edinburgh). The results obtained are 
described below together with methodology, which was based on Giles and Ruddle 
(1976) with slight modifications. 
Seven day embryonated pathogen-free chicken eggs were candled and the top 
of the air space was marked with an arrow indicating the position of the embryo. A 
horizontal line approximately 5 mm long was marked at the level of inner shell 
membrane, which delimits the bottom of the air space, on the side of the egg 
opposite the embryo. The second mark was placed in a position to avoid injecting 
virus into the yolk sac, if the yolk sac rises close to the level of inner shell 
membrane. The eggs which appeared to be infertile during candling were discarded 
and the fertilized ones were grouped into batches of 5 for inoculation into the 
allantoic cavity opposite to the embryo. The eggs were surface-sterilized by two 
washes with 70% ethanol after complete drying of each wash. Using a sterile 
dissecting needle as a punch and scalpel handle as a hammer, two small holes were 
made, one at the point of arrow over the air space (vent hole) and the other at a point 
2 to 3 mm above the horizontal line (site of injection). Six groups were injected with 
0.2 ml of a iO dilution of the infected allantoic fluid in Hank's Balanced Salt 
Solution (HBSS). Two groups were used as the control, one injected with HBSS 
alone and the other without any injection. The site of injection and the vent hole 
were sealed with small pieces of selotape. The injected eggs, eggs injected with 
HBSS only and uninjected control were incubated at 35.5 0C in the moist chamber 
for 72 hours and turned three times a day. 
At the end of incubation period all the eggs were candled again and any egg 
have dead embryo or any other abnormality was discarded. The eggs were placed in 
the cold room at 4 0C overnight to reduce the bleeding at harvesting procedure and 
also to kill the embryos. The surface of the eggs were sterilized and the inner shell 
membrane was exposed by cutting the shell above the air space with sharp scissors. 
Allantoic fluid (5 to 10 ml per egg) was aspirated by inserting a sterile syringe with 
1.5 inch 18-gauge needle through the inner shell membrane into the allantois. At this 
point all necessary precautions were adapted to avoid getting virus into the air. 
The allantoic fluid from the controls and the infected eggs was collected 
separately in sterile bottles and the titer or the haemagglutination activity was 
determined by an assay based on the Salk pattern method (see Cassals, 1967). A 
packed cell volume of 0.5 ml of chick red blood cells was washed twice in 10 ml 
aliquots of HBSS and resuspended in 100 ml of HBSS which was used throughout 
as the diluent. Serially increasing 2-fold dilution's were made in a tray (96 V shape 
wells; Sterilin, Bibby Sterilin Ltd., Stone, Staffs, UK) from an initial 1:10 dilution 
of allantoic fluid. To each 0.1 ml dilution, 0.1 ml of red blood cells suspension was 
added and mixed in each well. The tray was covered with Saran wrap and incubated 
for 2 hours at 4 0C. A negative agglutination reaction was indicated by a "button 
pattern", a diffuse or continuous sheath of red blood cells covering most of the 
wells. The virus titer was determined by highest dilution giving complete 
agglutination. The dilution was said to contain 1 haemagglutination unit (HAU) in 
the volume used (Cassals, 1967). The harvested allantoic fluid produced a titer of 
12800 HAU/ml while the control had no titer. 
The allantoic fluid from the injected eggs was centrifuged at 2000 X g in a 
refrigerated centrifuge for 20 mm. The supernatant was aspirated and saved and the 
pellet discarded. The supernatant was centrifuged in an ultracentrifuge at 16000 X g 
with zero deceleration for 1 hours. The supernatant was completely removed and 
discarded. The pellets from all the centrifuged tubes were broken up with a glass 
rod having a rounded fire-polished end, and the material was worked into a paste-
like consistency without lumps by adding small amounts of 1% bovine serum 
albumin (BSA) in HBSS without glucose (HBSS-G). The paste was resuspended 
in 1% BSA in HBSS-G to the volume one tenth of the starting volume, without 
atomizing the virus. This was achieved by expelling the suspension 8 to 10 times 
through the 25-gauge needle. BSA at this point was added to reduce the loss of 
HAU which may occur during inactivation (Kiebe et al, 1970) or low temperature 
storage (Neff and Enders, 1967). The virus suspension was centrifuged at 2000 X 
g for 20 minutes and transferred to a sterile bottle. At this stage the titer of the 
suspension was 102400 HAU/ml. 
A chemical method of inactivation was chosen, using 13-propiolactone (BPL; 
Sigma, UK) which destroys the viral RNA. The procedure was carried out at 40C 
with all solution kept on ice and pipettes equilibrated to the working temperature. A 
0.5% solution of BPL was diluted in a saline bicarbonate solution (1.68 g NaHCO3 
+ 0.85 g NaCl + 0.2 ml of 0.5% phenol red + 100 ml of double distilled water). 
One ml of 0.5% BPL in saline bicarbonate was added to each 9 ml of Sendai virus 
suspension and agitated for 10 mm. The solution was incubated at 37 0C for 2 hours 
with agitation and statically at 4 0C overnight to inactivate the remaining BPL. A 
sample was removed for HAU assay and infectivity determination. At this stage the 
titer had fallen to 12800 HAU/ml. The infectivity of the inactivated Sendai virus was 
determined by inoculating 7-day embryonated eggs with 0.2 ml of 1:4 and 1:20 
dilution of the inactivated material for 72 hours for the first egg passage. Samples of 
0.2 ml of undiluted allantoic fluid harvested for each series (1:4 and 1:20) of the 
first egg passage were used to initiate a second 72 hours egg passage. In the first 
egg passage 1:4 dilution gave 400 HAU/ml haemagglutination activity but no HAU 
was observed in a 1:20 dilution and in any of the following passages. It was 
considered that haemagglutination activity in the first passage of 1:4 dilution was the 
result of higher HAU after inactivation of virus with BPL. However, no HAU was 
observed in any of the further passages indicating that the virus had been completely 
inactivated. The virus suspension was stored in 1 ml aliquots at -70 0C till the 
completion of fusion experiments. 
3.6 DNA labeling techniques 
Two techniques of DNA labeling were employed to investigate the duration 
of Gi period and start of DNA replication in 3rd and 4th cell cycle of preimplatation 
mouse embryos: the pulse labeling for proliferating cell nuclear antigen (PCNA) and 
the rapid pulsing technique of incorporating 5-bromodeoxyuridine (BrdU). The 
detailed procedures have been discussed in chapter 6. 
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3.7-STATISTICAL ANALYSIS OF DATA. 
Details of the methods used for the statistical analysis of the experimental 
data are given in each experimental chapters. Those analysis were conducted with 
the help and advice of Mr. Dave Waddington (Roslin Institute). 
CHAPTER 4 
SYNCHRONIZATION OF DONOR NUCLEI 
4.1 INTRODUCTION 
Synchronization of the donor nuclei plays an important role in evaluating the 
effect of cell cycle co-ordination in the development of reconstituted embryos. 
Asynchronous cleavage is the characteristic of early embryonic processes in 
mammals which progressively increases among blastomeres throughout 
preimplantation development. Synchronization of the blastomeres within an embryo 
is more difficult as the embryo approaches the late cleavage stages. In nuclear 
transfer experiments, it is believed that blastomere asynchrony causes inconsistent 
nucleo-cytoplasmic interactions in the embryos reconstructed by nuclear transfer. 
The lower success rate in nuclear transfer experiments has been reported due to the 
negative effects of the absence of cell cycle synchrony between nuclear donor and 
recipient cytoplasm (Smith et at., 1990; Campbell et al., 1994 and Otaegui et at., 
1994). 
The study of Otaegui et at., (1994) in this laboratory demonstrated that 
nocodazole, an inhibitor of tubulin polymerization could successfully be used to 
synchronize donor blastomeres and to hold the donor embryos at mitosis stage for 
several hours. The 2-cell embryos exposed to nocodazole (3.0 p.g/ml) for 12.5 -14.5 
hours showed no toxic effects on development of embryos after release and 98% 
reached to blastocyst stage as demonstrated by Kato and Tsunoda (1992). However, 
prolonged exposure to nocodazole showed negative effect on the division rate of 
blastomeres in bovine embryos (Tanaka et at., 1995). The longer exposure to 
nocodazole also leads to chromatin dispersion in mouse embryos which could result 
in chromosomes abnormalities (Samake and Smith 1996a, b). The previous reports 
emphasized the need for a reliable method for synchronization to arrest the cell cycle 
of mouse embryos for longer periods of time, enabling the blastomeres to reach 
synchrony together and be able to used for reconstruction of embryos by nuclear 
transfer with convenience. Several cell cycle arrest drugs are available with specific 
mechanism of action in cell cultures for the inhibition of cell cycle progression. 
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An inhibitor of maturation promotion factor (MPF), 6-dimethyl aminopurine 
(6-DMAP) has been used to prevent germinal vesicle breakdown (GVBD) during 
invertebrate (Guerrier and Doree, 1975; Doree et al., 1983) and vertebrate oocyte 
maturation (Rime et al., 1989). The dependency of mouse oocyte maturation on 
protein synthesis and protein phosphorylation has been previously reported by many 
workers. These experiments shows that the germinal vesicle breakdown (GVBD) in 
mouse oocyte maturation does not require protein synthesis (Schultz and 
Wassarman, 1977; Hashimoto and Kishimoto, 1988) but needs protein 
phosphorylation (Rime et al., 1989). The critical period after which protein synthesis 
is required seems to be linked to the transition from prophase I to metaphase I 
(Hashimoto and Kishimoto, 1988) and metaphase I requires protein synthesis to 
maintain chromosomes in a condensed form (Clarke and Masui, 1983; Hashimoto 
and Kishimoto, 1988) but Rime et al., (1989) have postulated a need for protein 
phosphorylation rather than protein synthesis. It has also been reported that, the 
transition from metaphase I to the end of the first meiotic division is MPF 
independent (Hashimoto and Kishimoto, 1988), and formation of metaphase II and 
its stability until fertilization of the oocyte depends on protein synthesis (Siracusa et 
al., 1978; Clarke and Masui, 1983; Hashimoto and Kishimoto, 1988; Rime et al., 
1989). 
Phosphorylation has been shown to play an important role in the G2/M 
transition of mitosis (Adlakha and Rao, 1987; Cross et al., 1989) and meiosis 
(Lohka and Mailer, 1987; Mailer et al., 1989). As meiosis I proceeds towards 
GVBD, a large increase in phosphorylation of cellular protein occurs in conjunction 
with the appearance of maturation-promotion factor (MPF) activity (Lohka and 
Mailer, 1987; Ozon et al., 1987). This large burst of phosphorylation may involve 
elements necessary for nuclear dissolution (e.g., lamins, histones, nucleoplasm, 
nucleolar proteins, intermediate filaments, etc.; reviewed by Adlakha and Rao, 1987) 
The 6-DMAP has been shown to inhibit the GVBD in starfish and sea urchin (Neant 
et al., 1989; Neant and Guerrier, 1988a), and mouse (Rime et al., 1989). 
On the other hand, Taxol is an antimitotic agent and is an important new drug 
for the treatment of certain cancers (Rowinsky et al., 1990). Amongst the many 
microtubule-directed drugs, the Taxol family are unique in that they stabilize 
cytoskeletal microtubules against depolymerization. Taxol promotes the formation of 
discrete bundles of stable microtubules that result from the reorganization of the 
microtubule cytoskeleton (Schiff PB and Horwitz SB, 1980). The novel 
characteristic of Taxol is its ability to polymerize tubulin in vitro in the absence of 
guanosine 5'-triphosphate (GTP), which is normally required for tubulin assembly 
(Schiff et al., 1979). It is only drug known to bind at a specific site on the 
microtubule polymer (Parness and Horwitz, 1981), and study with a Taxol 
photoaffinity analogue have identified the amino-terminal 31 amino acids of 3-
tubulin as the main site of photoincorporation (Rao et al., 1994). The other indicates 
a 2.5-fold higher labelling of - tubulin than a- tubulin (Combeau et al., 1994). The 
recent study of Isabelle and Richard by using guany1-((x&)-methylene-
diphosphonate (a non-hydrolyzable GTP analogue), showed that microtubule 
stabilization with Taxol is accompanied by a conformational change in the 
microtubule lattice and, implicitly, in the tubulin dimer. Taxol blocks the cell cycle in 
its GI and M phases by stabilizing the microtubule cytoskeleton against 
depolymerization--the basis of its clinical use in cancer therapy. In vitro , it decreases 
the critical concentration of tubulin assembly, increases the polymerization rate and 
stabilizes microtubules against the effects of cold, the presence of calcium, dilution 
or the action of other drugs. Because of its microtubule stabilization property, it is 
also used in experiments where stable microtubule assemble is required. 
In recent years 6-dimethylaminopurine (6-DMAP), the inhibitor of protein 
phosphorylation has been successfully used to arrest cleavage in 4-cell mouse 
embryos (Samake and Smith, 1996a). So it was decided to evaluate the effect of 6-
DMAP for the synchronization of cell division and on the other hand the effect of 
Taxol, the microtubule stabilizer drug on the cell cycle arrest was also studied. 
4.2 EMBRYOS 
The Fl female mice (C57BL/6 x CBAJ Ca) of 4-7 weeks old were 
superovulated by using superovulation regime (see section 3.3.2) and mated with the 
same Fl males immediately post hCG injections. The mice were killed by cervical 
dislocation 44-48 hours post hCG injections and mating. The 2-cell embryos were 
recovered from the oviducts in M2 medium and washed 2-3 times with M2. The 
embryos were stored at low temperature (4°C) in a glass dish containing M2 covered 
with mineral oil until required till their exposure to different synchronization 
treatments 
4.3 - STATISTICAL ANALYSIS. 
The data was analyzed using Generalized Linear Mixed Model (Breslow and 
Clayton, 1993) looking at the effect of treatment whilst allowing for differences 
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between days. The treatment effects were tested using a Wald statistics (distributed 
as chi-squared) and, if significant, differences between means were assessed by an 
approximate t-test. Means declared to differ, differ at the 5% level or better. 
4.4- EXPOSURE TO 6-DIMETHYLAMINOPURINE (6-
DMAP) 
The aim of the present study was ; To determine the reliability of 6-
dimethylaminopurine (6-DMAP), an inhibitor of maturation promotion factor, to 
arrest and to synchronize blastomere division in cleavage stage murine embryos and 
to assess its toxicity in vitro. 
The experiments were planned to establish the minimum dose concentration 
of 6-DMAP required to hold and maintain the cell cycle at mitosis. The second 
objective of this study was to determine the maximum period of time in the particular 
concentration, compatible with normal development to blastocyst after release. In 
most of the experiment performed under this Ph.D. project, 4-cell donor were used 
as nuclear donor for development studies. There was a need to establish a more 
reliable method for the synchronization of 2-cell mouse embryos. 
4.4.1 EXPERIMENTAL DESIGN 
The 2-cell mouse embryos were recovered 48 hours post hCG injections and 
exposed to 6-DMAP to evaluate the effect of different concentrations and time of 
exposure on the proportion of embryos arrested at mitosis and development after 
release. The embryos were washed 2-3 times with M2 and were exposed to different 
concentrations of 6-DMAP in sM16 medium. For this purpose 60 mm petri dishes 
containing 30 .tl microdrops of 5.0, 2.5 and 1.25 mM concentrations of 6-DMAP in 
sM16 were prepared at least 2 hours prior to the start of each treatment and were 
equilibrated at 37°C in 5% CO2 in air in the humidified incubator. 
After the end of each treatment, the ability of the different concentrations of 
6-DMAP to arrest the cell cycle and to hold the embryos at mitosis was determined. 
The number of cells in each embryo were counted to determine the proportion of 
cells divided after exposure to the treatment. They were also treated either with 
Hoechst 33342 (1.0 p.g/ml) in M2 for 10 minutes or they were stained with aceto-
orcene to determine the proportion of nuclei at mitosis. 
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The embryos were washed several times with M2 and sM16 to remove the 
affect of 6-DMAP from the embryos and cultured in the microdrops of sMl6 under 
liquid paraffin at 37°C in an atmosphere of 5% CO2 in air and the developmental 
potential of the embryos was determined. 
4.4.2- RESULTS 
The effect of different concentrations of 6-DMAP and length of exposure on 
the embryos arrested at mitosis is presented in Table 4.1. All embryos exposed to 
5.0 mM and 2.5 mM DMAP treatments for 9, 12 and 16 hours showed 100% cell 
cycle arrest at interphase (G2-M) (Figure 4. 1), it was not possible to conduct formal 
statistical analysis with large number of treatments having a proportion of one. 
When the embryos were exposed to 1.25 mM concentration of 6-DMAP for 
16 hours, 66% showed cell cycle arrest compared to control group where 96% of the 
embryos had shown cleavage to 4-cells. The exposure of the treated embryos at the 
end of treatment to Hoechst staining (1.0 jig/ml) revealed that all those embryos 
exposed to the minimum concentration of 2.5 mM 6-DMAP and above for 12 hours 
were with intact nuclear envelope (Fig. 4.2). The prolonged exposure of embryos to 
5.0 mM and 2.5 mM concentrations of 6-DMAP for 24 hours showed some negative 
effect on the embryos as 19% and 5% of the embryos had fragmented or appeared to 
be fluid filled respectively. In contrast, 100% of the embryos in the control group 
had divided. 
4.4.2.1- Development After Release 
The effect of toxicity of different concentrations of 6-DMAP treatment for 9, 
12 and 16 hours on the development of 2-cell embryos is presented in tables 4.2 to 
4.4 respectively. The development of treated embryos to 4-cell was shown to be 
greatly effected (p< 0.001) with varying concentrations of DMAP and higher 
proportions of development with decreasing concentration of DMAP was observed. 
However, different concentrations of DMAP when compared for 9 and 12 hours, 
provided no detectable difference in the development of embryos to 4-cell. All the 
embryos exposed to different concentrations of 6-DMAP for 16 hours when released 
from the drug exposure and further cultured in sM16 medium for 4 days, showed no 
development as compared to the control group where 89% development to morula 
stage was observed (Table: 4.4). When embryos were exposed to different 
concentrations of 6-DMAP for 9 hours, maximum development (77%) to morula and 
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Fig. 4.1 Two-cell mouse synchronized with 6-DMAP 
Two-cell mouse embryos synchronized with 5.0 mM 6-DMAP after 24 hours 
Two-cell mouse embryos synchronized with 2.5 mM 6-DMAP after 24 hours 
Two-cell mouse embryos synchronized with 1.25 mM 6-DMAP after 24 hours 
Note: 1.25 mM concentration is unable to hold the cells at mitosis and the 













Fig. 4.2 Hoechst staining of two-cell mouse embryos 
synchronized with 6-DMAP 
Hoechst staining of 2-cell embryos after 12 hours of synchronization 
with 5.0 mM concentration of 6-DMAP (Condensed nuclei) 
Hoechst staining of 2-cell embryos after 12 hours of synchronization 
with 5.0 mM concentration of 6-DMAP (normal nuclei) 
Hoechst staining of 2-cell embryos after 12 hours of synchronization 
with 2.5 mM concentration of 6-DMAP (looks normal) 
Hoechst staining of 2-cell embryos after 12 hours of synchronization 
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Fig. 4.3 Development after release of two-cell mouse 
embryos from synchronization with 6-DMAP for 9 
hours 
Development to blastocyst of embryos exposed to 5.0 mM 6-DMAP for 
9 hours after 3 days of culture. 
Development to blastocyst of embryos exposed to 2.5 mM 6-DMAP for 
9 hours after 3 days of culture. 
Development to blastocyst of embryos exposed to 1.25 mM 6-DMAP for 
9 hours after 3 days of culture. 













Table: 4.1 Effect of different concentrations of 6-DMAP and length of exposure on the 
proportion of 2-cell embryos arrested at mitosis.(3 Rep.) 
9 Hours 	12 Hours 	16 Hours 	24 Hours 
Concentrations 
5.0 mM 	55155(100)a 	78/78(100) 	60/60(100) 	39/48(81) 
2.5 mM 	43/43(100) 110/110(100) 80/80(100) 57/60(95) 
1.25 mM 	51/60(85) 33/80(41) 38/58(66) 3/60(5) 
Control 	 9/45(20) 8/45(18) 2/45(4) 0145(0) 
a Number (%) of embryos arrested at 2-cell at the end of each treatment. 
Table: 4.2 Development after release of 2-cell embryos synchronized for 9 hours with different 
concentrations of 6-DMAP. 
Conc. No Change 
(2-cell) 
4-cells 8-cells Morula Blastocysts 
5.0 mM 
24/40(60)a 
16/40(40) 14/40(35) 11/40(28) 11/40(28) 
2.5 mM 14/47(30) 33/47(70) 31/47(66) 31/47(66) 31/47(66) 
1.25 mM 11/47(23) 36/47(77) 36/47(77) 36/47(77) 36/47(77) 
Control 3/37(8) 34/37(92) 33/37(89) 33/37(89) 30/37(81) 
a Proportion (%) of development after release from synchronization for 9 hours. 
Table: 4.3 Development after release of 2-cell embryos synchronized for 12 hours with different 
concentrations of 6-DMAP. 




14/36(39) 14/36(39) 13/36(36) 13/36(36) 
2.5 mM 	23/57(40) 34/57(60) 20/57(35) 20/57(35) 20/57(35) 
1.25 mM 	3/35(9) 32/35(91) 32/35(91) 32/35(91) 32/35(91) 
Control 	3/37(8) 34/37(92) 33/37(89) 33/37(89) 30/37(81) 
a Proportion (%) of development after release from synchronization for 12 hours. 
Table: 4.4 Development after release of 2-cell embryos synchronized for 16 hours with different 
concentrations of 6-DMAP. 




0/48(0) 0/48(0) 0/48(0) 0/48(0) 0/48(0) 
2.5 mM 	27/47(57) 18/47(38) 0/47(0) 0/47(0) 0/47(0) 0/47(0) 
1.25 mM 	40/40(100) 0/40(0) 0/40(0) 0/40(0) 0/40(0) 0/40(0) 
Control 	3/37(8) 0/37(0) 34/37(92) 33/37(89) 33/37(89) 30/37(81) 
a Proportion (%) of development after release from synchronization for 16 hours. 
blastocyst stage was revealed with the lowest concentration of 6-DMAP (1.25 mlvi) 
used in this experiment (Table: 4.2) which was comparable to the control group 
(89%) (Fig. 4.3). 
The exposure to the 2.5 mM concentration for 9 hours showed slightly less 
development to morula and blastocyst i.e. 66%. In contrast, when the embryos were 
exposed to different concentrations of 6-DMAP for 12 hours, the developmental 
competence to morula and blastocyst was shown to be much higher (91%) in the 
embryos treated with 1.25 mM concentration of 6-DMAP as compared to the 35% 
development to morula/ blastocyst stage in the group treated with 2.5 mlvi 
concentration. For 5.0 mM concentration development to blastocyst was similar. 
These patterns resulted in an interaction between DMAP concentrations and exposure 
time (p< 0.01). Overall, blastocyst development enhanced by lower concentrations 
of DMAP (p< 0.001). 
4.4.3 - CONCLUSIONS. 
The minimum concentration of 2.5 mM could successfully be used to arrest 
the cell cycle up to 16 hours. However, the length of exposure to different 
concentration of 6-DMAP for more than 12 hours showed a negative effect on the 
development of all treated embryos as 0% development was observed in this 
experiment. The embryos exposed to 2.5 mM concentration of 6-DMAP for 9 hour 
could provide synchronized population of donor nuclei for nuclear transfer 
experiments. The lower concentration of 1.25 mM DMAP gave rise to better 
blastocyst production. 
4.5 EXPOSURE TO TAXOL. 
The aim of the present experiment was to assess the reliability of a 
microtubule stabilizing agent, Taxol for arresting and synchronizing blastomere 
division in cleavage stage murine embryos and to assess its reversibility and toxicity 
in vitro. 
4.5.1 EXPERIMENTAL DESIGN. 
To determine the reliability of a microtubule stabilizing agent, Taxol for 
arresting and synchronizing blastomere division in cleavage stage murine embryos 
and to assess its reversibility and toxicity in vitro, 2-cell embryos were recovered 
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from the F1 females 44-48 hours post hCG injection and mating with the same F 1 
males. The embryos were washed 2-3 times with M2 medium. The embryos were 
kept at low temperature (4°C) under paraffin oil in M2 medium till required. In this 
experiment, the 2-cell embryos were exposed to zero, 0.5 jiM, 1.0 jiM, 5.0 PM and 
10.0 jiM concentrations of Taxol in M16 medium. The 30 p.1 microdrops were made 
using 60 mm dishes and covered with paraffin oil. The dishes were prepared 2 hours 
prior to the start of each treatments and were equilibrated at 37°C in the atmosphere 
of 5% CO2 in air. 
To determine the effect of concentrations of Taxol and length of exposure on 
the proportion of mouse embryos arrested at metaphase, the embryos were exposed 
to different concentrations of Taxol for different periods of time. The ability of 
different concentration of Taxol to hold the cell cycle was assessed by counting the 
number of cells in individual embryos at 8, 12, 16, 20 and 36 hours after exposure 
to the different concentrations of Taxol. They were also exposed to fluorescence 
staining Hoechst 33342 (0.1 jig/ml) to observe the nuclei in the treated embryos. 
To assess the reversibility and toxicity, 2-cell embryos were released from 
the treatments by washing them several times with M2 and sMl6 to remove the affect 
of drug and cultured in sM16 medium. The observations on the developmental 
competence of the exposed embryos were recorded. 
4.5.2- RESULTS. 
At the end of each treatment, all embryos with 2 cells were considered 
arrested and those with more than 2 considered non-arrested (Fig.4.4a). The 2-cell 
embryos were exposed to different concentrations of Taxol for various length of time 
and the results are presented in Table: 4.5. The analysis of data showed no detectable 
interaction between Taxol concentration and exposure time in the proportion of 2-cell 
embryos arrested at mitosis, however, a highly significant effect of the presence of 
Taxol verses controls (p< 0.001) and exposure time (p< 0.001) was observed. The 
chromatin morphology were assessed by staining them with Hoechst 33342 and 
depicted in (Fig. 4.4 c&d). The results of the experiment based on the cell count of 
the treated embryos showed cell cycle arrest in 100% of 2-cell embryos treated with 
5.0 p.M concentration of Taxol for eight hours. The results in Table 4.5 also showed 
the ability of even the minimum (0.5 jiM) concentration of Taxol to arrest the cell 
cycle in 95% of embryos exposed. No difference was observed in the proportion of 
the embryos treated with 0.5 and 1.0 p.m of Taxol for eight hours. When the 
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Fig. 4.4 Two-cell embryos synchronized with Taxol 
normal morphology of the two-cell mouse embryos arrested at mitosis 
with 1.0 pM for 13 hours. 
most of the embryos in control groups are showing growth to 3-4 cells 
normal morphology of the nucleus of the 2-cell embryos synchronized 
with 10 gm Taxol for 8 hours. 
disturbed nuclear morphology of the 2-cell mouse embryo synchronized 






Table:4.5- Effect of concentration of Taxol and length of exposure on the proportion of 
mouse embryos arrested at metaphase(%). 
Treatments 8 Hours 	12 Hours 	16 Hours 	20 Hours 	36 Hours 
7/21(33)a 7/59(12) 7/42(17) 2/40(5) 1/19(5) 
21/22(95) 33/58(57) 30/40(75) 22/42(52) 9/23(39) 
21/22(95) 35/60(58) 32/41(78) 25/43(58) 9/22(41) 
22/22(100) 33/59(56) 32/40(80) 25/40(63) 7/23(30) 






a Number (%) of embryos arrested at the end of each treatment. Values are assessed by counting the number of cells 
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Fig: 4.5 
Graph showing development of 2-cell embrvs to 3-4-cell 
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Treatment 
Fig: 4.6 Graph showing the precetage of embryos homoghilsed after their 
release from synchronization with Taxol for various durations 
Fig:4.7 Graph showing 2-cell development to Morfl3Iast. after their 
release from s
ynchronization with Taxol for various durations 
embryos were exposed for 12 hours to different concentrations of Taxol, the cell 
cycle arrest in 2-cell embryos observed was 57, 58, 56 and 57% when exposed to 
0.5, 1.0, 5.0 and 10.0 tM concentrations of Taxol as compared to the control (non-
treated) groups (Fig. 4.4b), where 12% showed cell cycle arrest. The overall results 
showed in Table 4.5 demonstrated the positive effect (more than 30%) of all the 
concentrations of Taxol in arresting the cell cycle even up to 36 hours. The nuclear 
morphology of the embryos after different treatments showed disturbed metaphase 
assembly in the embryos exposed to 1.0 tM and 5.0 jiM concentrations of Taxol for 
12 hours. This conditions was observed in all the embryos exposed to more than 12 
hours to even the minimum concentration of 0.5 jiM of Taxol. 
4.5.2.1 DEVELOPMENT AFTER RELEASE 
The effect of toxicity of Taxol on the developmental competence of treated 
embryos for 12, 16, 20 and 36 hours to different concentrations of Taxol ranging 
from 0.5 jiM to 10.0 jiM was evaluated by culturing them after washing the treated 
embryos several times with M2 and M16. The results are presented in Fig: 4.5 to 
4.7. The analysis of the data for development of embryos to 3-4-cells out of the total 
showed no detectable interaction between Taxol concentrations and exposure time, 
however, significant effect of Taxol verses control (p<0.001) and exposure time 
(p<O.Ol) was observed. The results indicated absolutely no growth beyond 3-4 cells 
in all the embryos exposed to different concentrations of Taxol. In fact, in most of 
the embryos, the homogenized appearance was observed. Hoechst staining of all 
those embryos which developed to 3-4 cell showed disturbed/ scattered chromatin. 
4.5.3 CONCLUSIONS 
Taxol could be used to hold the cell cycle arrest. Minimum concentration of 
0.5 jiM of Taxol is able to arrest the cell cycle in 95% of 2-cell embryos. The 
exposure of cells to Taxol is said to be having a favorable effect on stabilizing 
spindle for microtubule kinetic studies. However, after the use of Taxol in 
preimplantation embryos for holding the cell cycle arrest, no embryo developed to 
morula or blastocyst stage. 
4.6- COMPARISON OF NOCODAZOLE AND DIFFERENT 
COMBINATIONS OF 6-DMAP. 
In this laboratory, exposure of mouse blastomeres to 10 jiM nocodazole was 
the preferred method of choice for synchronization. To evaluate the differences in the 
ability of different concentrations of 6-DMAP to hold the cell cycle at mitosis and to 
assess the difference in the developmental competence, it was planned to compare 
these differences with the previously preferred method for synchronization of mouse 
blastomere i.e. 10 pM nocodazole. 
4.6.1 EXPERIMENTAL DESIGN. 
The 2-cell embryos were exposed to 5.0 mM, 2.5 mM and 1.25 mM 
concentrations of 6-DMAP in sM16 medium. For comparison purposes the groups 
of 2-cell embryos were also exposed to 10 jtM nocodazole. The control groups were 
also prepared to compare the reversibility of both groups of embryos after exposure 
to the drugs. After the end of each treatment, the 2-cell embryos were washed with 
M2 and several drops of sM16 and cultured in the microdrops of M16 in 60 mm 
dishes prepared at least 2 hours prior to their transfer. The observations about the 
developmental competence of the embryos exposed to different treatments were 
recorded. 
4.6.2 RESULTS 
To compare the effect of different concentrations of 6-DMAP with 
nocodazole, the embryos treated with 10 jiM nocodazole and different concentrations 
of 6-DMAP ranging from 1.25 mM to 5.0 mM for 12 hours were washed and 
cultured in sM16 for 4 days and results are presented in Table 4.6. No difference in 
cell cycle arrest of the 2-cell mouse blastomeres was observed either exposed to 10 
jiM nocodazole or 2.5 mM and above concentration of 6-DMAP. Complete (100%) 
cell cycle arrest was observed in the embryos treated with 10 jim nocodazole, 2.5 
mM and 5.0 mM concentrations of 6-DMAP as compared to the group of embryos 
exposed to 1.25 mM concentration of 6-DMAP where 75% showed cell cycle arrest. 
The embryos arrested out of the total by treatment with 10 pM Nocodazole, 5.0 m?s4 
and 2.5 mM DMAP showed proportions equal to one, hence it was not possible to 
compare the treatment effect through statistical method. 
Table: 4.6 Effect of nocodazole (10 pM) and different concentrations of 6-DMAP for 12 hours on 
the proportion of 2-cells arrested at mitosis and their development in vitro. 
Treatments 
	
Replications. 	2-Cell 	Arrested at 	4-Cells (%) 	Blastocyst (%) 





























The results presented in table: 4.6 showed that the development to 
blastocysts/total after there release was greatly effected by different treatments (p< 
0.001). The embryos exposed to 10 jiM nocodazole and 1.25 mM DMAP for 12 
hours showed better (p< 0.05 or above) development to blastocysts/total as 
compared to 5.0 mM and 2.5 mM DMAP treatment and were comparable to control 
group. No toxicity effect of 10 jiM Nocodazole treatment on the developmental 
competence of the treated embryos was observed as 95% developed to blastocyst 
stage. On the other hand, although the 2.5 mM and 5.0 mM concentrations of 6-
DMAP were quite good for holding the cell cycle but development after release to 
blastocyst stage was adversely affected and remained restricted to 33 and 34% 
respectively. The lower concentration (1.25 m]\'l) of 6-DMAP had little effect on 
development to blastocyst and results are comparable to the control group and to the 
group treated with nocodazole. 
4.6.3 CONCLUSIONS 
There is no difference in development of embryos to blastocyst after their 
release form l0ji,M Nocodazole and 1.25 mM DMAP treatments for 12 hours and the 
results are comparable to control group. But, as depicted in Table 4.6, the inability of 
the 1.25 mM DMAP treatment to hold the cell cycle at mitosis for 12 hours suggests 
that nocodazole treatment is better and could successfully be used to arrest the cell 
cycle up to 12 hours with no affect on subsequent development to blastocyst stage. 
In contrast, exposure of embryos to 2.5 mM and 5.0 mM concentrations of 6-13MAP 
for 12 hours though good for holding the cell cycle, adversely affected the 
subsequent development to blastocyst stage. The lower concentration of 6-DMAP is 
unable to completely arrest the cycle but development is comparable to the control 
group and the group treated with 10 jiM nocodazole. 
4.7- DISCUSSION 
Experiments were conducted to study the effect of interactions of donor 
nuclei and recipient cytoplasms on the development of nuclear transfer embryos. The 
synchronized population of donor nuclei was required to capture different stages of 
donor cell cycle for interaction studies. Since the cell cycle synchronization of donor 
nuclei in the embryos is more difficult in early pre-implantation embryos, there is a 
need for a reliable method to synchronize mouse embryos. 
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In the present study, the results of experiments showed that 2.5 mM/mi 
concentration (or above) of 6-DMAP can successfully be used to arrest the cell cycle 
of 2-cell mouse embryos up to 16 hours. The exposure of embryos for more than 12 
hours showed negative effect on development after release from synchronization 
treatment. In this study, the exposure of embryos to 2.5 mIVI/mi concentration of 6-
DMAP for 9 hours, indicated that the effect of 6-DMAP is reversible and good 
proportion (66%) of embryos reached to blastocyst stage after their release. 
However, higher dose concentration of 6-DMAP (3.0 mM/mi) was suggested in 
previous studies ( Samake and Smith, 1996a, 1997) to successfully and reversible 
arrest the 4-cell and 8-cell mouse embryos. 
An inhibitor of meiosis/mitosis/maturation promotion factor (MPF), 6-
Dimethylaminopunne (6-DMAP) has been successfully used to prevent the germinal 
vesicle breakdown during invertebrate (Guerrier and Doree, 1975; Doree et al., 1983 
and vertebrate (Rime et al., 1989) oocyte maturation. The kinase inhibitor 6-DMAP 
caused significant reduction in the proportion of oocytes with spindles and 
condensed chromatin, indicate the necessity for phosphorylation events in the 
resumption of meiosis (Henry et al., 1997). Since DMAP inhibits the normal 
phosphorylation of proteins and interferes with the activity of MPF, the cell division 
is prevented (Neant et al., 1988a). Studies in marine invertebrates showed that DNA 
synthesis regulation in mitotic cells relies on 6-DMAP insensitive event (Neant and 
Dube, 1996) and in mammalian cell, though the presence of 6-DMAP after activation 
enhances the efficiency of activation and the speed of pronuclear formation but no 
effect on DNA synthesis was observed (Ledda et al., 1996). Since 6-DMAP inhibits 
the normal phosphorylation of protein and has no effect on DNA synthesis, it is 
predicted that 6-DMAP treated embryos are arrested at late G2 stage of the cell cycle, 
just before the rise of MPF activity. In this study, most of the embryos stained with 
Hoechst after their exposure to 6-DMAP have shown intact nuclear envelope as 
evident from fig. 4.2 suggests the synchronization of embryonic cells at late G2 
stage of cell cycle and the absence of MPF activity. The results of the present study 
to synchronization nuclear donor cells are in agreement with previous reports of 
Samake and Smith (1996a, 1997) indicating that 6-DMAP can be used to 
synchronize the donor cell at late G2-phase. The results concludes that the exposure 
of 2-cell embryos to minimum dose concentration of 2.5 mM of 6-DMAP can 
successfully arrest the cell cycle (100%) upto 16 hours and with higher reversibility 
and development to blastocyst (77%), when released after 9 hours of exposure. The 
failure in development of embryos to blastocysts after prolonged exposure of 16 
hours to 6-DMAP is expected due to its toxicity causing chromosomal abnormalities. 
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The experiment for synchronization of donor embryos were also conducted 
with Taxol. The results of the experiments indicated that embryos can successfully 
be arrested from cleavage with even 0.5 p.MIml concentration for 8 hours. But 
showed drastic effect on development after release. The development remained 
restricted at 3-4 cells and no embryo progressed further. In stead, they become 
homogenized after 3 days of incubation. The negative affect on development after 
release may be due to its toxicity, even with the lowest concentration (0.5 p.M) or 
due to the exposure time. However, it is suggested that further experiments using 
concentrations lower than 0.5 tM be conducted to find the possible beneficial role of 
Taxol in cell synchronization studies. 
Taxol is a new drug for the treatment of certain cancers (Rowinsky et al., 
1990) which blocks the cell cycle in its GI and M phases by stabilizing the 
microtubule cytoskeleton against depolymerization. It was inferred that this was due 
to the stabilization of cytoplasmic microtubules. Indirect immunofluorescence was 
used to show that Taxol treated cells displayed bundles of microtubules radiating 
from a common site in addition to their cytoplasmic microtubules. Ultarstructural 
observations showed that the mitotic cells contained microtubule bundles but no 
normal spindle. It was concluded that the inability of the cells to form a mitotic 
spindle in the presence of Taxol could be due to the fact that the cells were unable to 
depolymerize their microtubule cytoskeletons (Schiff PB and Horwitz SB, 1980). 
The results of the present experiment have shown drastic effect on the reversibility of 
treated embryos treated with different concentrations (0.5-10.0 pM) of Taxol is 
expected due to its toxicity as disturbed and scattered chromatin in treated embryos 
was observed after staining with Hoechst 33342. 
Taxol apparently induces the assembly of free microtubules in the cytoplasm, 
not attached to the centrsomes or kinetochores. In this experiment when the embryos 
were exposed to the higher concentrations of Taxol continuously for longer duration, 
the preexisting microtubules, attached to the organizing centers may not stabilized 
and disappeared and disturbed chromosomal configuration was observed (fig: 4.4). 
The study of Maro et at., (1985), demonstrated that even at very low doses of Taxol, 
only large bundles of microtubles in the spindle area of some cells were observed. 
Moreover, for higher doses (and/ or longer incubation time) cytoplasmic asters 
located near the cell surface were observed. In this study, the use of higher doses 
and longer duration could be the cause of disturbed chromatin and no development 
after release from Taxol. 
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Previous studies for synchronization of 2-cell mouse embryos with 
microtubule-disruptive drugs, colcemid and Nocodazole demonstrated that 
Nocodazole was more reversible than of colcemid in the majority of embryos treated 
with Nocodazole ( Maro and Bornens, 1980; Johnson et al., 1988; Tacke and 
Grunz, 1990, Otaegui et al., 1994). In this study the results of the experiment for 
comparing the effect of Nocodazole with different concentrations of 6-DMAP 
showed Nocodazole effect comparable with 1.25 mMJml of 6-DMAP when 
reversibility was considered but 1.25 mMIml 6-DMAP was unable to completely 
hold the cell cycle so Nocodazole was preferred in further experiments. 
The importance for synchronization between donor nucleus and recipient 
cytoplasts in nuclear transfer experiments is emphasized by previous studies in 
various mammalian species (Smith et al., 1988, 1990; Collas et al., 1992a; Campbell 
et al., 1993, 1994; Cheong et al., 1993; Otaegui et al., 1994; Stice et al., 1994). The 
present study concludes that 6-DMAP can successfully and reversibly be used to 
arrest the cell cycle at mitosis. In contrast, Taxol though is successful in arresting the 
cell cycle, but reversibility is greatly effected after release. Furthermore, Nocodazole 




ESTABLISHMENT OF PROTOCOL FOR 
THE ACTIVATION OF PARTHIENOTES 
AND RECONSTRUCTED EMBRYOS 
5.1 INTRODUCTION 
Most amphibian and mammalian oocytes become developmentally arrested at 
the germinal vesicle stage in prophase of the first meiotic division (reviewed by 
Masui and Clarke, 1979). Upon appropriate stimulation, meiosis resumes, the 
germinal vesicle breaks down, the first division is completed and the oocyte then 
becomes arrested at metaphase of second meiosis. This arrest is maintained by the 
cytoplasmic activity i.e. the activity of maturation promotion factor (MPF), which is 
central to cell cycle regulation. During meiosis the activity of MPF increases sharply 
before germinal vesicle break down (GVBD), remains high throughout first 
metaphase, declines slightly during anaphase and telophase and increases again at 
metaphase H. MPF has been identified as a complex of two sets of proteins, cyclins 
(Swenson et al., 1986; Labbe et al., 1989) and 34cdc2  (Dunphy et al., 1988; Labbe 
et al., 1989). MPF activity is partly a function of calcium (Ca 2 ). Any imbalance of 
components of the multi-cellular complex which is required for the cell cycle arrest 
may make the oocyte sensitive to activation stimuli during aging. Activation events 
include cortical granule release, completion of meiosis with the extrusion of the 
second polar body (PB2), and pronuclear (PN) formation. 
At fertilization the activation of the oocyte and inactivation of MPF is 
triggered by a series of intracellular C2 oscillation (Cuthbertson and Cobbold, 
1985; Collas et al., 1993; Swann and Ozal, 1994). These C2 oscillations are 
known to be important for resumption of the cell cycle (Kline and Kline, 1992). The 
studies in which C2 was increased artificially showed a critical role of Ca 2 in 
activation. Direct injection of C2, or application of Ca 21  ionophore A23187, both 
trigger parthenogenetic egg activation and PN formation in mammalian oocytes 
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(Steinhardt et al., 1974; Fulton and Whittingham, 1978; Kline and Kline, 1992; 
Vincent et at., 1992). The findings that there are many other parthenogenetic agent 
cause a C2 increase in mammalian oocytes suggests that Ca 21  is both necessary 
and sufficient trigger for activation (Whittingham, 1980; Swann and Ozal, 1994). 
Parthenogenetic activation of the oocytes may be used instead of fertilization 
by sperm to prepare the oocytes for nuclear transfer experiments. Parthenogenesis is 
the production of embryonic cells, with or without eventual development into an 
adult, from a female gamete in the absence of any contribution from a male gamete 
(Kaufman, 1981). It is now established that the natural activation stimulation induced 
by sperm penetration causes a series of Ca 2 transients in the egg which persists for 
many minutes or even hours (Miyazaki et al., 1993; Kline and Kline., 1992 and 
Carroll et al., 1996). These transient spikes are propagated throughout the fertilized 
egg in the form of a wave and initiate both cortical granule exocytosis (Miyazaki., 
1990) and escape from metaphase H arrest (Whitaker and Patel., 1990). 
In mammals, the activation of metaphase II oocytes can be induced by a 
variety of chemical and physical stimuli whose effectiveness increases with 
increasing post-ovulatory aging of the oocyte (Kaufman, 1981). The effectiveness of 
these procedures varies for parthenogenetic activation and development in mouse. 
Mouse oocytes have been activated by exposure to Ca 2 -Mg2 free medium 
containing Hyaluronidase (Graham, 1970), exposure to ethanol (Cuthbertson, 
1983), strontium (Sr 2+ ) (Bos-Mikich et al., 1995), Ca2 ionophores or chelators 
(Steinhardt et al., 1974; Kline and Kline, 1992), inhibitors of protein synthesis 
(Siracusa et at., 1978, Bos-Mikich et al., 1995) and electrical stimulation 
(Tarkowski et at., 1970, Swann and Ozil, 1994). The parthenogenetic studies shows 
that the mammalian parthenogenetic agents such as cycloheximide (Siracusa et at., 
1978; Clarke and Masui, 1983) and puromycin (Balakier and Casper, 1993) mediate 
their effects by inhibiting protein synthesis, and it is not clear if this effect is relevant 
to fertilization or other parthenogenetic stimuli. 
Fertilization and parthenogenetic development in mouse is also dependent on 
post ovulatory aging. Freshly ovulated oocytes are generally activated at low rates 
(Siracusa et at., 1978; Vincent et at., 1992; Swann and Ozil, 1994). It is also 
reported that in contrast to the oscillations at fertilization most parthenogenetic agents 
cause monotonic increase in Ca2 (Cuthbertson et at., 1981; Miyazaki and Igusa, 
1981; Swann and Ozil, 1994). A clear exception to this rule is Sr 2+  -containing 
medium, which induces C2 oscillations (Kline and Kline, 1994). The study of 
Bos-Mikich et al., (1995) has demonstrated the ability of the two parthenogenetic 
agents, strontium (Sr) and cycloheximide, to activate mouse oocytes. The results of 
their study shows that Sr 2' and cycloheximide act synergistically to promote 
parthenogenetic activation up to the pronuclear stage in oocytes collected immediately 
after ovulation. It is further demonstrated that parthenogenetic agents may have two 
important loci for activating mammalian oocytes and that the combined effect on Ca 2 
release and protein synthesis is most effective. 
5.2- 6-D1METHYLAMINOPURINE (6-DMAP), A 
REVERSIBLE INHIBITOR OF THE TRANSITION TO 
METAPHASE. 
The breakdown of the nuclear envelope, chromatin condensation, 
microtubule polymerization and the activity of microtubule organization centers 
(MTOCs) are the first indications of oocytes maturation (Szollosi et al. 1972a, b). 
These activities are regulated by a soluble cytoplasmic maturation factor (MPF) 
whose activity is temporally correlated with the M phase of the cell and is assumed to 
be controlled by a phosphorylation/ dephosphorylation cascade (reviewed by Mailer, 
1983; Ozon et at., 1987). Protein synthesis inhibitors like cyclohexamide, neither 
affect the initial appearance of MPF nor GVBD, but the reappearance of MPF at the 
time of first polar body extrusion is inhibited (Hasimoto and Kishimoto, 1988) 
which suggests that protein synthesis is required for the formation of MPF during 
the second meiotic cycle. 
It has been reported that phosphorylation plays an important role in the G2IM 
transition of mitosis (Adlakha and Rao, 1987; Cross et al., 1989) and meiosis 
(Lohka and Mailer, 1987; Mailer et at., 1989). A large increase in the 
phosphorylation of cellular protein occurs in conjunction with the appearance of 
MPF activity as meiosis 1 resumes to GVBD (Lohka and Mailer, 1987; Ozon et at., 
1987). The puromycin analog 6- dimethylaminopurine (6-DMAP) reversibly inhibits 
GVBD in starfish oocytes stimulated by the natural hormone 1-methyladenine (Neant 
and Guerrier, 1988b). In the metaphase 1 oocytes from the limpet Pateellaa vulgata, 
6-DMAP similarly induces decondensation of the chromosomes and reformation of 
the nuclear envelope (Neant and Guerrier, 1988a). In both these species, 6-DMAP 
appears to be an inhibitor of MPF formation. These investigations show that 6-
DMAP inhibits the burst of phosphorylation that normally occurs shortly before 
GVBD, without affecting the overall rate of protein synthesis. In nuclear transfer 
experiments, some protocols requires the use of the "Universal recipients". So there 
is need to establish a suitable activation protocol to activate mouse NM cytoplast to 
use them as "Universal recipients", with basal level of MPF. 
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The aims of the present series of experiments were: 1) to study the effect of 
6-DMAP on the chromatin configuration and development after exposure of mouse 
oocytes in metaphase II stage 2) to establish a suitable method for 
parthenogenetically activating the metaphase II oocytes and to use them as "universal 
recipients" and 3) the extent of parthenogenetic development in mouse oocytes by 
combining the standard activation protocol with the techniques which inhibits protein 
kinase activity by reducing phosphorylation of cellular protein ultimately suppressing 
the MPF activity in the metaphase H oocytes. 
The second objective of these experiment was to assess the rate of 
development of the embryos reconstructed by using the donor nuclei from different 
stages of 3rd cell cycle and pre-activated recipient oocytes (Universal recipients) with 
no MPF or with basal level of MPF. 
5.3 EFFECT OF INCUBATION TIME IN 6-
DIMETHYLAMINOPURINE, STRONTIUM CHLORIDE 
AND THEIR COMBINATION ON THE CHROMATIN 
MORPHOLOGY OF METAPHASE H OOCYTES. 
This study was conducted to determine the effect incubation time with 6-
DMAP ( protein kinase inhibitor), strontium chloride, and their combinations 
treatments on the chromatin morphology of metaphase H oocytes. 
5.3.1 EXPERIMENTAL DESIGN 
Cumulus free oocytes of 14-15 hours post hCG were exposed to the 
following treatments: 1) one hour exposure to 2.5mM 6-DMAP in M16; 2) one hour 
exposure to 2.5mM 6-DMAP plus 25 mM strontium chloride in M16 (calcium 
magnesium free strontium activation media); 3) one hour exposure to 25 mM 
strontium chloride in M16 (strontium activation media) alone ; 4) five hours exposure 
to 2.5mM 6-DMAP in M16; 5) sequential treatment with 25 mlvi strontium chloride 
for one hour and 2.5 mM 6-DMAP for two hours; 6) sequential treatment with 25 
mM strontium chloride plus 2.5mM 6-DMAP for one hour and 2.5 MM 6-DMAP for 
two hours; and 7) sequential treatment with 2.5mM 6-DMAP for one hour, 25 mM 
strontium chloride plus 2.5mM 6-DMAP for one hour and 2.5 mM 6-DMAP for one 
hour. Microdrop culture dishes for each treatment were made and equilibrated at 
37°C in 5% CO2 in air at least 2 hours prior to the initiation of each treatment. In 
Strontium chloride alone treatment group, the oocytes were exposed to 25 mlvi 
Strontium chloride for 1 hours and then cultured after washing with M2 medium in 
the nucrodrops of sM16. After 3 hours from the start of each treatment incubation 
(except for 5 hours DMAP group), the oocytes were washed with M2 medium and 
were mounted on the slides. They were fixed in an acetic acid: methanol (1:3, v/v) 
for 24 hours and were stained with 2% aceto-orcene. The chromatin morphology of 
the oocytes were examined under phase contrast microscope and observations on the 
different form of chromatin configurations and pronuclei were recorded. 
5.3.1.2- STATISTICAL ANALYSIS 
In this experiment, because many observations were equal to zero, the data 
was analyzed differently from all subsequent analysis. The actual numbers in the 
table were subjected to an extension of the Fisher exact test for interaction between 
treatments and category of chromatin morphology ( Program STATXACT, Cytel 
Software Corporation). The proportions were then analyzed by using Generalized 
Linear Mixed Model (Breslow and Clayton, 1993) looking at the effect of treatment 
whilst allowing for differences between days. The treatment effects were tested using 
a Wald statistics (distributed as chi-squared) and, if significant, differences between 
means were assessed by an approximate t-test. Means declared to differ, differ at the 
5% level or better. 
5.3.2 RESULTS 
The effect of 6-DMAP, strontium chloride and a combination of these 
treatments on chromatin morphology is shown in Table: 5.1 (Fig. 5.1). The 
statistical analysis showed a significant interaction (p< 0.00 1), indicating that 
different treatments result in different patterns of chromatin configuration. All those 
oocytes (Mil) who had left their metaphase II arrest following their exposure to any 
treatment were expected to be activated. The exposure of oocytes to combined 
treatment of strontium and 6-DMAP showed accelerated response to pronuclear 
formation. Exposure of metaphase II oocytes to 6-DMAP incubation for one hour 
induced activation in 8.6% of oocytes as they showed one pronucleus and one polar 
body configuration. On the other hand 80% of oocytes showed no affect of 6-DMAP 
incubation and were observed at metaphase II. The prolonged exposure of oocytes to 
DMAP for 5 hours showed abnormalities as 81.3% of ooctyes with disturbed 
metaphase were observed. 
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Fig. 5.1 Effect of 6-DMAP, 
treatment on the chromatin 
strontium chloride and combined 
morphology of metaphase II 
oocytes. 
Mil oocyte after the treatment of 6-DMAP for one hour 
anaphase stage of the oocyte after the treatment of St+6-DMAP for one 
hour 
anaphase/telophase stage of the oocyte after the treatment of St+6-DMAP 
for one hour 
telophase stage of the oocyte after the treatment of St+6-DMAP for one 
hour 
condensed chromosomes in some of the oocytes after the treatment of 6-
DMAP for one hour 
1) disturbed metaphase assembly after the treatment of St+6-DMAP for one 
hour in some of the oocytes 
one pronucleus formation (PN) in some of the oocytes after the treatment 
of 6-DMAP one hour then St+6-DMAP for one hour and again 6-DMAP for 
one hour 
1PN+1PB condition in some of the oocytes treated with strontium 
chloride for one hour and then 6-DMAP for 3 hours 
2PN condition in some of the oocytes after the treatment of 6-DMAP one 
hour then St+6-DMAP for one hour and again 6-DMAP for one hour 
more than 2 PN condition in some of the oocytes after the treatment of 6-










The combined treatment of 6-DMAP plus strontium chloride for one hour showed 
higher rate of activation as, 81.8% of oocytes showed exit from metaphase II arrest 
as compare to 38.9% which remained arrested in the treatment group which was 
exposed to strontium chloride alone for one hour. The chromatin configuration of 
oocytes exposed to 6-DMAP+Sr group, were observed to be as 30.3%, 30.3% and 
21.2% in anaphase, telophase and anaphase-telophase stage respectively. Staining 
also revealed 16.7% of oocytes with disturbed MIT when exposed to strontium 
chloride treatment for one hour. The effect of combined treatments is also shown in 
table 5. 1. 
When examined after a 3 hours of activation , there were difference in the 
pattern of activation. The combined treatment of strontium chloride (lh) then 6-
DMAP (2h), 6-DMAP+Sr.(lh) then 6-DMAP (2h) and 6-DMAP (lh) then 
DMAP+Sr.(lh) then 6-DMAP (lh) gave higher percentage of pronuclei between 85 
and 94%. These percentages were shown to be similar, but for these oocytes there 
was a difference between treatments in the proportion with 2PN (p< 0.05). The 
combined treatment of strontium chloride (lh) then 6-DMAP (2h) and 6-
DMAP+Sr.(lh) then 6-DMAP (2h) showed major effect on the formation of 2 
pronuclei (PN). The results shows 48.4% and 45.4% formed 2PN when exposed 
the combined treatments of strontium chloride (1h) then 6-DMAP (2h) and 6-
DMAP+Sr.(lh) then 6-DMAP (2h) respectively. The treatment with strontium 
chloride (lh) then 6-DMAP (2h) also induced 1PN+1PB configuration in 25.8% 
oocytes. On the other hand treatment with and 6-DMAP+Sr.(1h) then 6-DMAP (2h) 
did not induce the 1PN+1PB but 24.2% showed 1PN configuration. The data 
showed very less difference (16.1%v15.2%) between these two treatments as far as 
the percentage of more than 2PN are concerned. The data also revealed the mixed 
effect of combined treatment i.e. sequential treatment of 6-DMAP (lh) then 
DMAP+Sr.(lh) then 6-DMAP (lh) on the configuration of exposed oocytes as 21.2, 
27.3, 18.2, 24.2, and 3% showed 1PN+1PB, IPN, 2PN, >2PN and MIT 
configurations. 
5.3.3 CONCLUSION 
Treatment of metaphase II oocytes with 6-DMAP regardless of the time of 
incubation suggests that 6-DMAP itself have negligible effect activation, but it 
potentiates the effect of strontium, in that it apparently increased the proportion of 
activated ones and accelerated the response. 
Table: 5.1 Effect of 2.5 mM 6-DMAP and 25 mM Srontium chloride treatments and their combinition on the percentage 
of chromatin configuration of metaphase II oocytes. 
Tot. M11 Dis. M11 c.c Anaphase Telophase Ana-Tel 1PN+1PB ON 2PN >2PN 
*Stron.Chlorjde 36 38.9 16.7 0 44.4 0 0 0 0 0 0 
(iHour) 
*DMAP(lHour) 35 80.0 0 5.7 0 0 0 8.6 0 0 5.7 
DMAP(5 Hours) 64 15.6 81.3 0 0 0 3.1 0 0 0 0 
*DMAP+Sr (lHr) 33 0 0 18.2 30.3 30.3 21.2 0 0 0 0 
*Sr. Chlride(lHr) 	31 	3.2 	0 	0 	3.2 	0 	0 	25.8 	3.2 	48.4 	16.1 
+DMAP(2Hours) 
*DMAP+Sr (1 Hr) 33 	6.1 	0 	9.1 	0 	0 	0 	0 	24.2 45.4 	15.2 
DMAP(2 Hours) 
*DMAP(1 Hour) + 33 	3.0 	0 	6.1 	0 	0 	0 	21.2 	27.3 18.2 	24.2 
DMAP+Sr(1 Hour) 
DMAP(1 Hour) 
* The oocytes were fixed after 3 from the start of each treatment. All those oocytes which are at anaphase, telophase, anaphase-telophase, or showed 
pronuclear formation (1PN+1PB, 1PN, 2PN) are considered to be activated. The oocytes showing > 2PN are abnormal may be due to the effect of 
DMAP treatment. 
5.4 EFFECT OF TIME OF INCUBATION IN 6-
DIMETHYLAMINOPURINE, THE PROTEIN KINASE 
INHIBITOR ON THE PARTHENOGENETIC 
DEVELOPMENT OF METAPHASE II OOCYTES. 
The study was conducted to determine the effect of protein kinase inhibitor 6-
DMAP on activation and parthenogenetic development of metaphase II oocytes. The 
second objective of this study was to compare its effect with standard activation 
protocol i.e. one hour exposure to strontium chloride and its combined treatments 
with 6-DMAP on the activation and parthenogenetic development of metaphase II 
oocyte. 
5.4.1 EXPERIMENTAL DESIGN 
The oocytes recovered 14 hours post hCG were denuded using 300 i.u. of 
Hyaluronidase/mi in M2 medium. They were washed twice in M2 medium. The 
oocytes were randomly allotted to the following treatment groups : 1) control (-ive 
control); 2) one hour incubation in the microdrops of sM16 containing 2.5 MM 6-
DMAP; 3) one hour exposure/incubation with 25 mM strontium chloride in calcium 
magnesium free M16; 4) combined treatment of 2.5 mM 6-DMAP plus 25 mIVI 
strontium chloride in calcium magnesium free M16 for one hour; 5) sequential 
treatments of 2.5 mM 6-DMAP in sM16 for five hours and one hour incubation in 
strontium activation media containing 25 mM strontium chloride; and 6) sequential 
treatment of 2.5 mM 6-DMAP in sM16 for five hours and one hour incubation in 
strontium activation media containing 25 mM strontium chloride plus 2.5 mM 6-
DMAP. The microdrops for each treatment medium were prepared in 60 mm plastic 
dishes and were covered with liquid paraffin oil. These dishes were equilibrated at 
37°C in an atmosphere of 5% CO2 in air, well ahead before the start of experiment. 
The experiment was repeated twice. The observations with the developmental 
pathway were recorded. The blastocysts quality was assessed by staining them with 
Hoechst 33342 for 15 minutes and number of cell per blastocysts were counted. 
5.4.1.2- STATISTICAL ANALYSIS 
The data on the proportion of parthenogenetic development of oocytes treated 
with Strontium chloride, DMAP and their combinations were analyzed by using 
Generalized Linear Mixed Model (Breslow and Clayton, 1993) looking at the effect 
of treatment whilst allowing for differences between Days. The treatment effects 
were tested using a Wald statistics (distributed as chi-squared) and, if significant, 
differences between means were assessed by an approximate t-test. Means declared 
to differ, differ at the 5% level or better. 
5.4.2 RESULTS 
The effect on the parthenogenetic development of metaphase II oocytes 
exposed to 6-DMAP , strontium chloride and combined treatments for different time 
and combinations is depicted in Table 5.2. The oocytes in negative control group and 
those exposed to 6-DMAP alone for one hour showed no change after 20 hours of 
incubation in M16. However, on the second day fragmentation occurred in 48% of 
the control group and 46% of the DMAP group. A significant difference (p<O.Ol) 
between different treatments was observed when compared for development to 2-
cell/total. Strontium chloride (1 hour) treatment induced maximum rate of activation 
(81%) as compared to the combined treatment of DMAP+Sr (1 hour), which showed 
41% development to 2-cell stage (p< 0.01). The development to 2-cells stage in 
treatment groups where two groups of oocytes were first exposed to DMAP for 5 
hours and then each subsequently exposed to strontium chloride (1 hour) and 
DMAP+Strontium chloride (1 hour) showed 79% and 54 % respectively. The rate of 
development to morula stage was observed to 48% and 46% in the groups treated 
with strontium chloride (1 hour) and the combined treatment of DMAP (5 hour) with 
subsequent treatment of DMAP+Sr (1 hour). The rate of development by treating the 
oocytes with strontium chloride and other combined treatments was higher as 
compared to negative control and DMAP (1 hour) alone. The analysis of the data also 
showed a significant difference in different treatment when compared for 
development to blastocysts stage from treated oocytes. 
5.4.3 CONCLUSIONS 
The DMAP treatment is unable to induce any activation in metaphase II 
oocytes. The treatment of oocytes with strontium chloride provide good activation 
treatment and maximum number of parthenotes developed to 2-cells and stage. 
There is no difference in the development of parthenotes up to morula stage exposed 
to strontium alone and the parthenotes treated with DMAP (5 hours) then subsequent 
exposure to DMAP+Sr.(1 hour). 
AM 
0/31(0) 0/31(0) 0/31(0) 0/31(0) 
0135(0) 0135(0) 0135(0) 0135(0) 
25/31(81) 18/31(58) 15/31(48) 12/31(39) 
13/32(41) 7/32(22) 6/32(19) 6/32(19) 
31/39(79) 15/39(38) 8/39(21) 8/39(21) 







Table:5.2 Parthenogenetic development of oocytes treated with 2.5mM 6-DMAP and 25mM strontium chloride for different 
length of time and combinitions (%) 
Total 	2PB 	Frag. 	No change 	2-cell 	4-8 cell 	Morula 	Blastocysts 	Dead 
Control 31 0/31(0) 15/31(48) 16/31(52) 
DMAP(1 Hour) 35 0/35(0) 16/35(46) 19/35(54) 
Strontium Chloride 31 0/31(0) 4/31(13) 2/31(6) 
(1 Hour) 
DMAP+Strontium 32 0/32(0) 5/32(16) 13/32(41) 
Chloride (1 Hour) 
DMAP(5Hours)-* 39 33/39(85) 8/39(21) 0/39(0) 
Stron.Chlor.(1 Hour) 
DMAP(5 Hours)-* 37 0/37(0) 4/37(11) 0/37(0) 
DMAP+Sr(1 Hour) 
observations after 3 days of culture 
5.5- ACTIVATION AND PARTHENOGENETIC 
DEVELOPMENT OF METAPHASE II OOCYTES. 
The aim of the present study was to find out the reliable and suitable method 
for oocytes activation and the subsequent effect of activation treatment on the 
parthenogenetic development of metaphase H oocytes. A comparison was made 
between strontium and lonomycin and their co-activation protocols. 
5.5.1 EXPERIMENTAL DESIGN 
The cumulus free metaphase H oocytes (14-15 hours post hCG) were 
exposed to different treatments explained as follows: 1) control group (negative 
control); 2) one hour incubation in strontium activation media (25 mM strontium 
chloride); 3) 6 minutes in 5 mM lonomycin (Sigma) in M2 medium; 4) one hour 
exposure of metaphase II oocytes to the strontium activation media containing 25 
mM strontium chloride and then 3 hour incubation in M16 containing 2.0 mM 6-
DMAP; and 5) 6 minutes exposure to 5 mlvi lonomycin in M2 and subsequent 
exposure to 2.0 mM 6-13MAP in M16 for 3 hours. The control group (negative 
control) was made to assess any spontaneous parthenogenetic activation/ 
development and its comparison with the other treatments. The treatment groups 2 
and 3 were used to evaluate the effect of two different chemical stimuli on activation 
and parthenogenetic development of parthenotes. The treatment (4&5, the co-
activation protocols) were used to study the effect of protein kinase inhibitor (6-
DMAP) on activation and parthenogenetic development of parthenotes. The oocytes 
after each treatment were washed at least 3 times with M2 to minimize any nasty 
affect of drugs. At the end of each treatment each treatment group was incubated at 
370 C in the atmosphere of 5% CO2 in air in the microdrops of separately made 
dishes for each treatment a well ahead of time. They were observed for pronuclear 
formation 8 hour after their incubation in sM16. The observations along their 
developmental pathway up to blastocyst stage were also recorded. The blastocysts 
developed after each treatments were stained with Hoechst 33342 (0.1 tg/rril ) for 15 
minutes and the number of cells/blastocyst were recorded to evaluate the quality of 
blastocysts. The data obtained was analyzed by using the method described in 
section 5.4.2. 
5.5.2 RESULTS 
The effect on the extrusion of second polar body and pronuclear formation is 
shown in Table: 5.3. These observation were recorded 8 hours after beginning of 
activation treatment. No change was observed in negative control group. The pattern 
of activation varied with treatments. The higher percentage of 2PB were observed 
(30 and 37%) in strontium and lonomycin groups as compared to negative control 
and co-activation groups. The 1PN+1PB also revealed higher percentage (47 and 
33%) in the parthenotes treated with strontium chloride and co-activation protocol of 
strontium chloride and subsequent exposure to DMAP. The 2PN formation was 
significantly higher (p< 0.00 1) in the parthenotes that were also exposed to DMAP. 
The developmental competence of parthenotes is shown in Table: 5.4. The 
analysis of data revealed highly significant difference (p< 0.001) between different 
treatments when compared for development to 2-cell from treated oocytes. Strontium 
Chloride is better (p< 0.001) than the Jonomycin treatment (51% Vs 18%) and with 
DMAP treatment (94 and 59%) showed better (p< 0.05 or more) than without 
DMAP treatment ( 51, 18% ) and control group (5%) when the development from 
start to 2-cell was compared. In the absence of DMAP, more oocytes activated with 
strontium developed to morula and blastocyst stages (30% and 15%) than with 
ionomycin (3% and 0%). Activation followed by treatment with 6-DMAP increased 
these frequencies for both strontium (75% and 70%) and ionomycin (48% and 
47%). The overall analysis of the data indicates that treatment with co-activation 
protocol of strontium chloride and DMAP is the best treatment when development 
from start to blastocyst stage was compared. 
5.5.3 CONCLUSIONS 
The development of the parthenotes with the co-activation protocol of 
strontium chloride and DMAP suggests the need for longer exposure of the 
parthenotes to activation stimuli with subsequent exposure to DMAP. 
Though the 2PN formation is slightly higher in the parthenotes treated with 
lonomycin co-activation protocol, the subsequent development from 2-cell to morula 
and blastocyst stage is much higher in the parthenotes treated with strontium co-
activation protocol (Fig 5.2a) with higher cell number (Fig 5.2b). The results of 
experiments also favours the use of the protein kinase inhibitor 6-DMAP as an 
inhibitor of phosphorylation in activating the metaphase II oocytes. 
Table 5.3: Effect of different treatment for activation on the extrusion of second polar body and 
pronuclear formation (%) after 8 hours post activation (hpa). 
-ive Control 25 mM Strontium 	5 p.M lonomycin 	25 mM strontium 	5 p.M lonomycin 
Chloride(1 Hour) (6 minutes) chloride(1 Hour) (6 minutes) 
+ 2 mM 6-DMAP 	+ 2mM 6-DMAP 
(3 Hours) 	 (3 Hours) 
2 PB 	 0/92(0) 	28/92(30) 	 35/95 (37) 	 2/91(2) 	 4/94 (4) 
1 PN + 2 PB 	0/92(0) 	43/92(47) 	 7/95 (7) 	 30/91 (33) 	 6/94 (6) 
2 PN + 1 PB 	0/92(0) 	4/92(4) 	 0/95 (0) 	 59/91 (65) 	 66/94 (70) 
hpa= hours post activation 
Table : 5.4 Effect of different treatment for activation on the parthenogenetic development o f 
activated oocytes .(%) 
-ive Control 	25 mM Strontium 
Chloride(1 Hour) 
5 i.M lonomycin 
(6 minutes) 
25 mM strontium 
chloride(1 Hour) 
+ 2 mM 6-DMAP 
(3 Hours) 
5 iM lonomycin 
(6 minutes) 
+ 2mM 6-DMAP 
(3 Hours) 
2-cells 5/92 (5) 	47/92(51) 17/95 (18) 86/91 (95) 55/94 	(59) 
4-cells -- 	 44/92(48) 5/95 (5) 79/91 (87) 48/94 	(51) 
8-cells -- 	 29/92(32) 3/95 (3) 76/91 (84) 46/94 (49) 
Morula -- 	 28/92(30) 3/95 (3) 68/91 (75) 46/94 	(49) 
Blastocyst -- 	 14/92 (15) 0/95 (0) 64/91 (70) 44/94 	(47) 
Fig. 5.2 Development after parthenogenetic activation 
of M11 oocytes using the activation protocol of 
Strontium chloride one hour with subsequent exposure 
to 6-DMAP for 3 hours. 
development to blastocysts after 5th day 
Hoechst stained blastocyst showing higher number of blastomere nuclei on 
5th day 
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5.6 DEVELOPMENTAL POTENTIAL OF THE 
RECONSTRUCTED EMBRYOS USING MOST 
FAVOURED ACTIVATION PROTOCOL. 
This study was planned to study the effect of most favourable activation 
protocol ( one hour incubation in strontium activation media containing 25 mm 
strontium chloride and subsequent exposure to 2.0 mM 6-DMAP) for the 
parthenogenetic development of parthenotes to blastocyst stage, on the 
developmental competence of embryos reconstructed by using donor nuclei of 
different cell cycle stage of 3rd cell cycle and enucleated pre-activated oocytes with 
no MPF or with basal level of MPF. 
5.6.1 EXPERIMENTAL DESIGN 
The oocytes were recovered 14 hours post hCG injections. The cumulus 
were removed using 300 i.u. of Hyaluronidase/mi in M2 medium. The denuded 
oocytes were exposed to the Hoechst 33342 staining (0.8 mg/ml) for five minutes in 
M2 medium. They were first washed with M2 medium immediately after enucleation 
to wash out the effect of Nocodazole and Cytochlasin B drugs used during 
manipulation in the manipulation chamber. The enucleated oocyte were then exposed 
to the activation protocol as follows: one hour exposure to the strontium activation 
media containing 25 mM strontium chloride; washed with M2 and then exposed for 3 
hours to 2.0 mM 6-DMAP in sM16. Donor embryos recovered at late 2-cell stage 
(44-48 post hCG) were synchronized using 10 mM Nocodazole (Otaegui, Ph.D. 
thesis) and were released according to the requirement of the experiment at different 
stages of 3rd cell cycle. 
During an earlier experiment it was noted that donor nuclei at G  stage of cell 
cycle contained more than 5 nucleoli. In this experiment and the next experiment, 
donor nuclei were selected having more than 6 nucleoli as a convenient and effective 
criterion. The donor nuclei at GI stage of cell cycle were obtained 60-75 minutes 
after release from synchronization. Nuclear transfer was performed by using donor 
nuclei at Gi, S and G2 (Otaegui, 1995 Ph.D. thesis) phases of 3rd cell cycle to the 
pre-activated (4 hpa) enucleated oocytes by using the most favoured activation 
protocol mentioned above. The couplets were fused by using 3 volts AC for 3.5 
second followed by single DC pulse of 1.5 kv for 100 p. sec. in electrofusion 
chamber containing 03M manitol solution. The couplets were then washed and 
incubated in the microdrops of sM16 containing 10 p.M Nocodazole and 10 p.g/m1 
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Cytochalasin B. After one hour the fusion rate was assessed and the fused embryos 
were washed several times with M2 and drops of sM16 to remove the effect of drugs 
and cultured in sM16. Two control groups, one which got activation stimuli to 
verify the quality of oocytes and the other, not exposed to activation stimuli to detect 
any non-intended activation. The donor group was also included in this experiment 
to confirm the quality of karyoplasts. The observations were recorded along the 
developmental pathway to blastocyst stage. The quality of the blastocysts was 
assessed by counting the cell number in each blastocyst after staining with Hoechst 
33342 for 15 minutes. 
5.6.2 RESULTS 
There were significant effect of donor cell cycle stage effect (p< 0.001) on 
development to morula and blastocyst after nuclear transfer (Table: 5.5). The 
embryos reconstructed with donor nuclei at GuS stage and control group activated 
with co-activation protocol showed 97 % rate of development to 2-cell was 
significantly better (p< 0.001) as compared to the embryos reconstructed by using S-
phase (81%) and G2-phase (84%) of cell cycle stage. The subsequent development 
to morula and blastocyst stage was significantly (p< 0.001) higher (85 and 79%) in 
the embryos reconstructed using donor nuclei at GuS phase of cell cycle stage as 
compared to the embryos reconstructed by using S-phase (40 and 23%) and G2-
phase (47 and 27%) of cell cycle stages. The analysis of data for development also 
indicated that embryos reconstructed by using GI or GuS donor nuclei are best 
donor and development was comparable with donor controls. Fig. 5.3 shows the 
example of blastocyst developed following nuclear transfer of Gi and S phase donor 
nuclei. There was difference in the morphology of the blastomeres nuclei as 
observed after Hoechst 33342 staining. The appearance of the blastomeres in some 
of the blastocysts produced following transfer of 4-cell S-phase donor nuclei was 
unhealthy (Fig. 5.3b) whilst the blastocysts from Gi donor appeared normal (Fig. 
5.3a) 
Table 5.5: Development after nuclear transfer of reconstructed embryos using donor nuclei 
from different stages of 3rd cell cycle and pre-activated oocytes (4 hpa) with strontium chloride 
(1 hour) + 2mM 6-DMAP (3 hours) protocol.(%) 
Donor 
cell cycle stage 








Gi or GuS 3 57 39 (68) 38 (97) 36 (92) 33 (85) 31(79) 
S 3 79 47 (59) 38 (81) 21(45) 19 (40) 11(23) 
G2 3 79 49 (62) 41(84) 36 (73) 23 (47) 13 (27) 
+ive control 9 119 -- 115 (97) 87 (73) 73 (61) 64 (54) 
-lye control 9 127 -- 7 (5) -- -- -- 
Donor control 2 21 -- -- 19 (90) 17 (81) 16 (76) 
Fig. 5.3 Difference in nuclear morphology of the 
blastocyst's nuclei of embryos reconstructed with Gi 
and S-phase stages. 
blastocyst nuclei of the embryos reconstructed by transferring donor 
nuclei from 4-cell at Gi stage of cell cycle into cytoplasts pre-activated 
using strontium and 6-DMAP protocol. 
blastocyst nuclei of the embryos reconstructed by transferring donor 
nuclei from 4-cell at S-phase of cell cycle into cytoplasts pre-activated using 





A number of reconstructed embryos were examined post fusion for evidence 
of NEBD (Table; 5.6). In one case the membrane was non distinct, but the 
chromosomes had not condensed. These observations confirms that the activation 
protocol did lower MPF activity as obvious from the intact nuclear envelope of the 
transferred nuclei (Fig 5.4). 
Although all three nuclear transfer protocols were expected to maintain 
normal ploidy, there were significant differences in development. Development was 
more frequent when the donor cell was in GI or GuS phase. 
The results of the present experiment suggests that though there is role of 
MPF in the development of reconstructed embryos but their could be other 
cytoplasmic factor which plays their role in remodelling and reprogramming of the 
transferred nuclei or cell cycle stage of the donor nuclei (the stage effect) could be the 
cause of lower development in embryos reconstructed by using S-phase and G2-
phase stage of cell cycle. For G2 donor nuclei tetraploidy could be another cause of 
lower development. 
5.7 COMPARISON OF THE EFFECTIVENESS OF TWO 
PROTOCOLS: ONE HOUR IN STRONTIUM ACTIVATION 
MEDIA VERSUS ONE HOUR EXPOSURE TO 
STRONTIUM ACTIVATION MEDIA (25 mM Sr) WITH 
SUBSEQUENT EXPOSURE OF THREE HOURS TO 2.0 mM 
6-DMAP, THE PROTEIN KINASE INHIBITOR. 
The results of the study (Table: 5.3) demonstrated maximum development 
(79%) by using the favourable activation protocol based on the parthenogenetic 
development of metaphase II oocytes, with the embryos reconstructed from the Gil 
S phase of 3rd cell cycle by using enucleated pre-activated (4 hpa) oocytes by using 
favoured activation protocol i.e. one hour incubation in strontium activation media 
containing 25 mM strontium chloride and subsequently 3 hours exposure to 2.0 mM 
6-DMAP in sMl6. On the basis of these results it was decided to compare the effect 
of two different protocols on the development of the embryos reconstructed by using 
nuclear donors at G 1/S phase of the 3rd cell cycle with the enucleated oocytes 
activated using above mentioned protocols. 
Table: 5.6 Effect of activation protocol (25 mM Strontium chloride 1 hour + 2.0 mM 6-DMAP 3 hours) on the 
morphology of transferred nuclei after one hour of fusion.(%) 
Donor cell stage 	Total 	Fused 	ON 	Intact Nuclear! 	NEBDI 	NEBD+PCCI 
observed observed observed 
Gi or G1!S 	 14 	12 -- 	11!11(100) 0!11(0) 0/11(0) 
S-phase 	 12 	11 -- 	10/11(91) 1/11(9) 0/11(0) 
Control 	 25 	-- -- 	24/25(96) 0/25(0) 0/25(0) 
Fig. 5.4 Maintenance of nuclear envelope in embryos 
reconstructed from S-phase stage of donor nuclei 




5.7.1 EXPERIMENTAL DESIGN 
The oocytes were recovered 14 hours post hCG injections. They were 
denuded by using 300 i.u. of Hyaluronidaze They were stained by using Hoechst 
33342 (0.8 mg/ml). Enucleation of the oocytes was performed in the 
micromanipulation chamber containing 10 p.M of Nocodazole and 10 jig 
Cytochalasin B in M2 medium. The enucleated oocytes were washed thoroughly 
with M2 medium to remove any affect of drugs used. They were activated by using 
calcium magnesium free strontium activation media containing 25 mM strontium 
chloride for one hour at 37 0C with 5%CO2 in air. The activated oocytes were divided 
into two groups after washing with M2 with several changes. One group was 
incubated in the microdrop of sM16 medium for three hours and the other was 
exposed to 2.0 mM DMAP for three hours. 
The donor nuclei at 2-cell stage were recovered 44-48 hours after hCG 
injections followed by mating with Fl males. They were synchronized for 9-12 
hours using 10 p.M of Nocodazole in M16 medium at 37°C. They were released in 
groups by washing them thoroughly with several changes of M2 to remove the effect 
of Nocodazole. The released embryos started dividing after 60 minutes. They were 
used for nuclear transfer 75 minutes after their release (Otaegui, 1995 Ph.D. thesis). 
The enucleated oocytes and the donor 4-cells were transferred into the 
micromanipulation chamber containing Nocodazole (microtubule inhibitor) and 
Cytochalasin B (cytoskeleton inhibitor). The stage of the cell cycle was recognized 
by evaluating the number of nucleoli. All those containing 6 or more than 6 nucleoli 
were considered in G 1-phase. After reconstruction the couplets were fused by using 
3 volts AC for 3.5 second followed by single DC pulse of 1.5 kv for 100 p. sec. in 
an electrofusion chamber containing 0.3M mannitol solution. The control groups 
were exposed with the same treatment but without enucleation to evaluate the ability 
of activation protocols and to compare them with the reconstructed groups. -ive 
control groups were used to identify any spontaneous activation in the oocytes with 
age or any other stimuli. The observations along the developmental pathways were 
recorded. The blastocyst' s quality was evaluated by staining them with Hoechst 
33342 for 15 minutes by exposing them to the UV light. The data was analyzed by 
using the method described in section 5.4.2. 
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5.7.2 RESULT 
The fusion rate of the reconstructed couplets by using enucleated and pre-
activated oocytes with strontium activation protocol was 68% as compare to the 
embryos reconstructed using enucleated and pre-activated oocytes with strontium co-
activation protocol (80%) (Table: 5.7). Developmental competence of embryos to 2-
cells stage also showed significant effect (p< 0.001) when two different activation 
protocols were compared. The subsequent development up to morula and blastocyst 
was higher in the embryos reconstructed by using pre-activated oocytes with 
strontium co-activation protocol as compared to those reconstructed by using 
strontium protocol, but statistical analysis showed non significant difference. Their 
was also a difference in the development of fused embryos to blastocyst (p< 0.05) 
within the group of strontium protocol between reconstructed embryos and non 
enucleated parthenotes which was not present within the strontium co-activation 
group. The overall analysis of the data on development from start to 2-cell indicated 
that strontium co-activation treatment did better than the strontium alone and the 
embryos reconstructed using GI or GUS donor nuclei developed better than the 
control. When development from 2-cell to 4-cell was compared, the Strontium co-
activation protocol proved better than the Strontium alone protocol. However, the 
comparison of development from start to blastocyst showed Strontium co-activation 
treatments (+DMAP) not distinguishable from donor control and (-DMAP, Gi or 
GuS) but better than (-DMAP, control). Moreover, donor control were better than 
the both Strontium alone treatments. 
5.7.3 CONCLUSIONS 
The results of the experiment proved the use of strontium co-activation 
protocol for the activation of enucleated ooêytes, when pre-activated recipient with 
no MPF would be required. 
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Table 5.7: Development after nuclear transfer of reconstructed embryos using donor nuclei from 
Gi stage of 3rd cell cycle and pre-activated oocytes (4 hpa) with strontium chloride (1 hour) and 
strontium chloride (1 hour) + 2mM 6-DMAP (3 hours) protocols.(%) 
Donor Activation 	Replicates Fused 	2-cell! 4-cell! Morula! Blastocystl 
cell cycle Protocol Fused Fused Fused Fused 
stage 
G 1  or  GuS 3 36/53(68) 	30/36(83) 21/36(58) 21/36(58) 21/36(58) 
Strontium 
Chloride 
+ Control* 3 -- 	16/32(50) 14/32(44) 10/32(31) 5/32(16) 
G 1  or  GuS 3 	36/45(80) 	45/45(100) 	41/45(91) 41/45(91) 35/45(78) 
Strontium 
Chloride+ 
+ Control* 	DMAP 3 	 -- 	30/34(88) 	27/34(79) 26/34(76) 24/34(71) 
Donor 	-- 3 	 -- 	 -- 	38/43(88) 38/43(88) 38/43(88) 
control* 
-ive Control* 	-- 3 	 -- 	3/32(9) 	2/32(6) 0/32(0) 0/32(0) 
* The percentages are worked out of their total number. 
5.8 - DISCUSSION 
The results of the series of experiments presented in this chapter 
demonstrates the beneficial role of using 6-DMAP when used in combination with 
the activation stimuli. The results highlighted that 6-DMAP itself has negligible effect 
on activation but potentiates effect of Strontium, in that it apparently enhanced 
proportion activated and accelerated the response (table 5.1). There are different 
methods of activation available. In this study three methods of activation were tried 
to find out the optimum activation protocol for mouse oocytes activation. Studies on 
the parthenogenetic activation of mouse oocytes using divalent ions like Strontium, 
barium and manganese has suggested that these ions releases Ca 2 from intracellular 
stores (Whittingham and Siracusa, 1978; Fraser, 1987; 0' Neill et al., 1991). The 
results shown in table 5.5 demonstrates that when the oocytes after activation were 
exposed subsequently with 6-DMAP, a higher activation proportion was achieved 
using strontium co-activation protocol. 
6-DMAP, inhibits protein phosphorylation without inhibiting protein 
synthesis, in sea urchin, starfish, and mouse oocytes (Rebhun et al., 1973, Neant 
and Guerrier, 1988a,b, Neant et al., 1989, Rime et al., 1989, Szollosi et al., 1993). 
In mouse eggs, 6-DAMP inhibits protein phosphorylation by approximately 20% 
(Rime et al., 1989). Thus it is apparent not all protein kinases are inhibited by 6-
DMAP. For example protein kinase C (PKC), which is activated by the phorbol 
ester, phobol 12-myristate 13 acetate (PMA) (Nishizuka, 1984), including 
parthenogenetic activation in mouse eggs (Cutterbertson and Cubbold, 1985), does 
not appear to be inhibited by 6-DMAP, instead 6-DMAP enhanced PMA-induced egg 
activation (Moses and Masui, 1994). The results presented in table 5.1 demonstrates 
that the combination treatments of strontium and 6-DMAP for 3 hours enhanced 
pronuclear formation (more than 85%) as compare to strontium alone (1 hour) when 
observed 3 hours after staining. 
The data on the observation of polar body and pronuclear formation (8 
hpa)(table 5.3) demonstrates the effectiveness of the combined protocol of strontium 
(1 hr) with subsequent exposure to 6-DMAP (3 hr) on oocytes activation, all of the 
oocytes exposed to this combined protocol showed polar body formation. In 
contrast, 81% and 44% of the exposed oocytes to strontium and ionomycin alone 
showed polar body formation. The exposure of oocytes to strontium and lonomycin 
alone showed very little effect of lonomycin exposure on parthenogenetic activation. 
But when the embryos were subsequently exposed to DMAP, enhanced response to 
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development was noted. Poor activation rate (44%) was observed in oocytes 
exposed to ionomycin alone but when the oocytes were exposed to the subsequent 
exposure of 6-DMAP, the activation rate was enhanced to 80%, comparable to 
strontium alone. The maximum development to morula/blastocyst was achieved 
using strontium co-activation protocol. 
In mouse, the shorter exposure to lonomycin may not be helpful in 
completely activating the oocytes. In contrast, the higher activation rate in strontium 
treatment group may due to longer exposure of oocytes (60 mm.) to Strontium. The 
fact that strontium treatment produces Ca 2 transient comparable to sperm activation, 
the difference observed in parthenogenetic development may be due to the mode of 
intracellular calcium elevation. lonomycin actually mobilizes the intracellular stores 
(Hoth and Penner, 1992) but induces only a single wave as compare to the repetitive 
series of calcium waves generated during fertilization. In contrast, prolong exposure 
to Strontium may be helpful in generating a series of calcium transients. Poor 
activation rates of freshly ovulated oocytes treated with some parthenogenetic agent 
such as A23187 has been suggested because they may generate only a single Ca 2 
increase (Ozil, 1990; Swann and Ozil, 1994). These studies highlighted the function 
of Ca2 oscillation in oocyte activation. This .is supported by the observations that 
100% of freshly ovulated mouse and rabbit eggs can be activated by repetitive 
electric pulse application to generate repetitive Ca 2 transient (Ozil, 1990; Swann and 
Ozil, 1994). 
In most of the mammalian species, sperm entry into oocyte provides natural 
stimuli for egg activation. It is establishes that the natural activation stimuli induced 
by sperm penetration induces a series of Ca 2 transients in the egg which persists for 
many minutes or even hours (Miyazaki et at., 1993; Kline and Kline, 1992; Carroll 
et at., 1996). In mouse first sperm-induced Ca 2 transient is distinctive and unlike 
the later Ca2 transient; it consists of small pacemaker-like rise in intracellular Ca 2 , 
followed by a rapid rise to a large, long lasting plateaus phase. Several fast Ca 2 
spikes of large amplitude and short duration are often superimposed on the first 
transient (Kline and Kline, 1994). The release of Ca 2 from intracellular stores in 
oocytes is thought to be due to inositol 1 ,4,5-triphosphate receptors (insP 3 R) and 
ryanodine receptors (RyR); InsP 3 R channels being involved in propagation and 
maintaining the Ca2 waves and RyR channels have been linked to the conversion of 
the zona glycoprotein (ZP 2 ) to its post fertilization form ZP 2 f (Yue et at., 1995; 
Kenneth and Yue, 1996). The increase in intracellular calcium concentration that 
result from fertilization, inactivates MPF and CSF and releases the eggs from 
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metaphase arrest (Meyerhof and Masui, 1977; Murray and Kirschner, 1989b). So 
the efficiency of the parthenogenetic activation agent depends on its ability to 
generate repetitive Ca 2 transients. 
When the oocytes were subsequently exposed to DMAP, the 2PN formation 
was observed in 65 to 70% of oocytes. The study of Maro et at., (1986) shows that 
6-DMAP inhibits spindle rotation and second polar body formation. These two 
events are controlled by interactions between the chromosomes and the oocyte 
cortex, resulting in the formation of a microfilament-rich domain overlying the 
spindle. Normal activation requires close association between one of the rotating 
spindle poles and the cortical actin layer. The lack of this contact in the presence of 6-
DMAP suggests that protein phosphorylation is involved in the maintenance of 
spindle pole-cortex association and successful spindle rotation. Extrusion of first 
polar body was also often inhibited by 6-DMAP during mouse oocyte maturation 
(Szollosi et at., 1991) as well as the formation of both polar bodies in maturing 
oocytes of Echinoderms (Neant et al., 1989). The inhibition of second polar body in 
present study resulted in the formation of 2PN in oocytes exposed to 6-DMAP after 
activation with strontium or ionomycin. However, only 65% of the oocytes showed 
2PN formation when treated with strontium co-activation protocol, may be due to the 
exposure time to strontium (60 mm.) before its exposure to 6-DMAP. All those 
oocytes activated in the start of the exposure to strontium may have organized their 
spindle and spindle rotation which ultimately resulted in the formation of IPN + 
1PB. In contrast, the oocytes activated later with strontium was unable to form their 
spindle due to their exposure to 6-DMAP, resulted in the formation of 2PN. This is 
evident from the results of experiment (table 5.3) that oocytes exposed to strontium 
co-activation protocol showed 33% oocytes with 1PN + IPB formation as compared 
to the ionomycin co-activation protocol, 6% showed IPN + 1PB formation. 
The observations of the present study suggests that 6-DMAP accelerates the 
formation of pronuclei in oocytes activated in presence or absence of 6-DMAP (table 
5.1). These observations are in line with the previous studies of Szollosi et at., 1993; 
Ledda et at., 1996. However, formation of single pronucleus after DMAP exposure 
was also reported by Ledda et at., 1996; Loi et al., 1998 in bovine and ovine 
respectively. The exposure of oocytes to the co-activation protocol also enhanced the 
cell cycle progression, and higher number of cells in blastocysts on 4th day and 5th 
day was observed (data not shown) as compare to the strontium and lonomycin 
alone. The morphology of the blastocyst from the strontium co-activation treatment 
group was observed to be better than the strontium or lonomycin treated ones (Fig 
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5.2). The development of parthenotes to blastocyst stage (table 5.4) suggests 
difference in the effectiveness of different protocols used in this study. The 
formation of number of pronuclei and polar bodies is expected to alter the ploidy of 
the parthenotes. All those oocytes who showed 1PN + 1PB are expected to be 
haploid but those showing 2PN + 1PB represents two sets of haploid. However, the 
developmental potential of the parthenotes on this basis was not evaluated in these 
experiment. It is suggested that further experiments should be performed to evaluate 
the developmental potential of the haploid and diploid parthenotes. Previous study of 
Surani and Kaufman, (1977) using Ca 2 and Mg' free or Ca' alone medium 
resulting in suppression of second polar body extrusion demonstrated a proportion 
of cases with two pronuclear eggs or eggs that underwent immediate cleavage. 
However, the use of Cytochalasin D (CCD) or B could also be successfully used to 
block the polar body formation and the population of parthenogenetic oocytes with 
2PN (haploid) could be achieved. In this study the observation of 2PN + 1PB shows 
the presence of two haploid pronuclei. However, it is not studied that either the 
oocytes divided before the synthesis of another set of chromosomes or they cleaved 
immediately. The cytogenetic studies of the parthenotes could provide solid 
informations in recognizing the population of haploids and diploids. 
The observation on the nuclear morphology post fusion in embryos 
reconstructed by transferring G  or GuS phase and S-phase donor nuclei into pre-
activated oocytes using Strontium co-activation protocol showed no NEBD and 
PCC. The results provides the evidence that strontium co-activation protocol did 
lower the CSF and MPF activity. In contrast when the embryos were activated using 
Strontium chloride alone, the basal level showed 41.7% ± 4.22 NEBD and 10.25% 
± 3.7 NEBD & PCC in reconstructed embryos (Fig: 6.2) which is the evidence of 
the presence of some MPF activity. These observations suggests the need for longer 
exposure to strontium or the use of strontium co-activation protocol (strontium 1 hr 
then 6-DMAP 3 hr) to activate the recipient cytoplast to use them as "Universal 
recipient". The results of experiments also demonstrates that the cytoplasts activated 
using Strontium co-activation protocol support development with higher proportions 
of embryos reconstructed by using donor nuclei from any stage of 3rd cell cycle. 
The results presented in table 5.6 that except one, none of the embryos 
reconstructed by nuclear transfer showed NEBD or NEBD & PCC. As evident from 
figure 5.4, no nuclear envelope breakdown and premature chromosome 
condensation occurred in the donor nuclei after fusion, suggesting the absence of 
MPF activity. Campbell et al., (1993) suggested the use of pre-activated oocyte with 
no MPF to reconstruct the embryos in nuclear transfer experiments . It was also 
suggested that if no NEBD and PCC occurs, all the donor nuclei will support 
development regardless of their cell cycle stage. These changes in donor nuclei are 
induced by the complex of p34cdc2 and cyclin B (Nurse, 1990). The maturation 
promotion factor is regulated by its phosphorylation state. The higher cytoplasmic 
activity of MPF causes NEBD and chromatin condensation. All embryos 
reconstructed by nuclear transfer into MIT cytoplasts when MPF activity was high 
underwent NEBD & PCC (Fig: 6.2). The results of the experiments presented in 
table 5.5 are in agreement with Fulka et al., 1996 and Campbell et al., 1993) who 
reported development in nuclear transfer embryo reconstructed after lowering the 
level of MPF. The enhanced development of embryos reconstructed by using 
cytoplasts activated with Strontium co-activation protocol (+DMAP) is interpreted in 
the sense of the treatment of cytoplasts with DMAP, preserved the integrity of the 
nuclear envelope and normal synthesis of DNA. The use of DMAP treatment in these 
experiments helped in lowering the MPF activity and embryos reconstructed by 
nuclear transfer from donor nuclei of different stages in the absence of MPF undergo 
for development. 
These experiments established that the sequential exposure to strontium and 
6-DMAP provide a more effective means of activating represent oocytes than the use 
of strontium alone. However, the study of Wakayama et al., (1998) demonstrated 
the use of lower concentration (10 mM) of strontium for longer duration to properly 
activate the reconstituted embryos. The study also concludes that treatment of 
cytoplasts with 6-DMAP after activation provides good opportunity to create 
"Universal recipients" and to enhance development by transferring donor nuclei from 
all stages of 3rd cell cycle. It further suggests that the integrity of the nuclear 
envelope could be maintained and normal ploidy is expected in nuclear transfer 
embryos by using strontium co-activation protocol and difference in development 
between treatments is expected due to cell cycle stage effect of donor nuclei. 
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CHAPTER 6 
THE EFFECT OF CYTOPLASMIC 
ENVIRONMENT 
6.1- INTRODUCTION 
Previous experiments on nuclear transfer in mammalian species have 
demonstrated the role of cytoplasmic environment on the morphological changes in 
the donor nuclei after transfer and fusion with the enucleated metaphase II oocytes. 
These include nuclear envelope breakdown (NEBD), premature chromosome 
condensation (PCC), dispersal of nucleoli, reformation of nuclear envelope and 
nuclear swelling (Collas et al., 1992). In contrast, when pronuclear zygotes were 
used as recipient cytoplasm, no NEBD and PCC was observed. Reports of the 
previous studies have shown that NEBD and PCC are essential for the 
reprogramming of gene expression and these events increase the developmental 
potential of the reconstructed embryos (e.g., in the rabbit [Collas et al., 1992a]). 
However, the extent and timing of these events vary between species and the stage of 
the donor cell cycle (Collas et at., 1992b). 
The development to blastocysts of reconstructed embryos have been reported 
to be greatly effected by the stage of the cell cycle of the donor nuclei, transfer of 
donor nuclei at Gi or early S-phases of cell cycle proved better as compared to those 
transferred at late S and G2 phases (Collas et at., 1992a). The morphological 
examination of the embryos reconstructed by using donor nuclei at GI and early S-
phase had suggested very little effect of cytoplasmic environment on the 
chromosomal constitution of the donor nuclei. In contrast, large chromosomes and 
other chromosomal abnormalities have been observed in the embryos reconstructed 
from late S phase (Collas et at., 1992b). Reports of previous studies suggests that 
this effect is induced by high level of maturation promoting factor (MPF) activity, 
present in Mill oocytes and in mitotic cells (reviewed by Nurse, 1990 and Mailer, 
110 
1991). MPF was shown to be universal regulator of G2IM transition in eukaryotes 
(reviewed by Masui, 1992). MPF is the complex of two sets of proteins, cyclins 
(Swenson et al., 1986; Labbe et at., 1989) and 34cdc2  protein kinase (Dunphy et at., 
1988; Labbe et al., 1989) whose activity is measured using exogenous histone Hi as 
a substrate. Activation of the p34 cdc2 lunase requires cyclin (Murray et al., 1989) and 
the kinase activity of p34 cdc2  -cyclin complexes is regulated by the changes in the 
phosphorylation state of both components (reviewed by Clarke and Karsenti, 1991). 
Mammalian oocytes remain arrested at metaphase of second meiotic division 
until they are fertilized or activated (spontaneously or artificially). This arrest is 
maintained by high levels of maturation promotion factor (MPF) (Kubiak et at., 
1993), which is stabilized by the action of another cytoplasmic component, the 
cytostatic factor (CSF) (Gerhart et al., 1984 and Watanabe et al., 1989). The 
cytostatic factor (CSF) is now known to be the c-mos proto-oncogene product 
(Mos) (Sagata et al., 1989). At fertilization, a series of repetitive Ca 2 transients 
occur (Cuthbertson and Cobbold, 1985; Igusa and Miyazaki, 1986 and Taylor et al., 
1993) which are responsible for the destruction of MPF and re-entry into the cell 
cycle (Kline and Kline, 1992). The C2 transients stimulated at fertilization continue 
until the formation of pronuclei in the one cell mouse embryo (Jones et al., 1995). In 
nuclear transfer experiments, the Ca 2 releasing activity of karyoplasts from fertilized 
embryos has been demonstrated previously by their ability to activate ME-arrested 
oocytes (Kono et al., 1995). The study of Kono et al., (1996) demonstrates that 
fertilized embryos generate transients at nuclear envelope breakdown (NEBD) and 
during mitosis. In contrast, parthenogenetic embryos produced by 2-hr exposure to 
strontium containing medium do not generate detectable Ca 2 transients at NEBD or 
in mitosis. These studies suggests that the donor nuclei at all cell cycle stages except 
M-phase when transferred into ME-arrested cytoplasts generate Ca 2 transient at 
NEBD. The findings that local Ca 2 changes (Cheong et at., 1993; Yao and Parker, 
1994) and that NEBD releases Ca 2 supported the view that local Ca 2 transients in 
the nuclear region may induce NEBD and progression through mitosis. 
CSF or Mos is also inactivated by the transient increase in the cytoplasmic 
free calcium (Meyerhof and Masui, 1977; Watanabe et al., 1989 ) and it was 
demonstrated that CSF inactivation is the primary cause of MPF inactivation on 
meiotic release (Sagata et al., 1989; Newport and Kirschner, 1984; Gerhart and 
Kirschner, 1984;). Degradation of the proto-oncogene product p39mos is not 
necessary for cyclin proteolysis and exit from meiotic metaphase (Lorca et al., 
1991). The study of Watanabe et al., (1991) in Xenopus eggs demonstrates that at 
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molecular level, cyclin subunit of MPF are degraded before Mos is degraded and, at 
physiological level, that MPF activity is inactivated before CSF activity during 
activation. These results have provided the evidence that a calcium transient on 
fertilization induces a CSF-independent pathway for MPF inactivation, whereas CSF 
inactivation during meiotic release serves only to allow the fertilize egg to enter 
mitosis. So the activity of CSF after activation decreases slowly. 
After reconstruction of embryos with the technique of nuclear transfer, 
nuclear envelope breakdown (NBBD) and premature chromosome condensation 
(PCC) occur in the donor nucleus (e.g. in mouse Czolowska et al., 1984). The 
induction of NEBD and PCC is mediated by maturation promotion factor (MPF), 
(reviewed by Nurse 1990 and Maller, 1991). Studies of Campbell et al., (1993) in 
bovine, suggests that all nuclei transferred into Mil cytoplasts in which MPF activity 
is high undergo NEBD and PCC. In contrast when the embryos were reconstructed 
after the disappearance of MPF activity (10 hours post activation), no NEBD and no 
PCC were observed. However, the study showed the level of MPF after activation 
as measured by Hi kinase reached to its basal level of 20 ± 6% at 120 minutes. The 
study further suggested that if MTI cytoplasts were used to reconstruct the embryos 
- - -. then only Gi should..be transferred at the time of activation. In contrast, the use of 
pre-activated cytoplast ( Universal Recipient) creates a cytoplasmic environment able 
to support development of embryos reconstructed using donor nuclei from any stage 
of cell cycle. In mouse, it may be difficult to establish "Universal recipient". 
Thus the present series of experiments was planned to optimize the time for 
embryo reconstruction using GI and G2 donor nuclei into different cytoplasmic 
environment after cytoplast activation and to find out the cytoplasmic environment 
representative of "the Universal recipient " in mouse. 
The results of lower development in the above mentioned experiment 
suggested the need to re-ensure the length of cell cycle in enucleated and non-
enucleated oocytes. So the experiments were also performed to evaluate the cell cycle 
length of enucleated and non-enucleated oocytes. 
The third series of experiments were planned to map the level of MPF and to 
find out the basal level of MPF representative of the "Universal recipient". 
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6.2- DEVELOPMENT AFTER NUCLEAR TRANSFER 
The study of Otaegui, 1995 (Ph.D. thesis), investigating the effect of 
interaction between donor nuclei and recipient cytoplast cell cycle phases 
demonstrated the use of cytoplasts at different stages of cell cycle. However, the 
proportion of development to blastocysts in embryos reconstructed by transferring S-
phase and G2 phase remain restricted at low level. As the level of MPF activity 
varies after activation which give rise to different type of cytoplasmic environments, 
it was decided to reconstruct the embryos at various times post activation to optimize 
the time of Gi and G2 donor nuclei for reconstruction of embryos and to find out the 
cytoplasmic environment representative of "the Universal recipient" in mouse. 
6.2.1- EXPERIMENTAL DESIGN 
Oocytes recovered after 14 hours post hCG injection were denuded using 
300 i.u. hyaluronidase/mi in M2 medium. The oocytes were enucleated by using 
micromanipulation procedures (see section 3.4.4). The enucleated oocytes 
(cytoplasts) were activated by using 25 mM strontium chloride in M16 medium for 1 
hour. The donor 2-cell embryos were recovered at 44-48 hours post hCG injections 
after mating with the same F1 hybrid males. Until required they were placed at low 
temperature in M2 medium under paraffin oil. They were synchronized by culturing 
them in sM16 medium containing 10 gM Nocodazole for 8-12 hours. They were 
released in batches after washing them thoroughly with M2 medium several times to 
remove the effect of Nocodazole. They were cultured in sM16 and were used for 
reconstruction of embryos as soon as possible to capture the Gi stage of 3rd cell 
cycle (4-cell). The donor nuclei started dividing within 60 minutes and used for 
nuclear transfer 75 minutes after their release from synchronization. The donor nuclei 
at this time were considered at GI or 01/S stage of cell cycle. The embryos were 
reconstructed at zero, 2-3, 4, and 6 hours post activation. On the other hand 2-cell 
donor nuclei were recovered at 40-44 hours post hCG injection and mating, to use 
them at G2 stage of 2-cell cycle and the embryos were reconstructed at 3, 4, and 6 
hours post activation of cytoplasts. All couplets were fused by using sendai virus 
(8000 HAU). The observations on the development competence of the reconstructed 
embryos were recorded. 
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6.2.1.1- STATISTICAL ANALYSIS 
The data was analyzed using Generalized Linear Mixed Model (Breslow and 
Clayton, 1993) looking at the effect of treatment whilst allowing for differences 
between days. The treatment effects were tested using a Wald statistics (distributed 
as chi-squared), and if significant differences between mean were assessed by an 
approximate t-test. Means declared to differ, differ at the 5% level or better. 
6.2.2- RESULTS 
The experiments were conducted to reconstruct the embryos at different times 
post activation of the cytoplasts and the results are presented in Table 6.1. The fusion 
rates are appreciably higher in the embryos reconstructed at 4 hours (96%) and 6 
hours (87%) post activation by using 2-cell (G2) donor nuclei as compare to the 
embryos reconstructed by using 4-cells (GI or GuS) donor nuclei. 
Using 4-cell (GI or early S) donor nuclei at 0, 2-3, 4 and 6 hours post 
activation, the development to 2-cell was observed 34, 47, 50 and 29% respectively. 
A significant time effect (p< 0.01) was observed when the development to 2-cell 
from fused were compared. The development to 2-cell is shown to be good when 
embryos were reconstructed using cytoplasts at 2-3 or 4 hours post activation as 
compared to the embryos reconstructed 6 hours post activation. However, the 
analysis showed no distinguishable difference from all others when compared with 
the embryos reconstructed at 0 hours post activation. 
The maximum development to morula/ blastocysts was observed to be 39% 
and 29% respectively, when 2-3 and 4 hours pre-activated oocytes were used at the 
time of Gi blastomere deposition. In contrast when 2-cell (G2) stage donor nuclei 
were used for reconstruction of embryos at 3, 4 and 6 hours post activation, 42, 46 
and 26% respectively, development to 2-cell was observed and the analysis of the 
data showed a significant time effect (p< 0.01). The development to 
morula/blastocyst (Table: 6.2) stage is shown to be 11. 1, 14 and 2% respectively. 
Slight difference in the development up to 2-cells stage of embryos reconstructed at 
3,4, and 6 hours post activation using donor nuclei at 4-cell (Gi or GuS) and 2-cells 
(G2) stages is observed, however, the analysis showed no donor effect. 
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Table. 6.1 
Development after nuclear transfer of embryos reconstructe 
at various times post activation of enucleated oocytes by 
using 2-cell (G2) and 4-cell (Gi or early S) blastomeres 
Nucl.Donor 	Trt. 	Rep. Tot. Fused % 2-cell/fu % Mor/Bl. 
	
0 h 	3 	64, 	34 	8 
2-3hpa 4 49 47 39 
4-cell 	4 hpa 	4 	34 	50 	29 
(Gi or 6hpa 2 17 29 6 
Gj/S) 
3hpa 	4 	36 	42 	11.1 
2-cell(G2) 	4 hpa 7 96 46 14 
6hpa 	5 	87 	26 	2 
hpa = hours post activation 
6.2.3- CONCLUSIONS 
Development to morula/blastocyst stage in the embryos reconstructed using 
donor nuclei from 4-cell embryos is shown to be maximum when 4-cell donor nuclei 
(Gi or early S) were fused at 3 and 4 hours post activation of oocytes. 
No significant difference was observed in the development of the 
reconstructed embryos to 2-cell, by transferring donor blastomeres from 4-cell (GI 
or GuS) and 2-cell (G2) at 3, 4, and 6 hours post activation of cytoplasts, however, 
further development to morula/blastocyst is shown to be much higher in the embryos 
reconstructed at 2-3 and 4 hour post activation of cytoplast using 4-cell (Gi or GuS) 
blastomeres. 
The development using 4-cell donor nuclei at Gi stage of cell cycle at the time of 
activation (0 hpa) was unsuccessful. This could be explained due to improper use of 
donor cell cycle stage. The donor nuclei might not be at Gi stage of cell cycle 
because later experiments showed enhanced rate of development with Gi donor 
blastomeres. The lower rate of development by using 2-cell (G2) nuclei as donor 
blastomeres is expected due to partial exposure to MPF, unable to cause complete 
chromatin condensation or nëessiryrépr6graniining. 
6.3- MAPPING OF FIRST CELL CYCLE LENGTH 
The reconstruction of embryos by transferring donor nuclei at different stages 
of recipient cell cycle failed to reveal the stage of recipient cytoplast representative of 
the universal recipient and suggests that perhaps there is a small window in the cell 
cycle for basal level of MPF. So it was advisable to check the length of the first cell 
cycle. Thus the present experiment was planned to investigate the length of the 1st 
cell cycle of the enucleated and non enucleated oocytes. 
6.3.1- EXPERIMENTAL DESIGN 
To map the cell cycle length, the oocytes were recovered 14 hours post hCG 
injections and were treated with hyalauranidase (300 i.u./ml) to denude them from 
the cumulus cells. The oocytes were divided into two groups. One group of oocytes 
were enucleated by using micromanipulation procedures (see section 3.4.4). Both 
the groups (nucleated and non-enucleated) of oocytes were activated by using 25 mM 
of strontium chloride in Ca, Mg free M16 for one hour. The oocytes after activation 
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were washed with several changes of M2. They were incubated in the microdrops of 
sM16 at 37°C in 5% CO2 in air, in 60 mm plastic petn dishes prepared at least 2 
hours prior to incubation. Both the groups were observed every hour after activation 
until the time of first fragmentation / cell division and then observed after every 30 
mm. to record the observations. 
6.3.2- RESULTS 
The first cell cycle length, assessed by activating the non-enucleated and 
nucleated oocytes, is presented in Table 6.2. The length of the 1st cell cycle of the 
non-enucleated oocytes ranged from 18.7-22 hours (Table: 6.2) with an average of 
20.41 hours. In contrast in the enucleated oocytes fragmentation (taken as attempted 
cleavage) was observed from 13.2-17.5 hours (Table 6.2) with an average of 14.5 
hours. 
6.3.3- CONCLUSIONS 
In fact the cell cycle of enucleated oocytes is short. The length of 1St cell 
cycle in. non enucleated parthenotes was observed to be 20.41 hours (Fig. 6.1). In 
contrast the length of the 1st cell cycle in enucleated parthenotes is shown 5.91 hours 
earlier i.e. 14.6 hours (Fig. 6.1). 
MPF activity starts declining after activation and reaches its basal level 
around 4 hours post activation and then starts rising again after 6 hours post 
activation (Fig. 6. 1), the rise in MPF in the absence of nucleus causes fragmentation. 
6.4- MAPPING THE LEVEL OF MPF, ITS EFFECT ON 
DONOR NUCLEI AND DEVELOPMENT 
The length of the 1st cell cycle in enucleated parthenotes is short which 
suggested the need for mapping the level of MPF and to investigate how long the 
MPF level stays at basal level. As the level of MPF declines with the passage of time 
after activation of the cytoplasts, the observations of the proportion of NEBD and 
NEBD&PCC of the transferred donor nuclei into the cytoplasm could provide good 
estimation of the level of MPF. 
The study aimed to map the level of MPF by evaluating its effect on the morphology 
of transferred donor nuclei through NEBD and NEBD&PCC.. 
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Fig: 6.1 Graph showing the timing of fragmentation 
or cleavage in enucleated and non-enucleated 
mouse parthenotes respectively 
—D-- % Fragmented (enucleated) 











First cell cycle length after activation of non-en ucleated and enucleated 
oocytes with 25mM Strontium chloride for 1 hours 
Groups 	 Rep. 	No. 
Enucleated 	4 	34 
Non- 	 3 94 
enucleated 




6.4.1- EXPERIMENTAL DESIGN 
4-6 weeks old F! hybrid (C57 BL/6 X CBA) female mice were 
superovulated and the oocytes were recovered 14 hours post hCG injections. The 
oocytes were denuded by using 300 i.u. hyaluronidase/mi in M2 medium. Oocytes 
were treated with lpg/mi Hoechst 33342 for 5 mm. to examine the chromosomes 
and stage of maturation. The 2-cell donor nuclei were recovered 40-44 hours post 
hCG injections and mating. 
The oocytes were enucleated within 3 hours of their recovery by using 
micromanipulation procedures (see section 3.4.4). The enucleated oocytes 
(cytoplasts) were activated by using 25 mM strontium chloride in Ca Mg free M16 
medium for 1 hour. Late 2-cell (G2) blastomeres were used as nuclear donor 
(Karyoplasts). The embryos were reconstructed at zero, 2-4, 4-6, 6-8, 8-10, and 10-
12 hours post activation. The zero hour of activation was considered, when they 
were first exposed to the activation medium (Strontium chloride). The donor nuclei 
were deposited into the perivitiline space of the zona pellucida of the cytoplast in a 
micromanipulation chamber containing 7.5 tg Cytochalasin B, 10 jiM Nocodazole 
and 10% FCS in M2 by using holding and injection pipettes. The fusion was Sendai 
virus mediated. After reconstruction, the couplets were immediately washed with M2 
medium with several changes and incubated in the previously prepared dishes 
containing microdrops of sM16 medium having 10 jiM Nocodazole until fusion. One 
hour after fusion, the oocytes were washed with M2 medium and were mounted on 
to the slides. They were fixed in an acetic acid: methanol (1:3, v/v) for 24 hours and 
were stained with 2% aceto-orcene. The nuclei of reconstructed embryos were 
examined for NEBD and NEBD&PCC under phase contrast microscope, 
photomicrographed and observations were recorded. 
6.4.2- RESULTS 
The effect of MPF activity on the NEBD and NEBD&PCC is shown in 
figure: 6.2. The scanning of reconstituted orcene stained embryos for NEBD and 
PCC under high magnification revealed that all donor nuclei fused at 0 hours of 
activation had undergone nuclear envelope breakdown (Fig. 6.3 photomicrograph 
for NEBD) and 90% ± 3.22 showed NEBD and PCC (Fig. 6.3 photomicrograph for 
NEBD&PCC). 
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Fig: 6.2 Graph showing NEBD and NEBD-I-PCC activity 
in reconstructed embryos (Mean±S.E.M.) 
-0- % NEBD 
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Fig. 6.3 Effect of MPF on the nuclear morphology o f 
transferred nucleus. 
NEBD and PCC in the embryos reconstructed at zero hour of activation 
NEBD in the embryos reconstructed 2 hours post activation 










The frequency of NEBD+PCC declines rapidly after 2 hours post activation as the 
percentage of donor nuclei which undergo NEBD & PCC decreased to 28.24% ± 
4.69. The basal level of MPF is observed 4 hours post activation where the 
percentage of NEBD and NEBD & FCC reaches to 41.7%±4.22 and 10.25% ±3.7 
respectively (Fig. 6.4 showing the nuclear envelope). The level of MPF starts rising 
again after 6 hours post activation as the percentage of reconstituted embryos which 
undergo NEBD and NEBD & PCC increases to 95.5%±2.78 and 34.86% ± 8.5 
respectively. 
The level of MPF almost reached pre-activation level after decay was attained 
at 10 hours post activation as the percentage of NEBD and NEBD & PCC was 
observed 97.78% ± 2.2 and 47.42% ± 4.6 respectively. 
6.4.3- CONCLUSION 
MPF activity in murine oocytes starts declining rapidly after activation within 
2-3 hours and reaches its basal level around 4 hours post activation and then starts 
rising again after 6 hours post activation (Fig. 6.2) 
The results imply that the MPF level stays for very short time at basal level. 
Hence the use of enucleated cytoplast as universal recipient is disappointing. 
6.5- DISCUSSION 
The results of experiments conducted to study the effect on development of 
mouse embryos reconstructed by nuclear transfer at different times after activation 
confirms that development to 2-cell is greatly influenced (p< 0.01) by the cell cycle 
stage of the recipient cells. The observations on the timing of the initiation of 
cleavage of non-enucleated and fragmentation of enucleated oocytes (Table: 6. 1) 
indicated that fragmentation time in enucleated post activated oocytes is about 5.5 
hours earlier than cleavage in the non-enucleated ones. One possible explanation of 
this early fragmentation in enucleated oocytes is that MPF activity returns after 
strontium activation. The early rise in the level of MPF during the time of pronuclear 
formation was unexpected (fig 6.2). It was anticipated that the level would remain 
low after strontium activation. The study of Jones et al., (1995) has demonstrated 
that the Ca2 transients stimulated at fertilization continue until the formation of 
pronuclei in the one cell mouse embryo. The observations of early rise in MPF in 
present study may be the use of strontium activation protocol in this experiment, 
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which does not mimic adequate events during activation. Although it initiates early 
development, the stimulus is inadequate and suggests the need for longer exposure to 
strontium. The study of Bos-Mikich et at., (1995) and Wakayama et al., (1998) in 
mouse demonstrates the use of 10 mM of strontium for longer period of time. 
However, the combination of strontium and protein phosphorylation inhibitor (6-
DMAP) was observed beneficial in parthenogenetically activating the metaphase II 
oocytes (chapter 5). The combination of Strontium and protein synthesis inhibitor 
was also shown to be effective in parthenogenetic activation of mouse oocytes (Bos-
Mikich et at., 1995). The study further demonstrates that strontium treatments leads 
to Ca" -dependent CSF destruction and cycloheximide leads to loss of MPF activity. 
The other reason may be due to the lack of feed back mechanisms in the absence of a 
nucleus. As observations on the level of MPF (Fig: 6.2) suggests that MPF starts 
rising after 6-8 hours post activation, this rise in the MPF level may induce cleavage-
the nucleus may be involved in direction of cleavage plane. Lack of a nucleus may 
disrupt this leading to uncoordinated cleavage and fragmentation. 
The results of experiment conducted to map the level of MIPF through evaluating 
the nuclear morphology (Fig: 6.2) that MPF disappears within 2-3 hours post 
activation and development to morula/blastocyst (39%) was observed in nuclear 
transfer embryos reconstructed 2-3 hours post activation of cytoplasts. It is evident 
from the experiment conducted to map the cytoplasmic activity of MPF that the 
cytoplasmic activity of MPF reaches its basal level around 4 hours post activation 
(Fig: 6.2) and development to 2-cell after nuclear transfer is 50% but shows less 
development (29%) to morula/blastocyst stage. The enhanced activation by further 
release of Ca2 transient with the NEBD of donor nuclei (Kono et at., 1996) in 
embryos reconstructed at 2-3 hours post activation with strontium containing medium 
could be responsible for increased development. The low rate of development to 
morula/blastocyst in the embryos reconstructed at zero and 6-8 hours post activation 
by using 4-cell (G I) donor nuclei was observed as 8 and 6% respectively. The results 
of the studies by Collas et at., (1992a) in rabbits and Cheong et at., (1993) in mice 
demonstrated high rate of developments when embryos reconstructed by using G 1 
stage donor nuclei and metaphase II recipient cytoplasts. In this study the difference in 
the development to morula/blastocyst stage of the embryos reconstructed at different 
times post activation of the cytoplasts could be because donor nuclei were probably in 
S-phase and not GI at the time of fusion and there was maximum activity of MPF and 
CSF at zero hours of activation and increased activity, after destruction, at 6 hour post 
activation. As a result of this MPF activity, NEBD and PCC occurred in donor nuclei 
and a lower rate of development to morula/blastocyst was observed. 
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The donor nuclei which were at late 2-cells or G2 stage, when fused to 6-8 
hours pre-activated oocytes, developmental competence to morula/blastocyst stage 
(2%) was quite low, which is expected because of the aneuploidylDNA damage of 
the chromosomes in the presence of MPF activity. The result could be correlated 
with the level of MPF , that level of MPF in enucleated activated cytoplasts stays at 
its basal level for short time and provides very small window of opportunity to use 
them as "Universal recipient". The level of MPF started rising again after 6-8 hours 
of activation, the donor nuclei which were at late 2-cells or G2 stage, when fused to 
6-8 hours pre-activated oocytes, did not develop to blastocyst stage perhaps because 
of the aneuploidyfDNA damage to the chromosomes due to increasing activity of 
MPF activity. 
When nuclei from 4-cell embryos were transferred to Mil cytoplasts, the 
largest proportion of embryos developed morula (34%) and blastocyst (8%), when 
the donor nuclei were in early Gi-phase. These result confirm earlier reports in 
which development to blastocyst was achieved with nuclei in GI-phase when 
embryos were reconstituted using metaphase II oocytes as recipient (Collas et at., 
1992a, Cheong et al., 1993). The maximum development in this case is probably 
due to synchrony in the cell cycle stage of both the donor nuclei and recipient 
cytoplasm. The proportion of reconstituted embryos that developed to blastocyst 
following nuclear transfer and activation at the same time was lower than that 
reported in the literature (Kono et at., 1991b; 1992; Cheong et at., 1993), suggests 
the need for manipulation practice. 
This study provides observations on the cell cycle co-ordination of donor and 
recipient cells. The Fragmentation in non-enucleated cytoplasts occurs earlier (13.5 
hr) in the absence of nucleus. The results implies that the MPF level stays for short 
time at basal level, hence there is very small window of opportunity for using the 
cytoplasts as universal recipients in mouse. However, further experiments to achieve 
proper activation stimuli through prolonged exposure of MiT cytoplast to strontium 
medium are suggested. 
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CHAPTER 7 
DNA Replication in 3rd and 4th cell cycle: 
Duration of the GI phase 
7.1: INTRODUCTION 
The studies of Campbell et al., 1993 in bovine in this laboratory suggested 
that normal development after nuclear transfer is expected only by maintaining the 
normal ploidy. The study of Otaegui, (1995 Ph.D. thesis) in mouse and other earlier 
findings demonstrates that development after nuclear transfer of reconstructed 
embryos is greatly influenced by the cell cycle phase of the donor nuclei (Smith et 
al., 1988; Tsunoda et al., 1989 and Kono et al., 1991b). Increased development 
after nuclear transfer of donor nuclei at Gi phase of cell cycle has been reported by 
different researchers (Collas et al., 1992a in rabbits; Cheong et al., 1993 in mice). 
The results obtained by Otaegui, (1995 Ph.D. thesis) demonstrate the use of 
GI donor nuclei as nuclear donor to reconstruct the embryos by using MIT or S-. 
phase cytoplasts. It was further suggested that by using the permissive window of 
the Gi-phase of the cell cycle, development after nuclear transfer could be 
maximized. The rate of development after nuclear transfer with the donor nuclei at 
Gi stage depends on the ability of the researcher to physically select the donor 
nuclei at Gi-phase of the cell cycle. In the experiments presented in chapter 5, the 
number of nucleoli (9-12) were used as the basis to select donor nuclei at Gi-phase 
of cell cycle. A short duration of the Gi-phase has been reported by Otaegui, (1995 
Ph.D. thesis) i.e. 45 minutes, however, 1 to 1.5 hours duration was reported by 
another study (Smith and Johnson, 1986). 
GI was originally defined as a time interval, a gap between the readily 
observed events of mitosis and DNA synthesis. The pre-DNA synthetic (Gi) period 
is usually considered as the time in the cell cycle when a cell is signaled to proceed 
for another round of DNA synthesis and subsequent mitosis (Prescott, 1976). In 
cultured mammalian cells, the duration of Gi may range from 2 to 20 hours. There 
is also the example of a Chinese hamster cell line (V79) which is devoid of Gi 
/ 
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period (Robbins and Scharff, 1967). The fact that mammalian cells without a Gi 
can be found suggests that this period (Gi) is not very essential and can be 
eliminated without affecting the rest of the cell cycle. In those cells having a long 
Gi period, the initiators of DNA synthesis were reported to be made toward the end 
of this phase (Prescott, 1976). The cell fusion studies of Rao and Johnson (1970) 
showed that binucleate cells produced by fusion between two GI cells entered S 
phase at about the same rate as mononucleate cells. However, the later study of 
Fournier and Pardee (1975) on Syrian hamster BHK21 / C13 cells indicated that 
binucleate cells, produced by treating mitotic cells with Cytochalasin B for 90 
minutes, completed Gi period significantly faster than their mononucleate 
counterparts. To explain these results, they proposed a model, according to which 
there is a nuclear cooperation for the initiation of DNA synthesis, which is non-
concentration dependent. They assumed that, among the multinucleate cells, each 
nucleus makes a critical substance during early G  which is utilized during late Gi, 
and the total amount, not the concentration, of the substance determines the 
duration of Gi. The greater the amount of this substance available, the shorter is the 
GI period. Because binucleate cells make twice the amount of this substance than 
the mononucleate cells they have shorter GI period. This provides the clue that 
why the cell cycle in mouse is longer in the start of development to 2-cells and then 
become shorter as development proceeds and showed shorter duration of G 1. 
Cell proliferation markers are a prerequisite to study the initiation of DNA 
replication in normal cell cycle. Experiments are performed to localize the 
proliferating cell nuclear antigen (PCNA) which is a highly conserved protein 
expressed only in cells committed to DNA synthesis. PCNA plays an essential role 
in nucleic acid metabolism as a component of the replication and repair machinery 
(Kelman, 1997). 
Proliferating cell nuclear antigen (PCNA) is a 36kD nuclear protein which 
has been demonstrated to be a co-factor for DNA polymerase 8 (Bravo et al., 1987) 
and is essential for the synthesis of DNA during the S-phase of cell division. PCNA 
is detectable immunocytochemically only at S-phase and may be used as a naturally 
occurring marker for cell proliferation (Galand and Degraef, 1989; Thaete et al., 
1989; Hall and Woods, 1990). Based on fixation procedures two forms of PCNA 
can be visualized in cultured cells (Bravo and MacDonald Bravo, 1987) 1) a soluble 
nucleoplasmic form, which persists throughout the cell cycle, and 2) an insoluble 
form, which appears during S-phase and is associated with the sites of DNA 
replication, exhibiting distinctive punctate staining patterns (Kill et al., 1991). 
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A previous study of Otaegui, (1995 Ph.D. thesis) to determine the DNA 
synthesis timing was based on the immuno-detection of BrdU incorporation which 
indicated that BrdU incorporation starts at 165 minutes after release from 
synchronization. As the minimum period of 45 minutes of incubation with BrdU 
was required to determine the DNA synthesis in preimplantation embryos , it was 
hypothesized that perhaps the lower development after nuclear transfer could be 
improved by using a more accurate selection criterion of using donor nuclei at G 1, 
based on the information of detection of PCNA localization and BrdU 
incorporation for the start of replication period. 
The following experiments were designed to determine: 
Length of G  phase 
Timing of the onset of DNA replication in the 3rd and 4th cell cycle of pre-
implantation mouse embryos by employing the techniques of pulse labeling. 
7.2 INITIATION OF DNA REPLICATION AND PCNA 
LOCALIZATION. 
The aim of the experiment was to determine the timing of events of mouse 
preimplantation embryos, to answer the question of how long the GI-phase lasts 
and when DNA replication starts in 3rd and 4th cell cycle of mouse preimplantation 
embryos. 
7.2.1 EXPERIMENTAL DESIGN 
To determine the timing of events of mouse preimplantation embryos and 
the start of DNA replication , 2-cell embryos were recovered from Fl females 44-
48 hours post hCG injections and mating. When 4-cell embryos were required, they 
were recovered 58 hours post hCG injections and mating. The embryos were 
exposed to 10 pM nocodazole in M16 at 37°C in 5% CO 2 in air for 9 hours for 
synchronization. Embryos were washed in many drops of M2 and sMl6 to released 
them from synchronization and cultured in drops of sM 16 under paraffin oil at 
37°C in the atmosphere of 5% CO2 in air. 
Embryos started dividing after 30 minutes of their release from the 
synchronization medium and mitosis was completed within 90 minutes (Data not 
shown). The embryos were divided into batches of 10-15 embryos in each groups. 
Embryos were exposed to PCNA staining in batches starting from 60 minutes after 
their release from synchronization. 
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7.2.1.1- METHOD OF PCNA STAINING 
The zona pellucidas of the embryos were removed by treating them with 
acid tyrodes. Because prolonged exposure to acid tyrodes is detrimental to 
embryos, the embryos were continuously observed during treatment and removed 
immediately as soon as the zona dissolved. Embryos were washed with PBS and 
placed on to clean coverslips with minimal amount of PBS (coverslips washed 
with 70% alcohol were used). The coverslips were dried briefly and fixed by using 
3.7% formaldehyde at 4°C for 30 minutes. The coverslips were washed with PBS 
and then treated with 0.5% triton X 100 (BDH) for 2 minutes at room temperature. 
It was learned here that different fixation method plays an important role in 
the detection of localization of PCNA. The coverslips were stored in the humidified 
chamber at 4°C till treated with anti-PCNA. The anti-PCNA/cyclin (Immuno 
concepts Cat: No. 2037) was diluted with PBS containing FCS (9.9 ml PBS ± 100 
iM FCS) with the ratio of 1:10 i.e. 450 .il of above diluent and 50 p.1 of anti-
PCNA. The mixture (anti-PCNA) was spun at 1300 rpm for 30 seconds and drops 
of 50p1 were placed on to the fixed embryos on coverslips. The coverslips were put 
in the humidified chamber at 4°C for over night then the coverslips were washed 
with PBS containing 1% FCS. 
The Texas red (Vector Lab. Cat: No. TI-3000) was diluted with PBS 
containing 1% FCS with the ratio of 1:20 and drops of 50 p.1 dilution of Texas red 
were placed on the embryos on coverslips. The coverslips were incubated for 1 
hour at room temperature in a humidified chamber in the dark. The coverslips were 
washed with 4 changes of PBS. The slides were cleaned and 5111  drop of vectashield 
with DAPI (Vector Lab. Cat:No. H-1200) was put on to the each slide and 
coverslips were mounted on them. The coverslips were sealed with nail varnish and 
stored at 4°C in the dark till scanning. 
7.2.2 - RESULTS 
7.2.2.1 DNA SYNTHESIS IN 4-CELL EMBRYOS AS 
DETECTED THROUGH LOCALIZATION OF PCNA 
The Gi-phase is very short as determined from the immuno-detection of 
1757 cells from 500 embryos through the localization of PCNA. DNA synthesis 
was detected as early as 60 minutes after the release of embryos from 
synchronization where 25±4.6% cell showed PCNA localization (Fig. 7.1). The 
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binomial distribution and presented in fig: 7.1 in the form of mean±SE. DNA 
synthesis showed a linear trend as 58.68± 4.48% PCNA positive nuclei were 
observed within 2 hours after their release from synchronization. DNA synthesis in 
embryos reached its maximum after 330 minutes of their release from 
synchronization and all the nuclei of the cells of the embryos were PCNA positive. 
The proportion of PCNA positive nuclei remained high up to 540 minutes after 
release then started to decline and reached to 43.86±6.5% at 630 minutes after 
release. The proportion of the PCNA positive nuclei started increasing again 
(73.68±5.05) at 660 minutes after release but declined again and reached 
30.98±5.4% at 690 minutes. 
7.2.2.2 DNA SYNTHESIS IN 8-CELL EMBRYOS AS 
DETECTED THROUGH LOCALIZATION OF PCNA 
The results of the experiments based on the observations of 3450 cell from 
the 484 embryos are presented in Fig: 7.2. The Gi-phase is quite short in the 8-cell 
embryos as 45.83± 4.5% cells showed onset of DNA replication at 60 minutes after 
release from nocodazole. DNA replication increased abruptly as over 90% cells 
showed localization of PCNA at 120 minutes after release from the nocodazole. 
DNA synthesis reached its maximum (100%) by 150 minutes after release. This 
continued up to 630 minutes after release and then started to decline at 660 minutes 
where 86.05±3.05% cells showed PCNA localization. The PCNA localization 
further decreased at 690 minutes after release and only 32.31±4.1% cells showed 
DNA replication. The PCNA localization started rising again at 720 minutes after 
release from the nocodazole. 
7.2.2.3 - CHANGES IN THE NUCLEAR DISTRIBUTION OF 
PCNA DURING S-PHASE IN CULTURED PRE-
IMPLANTATION MOUSE EMBRYOS; 
The technique of PCNA staining was employed to examine the distribution 
of PCNA localization during S-phase. Earlier studies have shown that during 5-
phase characteristic redistribution of PCNA localization occur and that similar if 
not identical patterns are observed for the sites of DNA replication. The embryos in 
3rd and 4th cell cycle were used after their release from synchronization for PCNA 
staining and the accumulation and distribution of PCNA during S-phase was 
observed (Fig. 7.4 a&b.) 
In these experiments, the patterns of PCNA staining in individual nuclei 
from one of the experiment were depicted in five types termed A-E (Fig. 7.3 ). In 
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Type A, a regular granular pattern was observed over the whole of the nucleus; in 
type B, the pattern showed very few foci of PCNA staining; in type C, the staining 
pattern was punctate but with predominant fluorescence over the perinuclear 
regions; the replication granules were completely excluded from nucleoli (visible 
as darker region Fig. 7.3 a &b) and later in this kinetic study, the nuclei showed 
significant fluorescence appeared over the perinuclear region including the 
perinuclear heterochromatin; in type D, extremely bright fluorescence was observed 
in smaller number of large granules and in type B, the diffused pattern of 
fluorescence was observed in nucleoli which may be the representative of G2 of 
the cell cycle. 
The results of different types of nuclear distributions of PCNA localization 
in 4-cell pre-implantation mouse embryos are shown in Fig.7.4a. Type A pattern 
appeared 60 minutes post their release from synchronization and 50 % nuclei 
showed this pattern and reached to its maximum (61%) at 90 minutes. Type B 
pattern observed was 7% at 60 mm. post release and maximum number (73%) of 
nuclei were observed at 210 mm. after release. Type C was observed (34%) at 120 
mm. post their release and appeared to be dominant in among all patterns observed. 
The higher proportion of nuclei with pattern C was observed at 300 mm. post their 
release from synchronization. Type D pattern was first showed at 330 mm. and 
higher proportion was observed at 630 mm. post release. Type D pattern was 
visible in some of the nuclei at 60 mm. post release may be due to delay in 
completion of mitosis in some of the cells in the embryos. This pattern was again 
shown to be visible at the end of cell cycle. The results of different type of nuclear 
distributions of PCNA localization in 8-cell pre-implantation mouse embryos are 
depicted in Fig. 7.4b. The higher proportion of type A was observed at 60 mm. post 
release from synchronization which decreased to 2% at 150 mm. The varying 
proportions of type B patterns were observed in 8-cell embryos. However, type C 
pattern was observed in 35% nuclei at 90 mm. post release and shown to be 
dominant in the 8-cell embryos. As compared to 4-cell, the nuclei showed higher 
proportion at 210 mm. post their release. Type D pattern was first observed at 360 
mm. post release. In contrast, type E in 8-cell was observed early (450 mm.) in the 
cycle as compared to 4-cell embryos which showed type E pattern near the time of 
mitosis. 
7.2.3.- CONCLUSIONS 
The Gi-phase of the 3rd cell cycle is very short. More than 70% of embryos 
could be used as G  nuclear donor if nuclear transfer was performed 60-90 minutes 
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Fig. 7.3 Different patterns of PCNA localization 
detected through pulse labeling technique 
type A pattern of PCNA localization detected 60 mm. After release 
from synchronization 
type B pattern of PCNA localization detected after release from 
synchronization 
type C pattern shows the perinuclear DNA replication and also 
replication on heterochromatin 
type D pattern was detected in late stages of S-phase 
type E shows the diffused pattern of PCNA localization on the nucleoli 
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Fig: 7.4a Graph showing different types of PCNA localizations indicative of DNA replication 
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Fig: 7.4b Graph showing different types of PCNA localizations indicative of DNA replication 
in S-phase of 4th cell cycle in pre-implantation embryos by pulsing technique. 
Time (mm.) After Release 
after their release from nocodazole. DNA replication reaches its maximum at 330 
minutes after release. DNA replication declined after 9 hours but started rising at 11 
hours after release. This suggests that perhaps cyclin production increases again. 
The Gi-phase of the 4th cell cycle is very short which provides less chance 
to use donor nuclei at GI stage of the cell cycle. The proportion of cells showing 
PCNA localization even at 60 minutes after release is larger than the proportion 
observed in 4-cells embryos which suggests that as the embryos advanced in their 
development, the GI permissive window shortened which creates more difficulties 
using of 8-cell donor nuclei at GI stage of the cell cycle. The increase in the 
localization of PCNA at 720 minutes after the decreasing trend Leads to the 
conclusion that cyclin production resumed again at the end of the cell cycle. 
7.3 - DNA SYNTHESIS AND BROMODEOXYURIDINE 
INCORPORATION 
Bromodeoxyuridine (BrdU) has been used as an alternative to tritiated 
thymidine ([ 3H]TdR) as a tracer for studying DNA replication. The introduction of 
a monocolonal antibody which recognized BrdU in single stranded DNA (Gratzner, 
1982) has enabled BrdU to be used for studying cell cycle kinetics in a similar 
manner to ([ 3H]TdR). Bromodeoxyuridine (BrdU) is a thymidine analog and is 
specifically incorporated into DNA during DNA synthesis. Anti-
Bromodeoxyuridine monocolonal antibody is used to identify cells that have 
incorporated BrdU. 
Otaegui, (1995 Ph.D.) studied DNA replication in preimplantation embryos 
and showed that the technique for the incorporation of BrdU required at least 45 
minutes of incubation. This incubation time might be misleading in concluding the 
timing of initiation of DNA replication in the preimplantation embryos. 
Recently a modified technique of rapid pulsing of BrdU incorporation has 
been introduced in starfish Asterina pectinifera (Nomura et al., 1993), which has 
provided the opportunity to test this in other species. 
The aim of the present experiment was to study the cell cycle kinetics 
through the detection of BrdU incorporation by using the rapid pulsing technique of 
Nomura et al., (1993) with some modifications. 
138 
7.3.1 EXPERIMENTAL DESIGN 
To study the cell cycle kinetics and the timing of initiation of DNA 
replication in 4-cell embryos, 2-cell embryos were recovered from Fl females 44-
48 hours post hCG injections and mating. The embryos were synchronized by using 
the 10 tM of nocodazole in sM16 for 9 hours at 37°C under paraffin oil in an 
atmosphere of 5% CO2. The embryos were released from synchronization medium 
and were washed with M2 and sM16 through several changes. They were cultured 
in sM16 under paraffin oil at 37°C in an atmosphere of 5% CO 2 . The embryos 
started dividing after 30 minutes of their release from synchronization. 
7.3.1.1. RAPID PULSING METHOD OF BrdU 
INCORPORATION. 
The zona pellucida of the embryos were removed by exposing them to the 
acid tyrodes solution. The embryos were continuously observed during their 
exposure to acid tyrodes and washed quickly with PBS as soon as the zona 
disappeared. The group of 10 embryos (8-cells) were exposed to the M16 medium 
containing 10 mM BrdU and 0.125% triton X 100 for 5-8 minutes. After 5-8 
minutes of labelling, the embryos were put on to the clean coverslips air dried and 
fixed later by: (i) treating with methanol for 10 minutes at -20°C, (ii) then with 
3.7% formaldehyde at 4°C for 20 minutes and washed with PBS. 
7.3.1.1.2 IMMUNOCYTOLOGICAL PROCEDURE 
The embryos were stained for the incorporation of BrdU with anti-BrdU-
fluorescein (Boehringer Mannheim Cat: No. 1202 693). The embryos on the 
coverslips were incubated at 37°C in 4 N HCl for 2 hours to denature the DNA. 
They were washed with PBS for at least for 5 minutes with 3 changes. The 
excessive PBS was drained off by touching the edge of the coverslip onto the tissue 
and stored in a humidified chamber. The embryos were covered with 50-100 il of 
solution containing 50p.g/ml anti-Bromodeoxyuridine-fluorescein diluted in PBS 
with 0.1% (w/v) BSA. The coverslips were incubated over night in a humidified 
chamber at 4°C. The next morning coverslips were washed with PBS with 3 
changes over a period of 10 minutes. The slides were cleaned and a 5p.l drop of 
vectashield with DAPI (Vector Lab. Cat:No. H-1200) was put on to the each slide 
and coverslips were mounted on them. The coverslips were sealed with nail 
varnish and stored at 4°C in the in the dark till scanning. 
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7.3.2. RESULTS 
The results were based on the observation of 1447 cells from 420 embryos 
for detection of BrdU incorporation are presented in Fig: 7.6. Data obtained by 
using the rapid pulsing technique of BrdU incorporation showed that DNA 
synthesis in 4-cell mouse embryos initiated at 90 minutes post release from 
synchronization. The standard errors were estimated from the usual expression for 
the variance of a binomial distribution and presented in the form of mean±SE%. 
The embryos released from synchronization showed DNA synthesis 32.86±5.5% at 
90 minutes. DNA synthesis in embryos was observed with an increasing trend in 
relation to time and reaches its maximum 90.28±3.49% at 660 minutes post their 
release from synchronization. However, the end point was not studied in this 
experiment. 
7.3.3. CONCLUSIONS 
The rapid pulsing technique of BrdU incorporation provides opportunities 
for early detection of DNA replication in the preimplantation embryos (Fig. 7.5). 
This technique could be used to determine the timing of the initiation of DNA 
replication in preimplantation embryos and the embryos could be used as donor 
nuclei at Gi stage of cell cycle. Though the pattern of BrdU incorporation showed 
the linear trend of DNA replication in the embryos, the technique needs more 
refinements to be used on regular basis. 
7.4 - COMPARISON OF PCNA AND BrdU PULSE 
LABELING TECHNIQUES IN THE DETECTION OF 
INITIATION OF DNA REPLICATION. 
The results of the above mentioned experiment for detection of initiation for DNA 
replication in 4-cell mouse embryos are depicted in Fig. 7.6. The comparison 
showed that PCNA localization occurred just after their release as about 25% nuclei 
were observed PCNA positive at 60 mm. In contrasts, the detection of initiation of 
DNA replication was first observed at 90 mm. post their release from 
synchronization. After removing the categories of type A and B pattern from the 
data, the result presented in fig 7.7 shows that even the pattern type C (7%) could 
be detected at 60 minutes post the release of embryos from synchronization. The 
results shows that the PCNA pulse labelling technique is more efficient than the 
technique of BrdU for the detection of DNA replication (S-phase) in early embryos. 
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Fig. 7.5 Detection of BrdU incorporation 
using rapid pulsing 
BrdU incorporation detected 390 minutes after release 
BrdU incorporation detected 420 minutes after release 
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Fig: 7.6 Graph showing the difference in recognition of the start of DNA replication 
through PCNA and BrDu techniques 
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Fig: 7.7 Graph showing the difference in recognition of the start of DNA replication 
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7.5 - DISCUSSION 
The results of the experiments presented in this chapter clearly showed the 
difference in the ability of the pulse labeling techniques. 
Of the two techniques used for detection of the initiation of DNA synthesis 
in 4-cell were employed, the PCNA pulse labeling technique proved more effective 
in the detection of initiation of DNA replication. The observation obtained through 
the detection of localization of PCNA suggested that DNA replication starts just 
after the release of embryos i.e. 60 mm. post release. In contrast, rapid pulsing 
technique BrdU incorporation first detected initiation of DNA replication 90 mm. 
post release. The chain elongation as measured by the rapid pulsing technique of 
BrdU incorporation might be due to the low level of BrdU incorporation in early S-
phase which was below the limits of detection. 
By using double indirect immunofluorescence to compare the timing of the 
appearance of PCNA foci with in replicon clusters and their relative distributions 
within S-phase nuclei, the study of Kill et al., (1991) shows that PCNA 
accumulates at the sites of DNA replication some time before any DNA synthesis 
can be detected at those sites. It is further demonstrated that although PCNA is 
located at the sites of active DNA synthesis, it appears to accumulate at these sites 
in a preinitiation complex up to fifteen minutes before replication starts. The results 
of present study in comparing the efficiencies of two techniques used to detect the 
timing of the start of DNA replication in 4-cell mouse embryos, shows that PCNA 
localization occurs some time before the detection of BrdU incorporation in mouse 
embryos. This implies that PCNA is organized into pre-initiation complex that is 
modified before use. 
The results contradicts the earlier findings of Otaegui, (1995 Ph.D. thesis) 
who reported the initiation of DNA replication 165 mm. post release from 
synchronization. The difference in the detection of the initiation of DNA replication 
is due to the difference in the pulse labeling technique of BrdU incorporation. 
The technique employed by Otaegui, (1995 Ph.D. thesis) required at least 45 
mm. for the incorporation of BrdU. In contrast, the rapid pulsing technique used in 
this study required only 5-8 mm. The results of this study for the detection of 
initiation of DNA synthesis by detection of PCNA localization suggests that the G 1 
duration is very short in early pre-implantation mouse embryos. This could be 
correlated with the results of earlier experiments (Chapter 6&8) with nuclear 
transfer using G1 donor nuclei based on the informations of G1 duration of 1.0 to 
145 
1.5 hours (Smith and Johnson, 1986). Previous reports have indicated that PCNA is 
required for eukaryotic DNA replication and have suggested that active DNA 
synthesis occurs at the sites of PCNA localization (Wong et al., 1987; Jaskulski et 
al., 1988; Bravo and MacDonald-Bravo, 1987). 
The results of present experiment that Gi duration is very short, 
demonstrated the use of donor nuclei as early as possible to catch the GI stage of 
the cell cycle. Hence, the nuclear transfer experiment were conducted using donor 
nuclei 15 minutes after their division (chapter 5). The donor nuclei at Gi stage were 
selected on the basis of the number of nucleoli in these experiments. All those 
nuclei containing more than 6 nucleoli were considered at Gi stage of cell cycle 
immediately after mitosis and enhanced development after nuclear transfer was 
achieved. But the nuclei with more than 6 nucleoli as studied in these experiments 
for PCNA localization showed positive staining confirmed the earlier report (Kill et 
al., 199 1) that the localization of PCNA occurred at the sites of DNA replication as 
pre-initiation complex. 
Five patterns of PCNA distribution were observed in the present study i.e. 
Type A-E ( Fig. 7.3). Type A and B pattern of PCNA localization are considered to 
be related with the pre-initiation complex but Type C and D relates to the DNA 
synthesis. Type A and B pattern were shown to be related to one of the pattern 
reported earlier (Bravo and MacDonald-Bravo, 1987). Out of five Types reported 
in this study, three patterns of PCNA distribution observed in the pre-implantation 
mouse embryos agrees with studies of different patterns of PCNA distribution in 
fibroblasts grown in culture (Nakamura et al., 1986; Bravo and MacDonald-Bravo, 
1987; Fox et al., 1991). 
The pattern observed in this study appeared to be a temporal sequence of 
replication in which euchromatin and nucleolar DNA is replicated before 
heterochromatin (Bravo and MacDonald-Bravo, 1987; Nakayasu and Berezney, 
1989). The results are in agreement with the study of Nakayasu and Berezney, 
(1989) who demonstrated that perinuclear synthesis occurs before the internal 
heterochromatin regions are synthesized. Another defused pattern (Type E) of 
PCNA localization was also observed in this study, this looks to be the staining of 
nucleoli in late cell cycle, however, the fluorescence is not bright, or might be the 
soluble nucleoplasmic form of PCNA. The results show that the GI period in pre-
implantation mouse embryos is very short. The PCNA localization occurs in early 
pre-initiation complex of DNA replica clusters. The temporal sequential changes 
occurs in PCNA distribution pattern during DNA replication. 
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CHAPTER 8 
DEVELOPMENT AFTER NUCLEAR 
TRANSFER 
8.1 INTRODUCTION 
The technique of nuclear transfer for the reconstruction of mammalian 
embryos has been extensively used to investigate the nucleo-cytoplasmic 
interactions during early development (McGrath and Solter, 1986). There are two 
ways in which a transferred nucleus may be able to support development, either the 
donor cells may be undifferentiated or the nucleus may be differentiated but be 
amenable to reprogramming by the recipient cell (Wilmut et al., 1992. The 
experiments of nuclear transfer in mouse revealed that the ability of donor nuclei to 
support development to blastocyst stage in vitro and to term depends on the cell 
cycle stage of the of the recipient cytoplast to which it is fused. Previous studies of 
nuclear transplantation in mice and rats have shown limited preimplantation 
development of embryos reconstructed by using enucleated zygote and late 2-cell or 
more advanced donor nuclei (McGrath and Solter, 1984; Robl et al., 1986; Tsunoda 
et al., 1987; Kono and Tsunoda, 1988). However, development after nuclear 
transfer by reconstructing the embryos using donor nuclei from the early stage of 2- 
4- and 8-cell embryos with MIT oocytes as recipient cytoplasts was achieved 
(Cheong et al., 1993). 
The stage of cell cycle of the donor nucleus and recipient cytoplasm are 
important factors for successful development of reconstituted embryos. On the other 
hand this could be explained in a sense that the stage of the cell cycle of the donor 
nucleus at the time of reconstruction be in a state which could be reprogrammable by 
the recipient cytoplasm i.e. metaphase II oocyte. As the cell cycle of the recipient 
oocytes is restarted by activating them with electric pulse or by ethanol or strontium 
chloride (Whittingham, 1980), altering the timing of oocyte activation with respect 
to the time of fusion of donor nuclei provides a number of possible approaches to 
reconstruct the embryos for developmental studies. 
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It has been reported by previous studies that the fusion of interphase donor 
nuclei with metaphase II ooplasm resulted in chromatin undergoing premature 
chromosome condensation (PCC) (Czolowska et al., 1984; Szollosi et at., 1988; 
Collas et at., 1992; Cheong et al., 1994). The PCC and NIEBD are induced by the 
maturation promotion factor (MPF), a complex of p34 2 and cyclin (Choi et at., 
1991; Kubiak et at., 1993; Whitakar, 1996). The study of Campbell and colleagues 
(1993) demonstrates that normal development from nuclear transfer could be 
expected by maintaining the ploidy of the reconstructed embryos. Two main 
approaches to maintain the normal ploidy were suggested. If the cytoplast has a high 
level of MPF then a diploid nucleus should be transferred, while pre-activation 
creates a recipient cytoplast able to support development of embryos reconstructed 
by using donor nuclei at any stage of cell cycle. 
The aim of present series of experiments was to study the interactions of 
different stages of second and third cell cycle donor nuclei with enucleated 
metaphase II oocytes with respect to fusion and activation at different time. In this 
study two different protocols were initially used. The donor nuclei were fused with 
enucleated recipient oocytes as follows: (1) the donor nuclei were fused with 
enucleated oocytes and activated at the same time, (ii) the donor nuclei were fused to 
enucleated and pre-activated oocytes. 
Previous report on nuclear transfer experiments with G2-phase donor nuclei 
into metaphase II oocytes demonstrates that the donor nuclei undergo premature 
chromosome condensation (PCC) (Kono et at., 1991b, 1992) due to the high level 
of MPF (Kubiak et at., 1993). After artificial activation, normal diploid nuclei were 
reported following karyokinasis (Kono et al., 1991b, 1992). The lower rate of 
development to term from late 2-cell donor embryos was also reported (Kono et al., 
1993). It was suggested that oocytes receiving a G2-stage nucleus do not develop a 
normal spindle. The study of Kwon and Kono, (1996) demonstrated the production 
of identical sextuplet mice from 4-cell metaphase nuclei through serial nuclear 
transfer. The study suggested the beneficial use of prolonged exposure of donor 
nuclei to cytoplasmic environment (Mil) before activation. 
Thus the experiments were also performed using the method of delayed 
activation of reconstructed embryos which gave rise to another type of protocol i.e. 
(iii) the donor nuclei were fused to enucleated oocytes which were activated later on 
(delayed activation). 
8.2 Effect of interaction of donor nuclei cell cycle phase 
with recipient cell cycle phase on the development of 
embryos reconstructed by nuclear transfer from 2-cell. 
The aim of present experiment was to study the effect of interaction of 2-cell 
donor nuclei at G2 stage of cell cycle with the two types of recipient cytoplast with 
respect to the level of MPF on the development of reconstructed embryos. 
8.2.1 EXPERIMENTAL DESIGN 
To study the interaction of 2-cell donor nuclei at G2 stage with two different 
types of cytoplast recipients, the Fl female mice were superovulated following the 
super ovulation regime (section 3.3.2). The oocytes were recovered 14 hours post 
hCG injections. The donor 2-cell embryos at G2 stage of cell cycle were recovered 
40 hours post hCG injection from the mated Fl females. The oocytes were denuded 
from cumulus and enucleated using micromanipulation procedures (Section 3.4.4). 
All the micromanipulation were performed in M2 medium containing 10 iM 
nocodazole, 7.5 pjg/mi Cytochalasin B and 10 % FCS. The embryos were 
reconstructed at zero hours of activation (enucleation => fusion/activation) by using 
2-cell donor nuclei at G2 stage of cell cycle at the time of enucleation. The recipient 
cytoplasts at this stage were considered to be with high level of MPF (see 7.2.2) 
and the donor nuclei were exposed to partial exposure to MPF 
The experiments were also conducted to reconstruct the embryos by using 2-
cell donor nuclei at G2 stage of cell cycle 4 hours after the activation of enucleated 
metaphase II oocytes (enucleation/activation => fusion). The activation stimuli in 
these experiments were achieved by exposing the enucleated oocytes or 
reconstructed embryos to 25 mM concentration of strontium chloride in M16 for one 
hour. The zero hour was considered when they were first exposed to strontium 
chloride. The pre-activated cytoplasts used in this experiment were considered to be 
with basal level of MPF (see 7.2.2). Two control groups were also made to 
compare the effect of activation stimuli and auto-activation of the oocyte with any 
other physical or chemical stimuli. The Sendai virus mediated method was used for 
fusion of reconstructed embryos. 
8.2.1.1 STATISTICAL ANALYSIS 
The data on development after nuclear transfer was analyzed using 
Generalized Linear Mixed Model (Breslow and Clayton, 1993) looking at the effect 
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of treatment whilst allowing for differences between days. The treatment effects 
were tested using a Wald statistics (distributed as chi-squared), and, if significant, 
differences between means were assessed by an approximate t-test. Means declared 
to differ, differ at the 5% level or better. 
8.2.2- RESULTS 
Development after nuclear transfer has been shown to be affected by the cell 
cycle stage of the recipient cytoplast (p< 0.001). The results presented in table: 8.1 
shows that when the embryos were reconstructed using 2-cell donor nuclei at G2 
stage of cell cycle at the time of enucleation of metaphase II oocytes by using 
enucleation, fusion/activation at the same time, the development beyond 2-cell is 
greatly effected. Though 38% embryos showed pronuclear formation only 26 % 
developed up to 2-cell stage and 2% reached to morula/blastocyst stage. When the 
embryos were reconstructed by using the pre-activated metaphase II oocyte (4 hpa) 
using enucleation/activation = fusion protocol, 77% showed pronuclear formation 
(p< 0.001) and 58% developed to 2-cell stage. The development to 
morula/blastocyst stage in embryos reconstructed by using pre-activated enucleated 
Mil oocytes was high (p<0.001) as compared to the embryos reconstructed at the 
time of enucleation/activation (16% Vs 2%). The parthenogenetic development in 
activation control group (+ive control) shows the ability of activation stimuli. 
However, no difference in development to 2-cell was found when compared with 
the embryos reconstructed by using pre-activated cytoplast (87% Vs 77%) 
respectively. 
8.2.3 CONCLUSIONS 
The results of the present experiment shows that the development after 
nuclear transfer is greatly affected by the cell cycle stage of the donor nuclei and 
recipient cytoplast. The development of embryos reconstructed by using the G2 
stage of 2-cell embryos with recipient cytoplast by using enucleationlfusion and 
activation at the same time protocol, is minimum (2%). The partial exposure of G2 
stage donor nuclei to high level of MPF may not be able to completely reprogram 
the donor nuclei. The disturbance in the normal ploidy as NEBD and FCC is 
expected in the reconstituted embryos in the presence of high level of MPF at the 
time of reconstruction and re-replication of the already replicated chromosomes at 
G2 stage may leads to lower development of reconstituted embryos to 
morulaiblastocyst stage. In contrast when the embryos were reconstructed by using 
pre-activated recipient cytoplasts, the development of reconstituted embryos to 
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Table: 8.1 DEVELOPMENT AFTER NUCLEAR TRANSFER OF EMBRYOS RECONSTRUCTED 
BY TRANSFERRING 2-CELL (G2/M) DONOR NUCLEI INTO ENUCLEATED METAPHASE II 
OOCYTES (0 hpa) AND PRE-ACTIVATED RECIPIENT CYTOPLASTS (4 hpa). 
Treatments 	NUCLEAR 	REPLICATES TOTAL 	FUSED! 	PN/ 	2-cell! 	Morula/ 
(recipients) DONOR TOTAL(%) FUSED(%) FUSED(%) Blast.(%) 
Enuceation 
fusion/activation 	2-Cell (G2) 	5 	98 	87/98(89) 	33/87(38) 	23/87(26) 2/87(2) 
0 hours* 
Enucleation 
activation = fusion 	2-Cell (G2) 	7 	117 	86/117(77) 66/86(77) 	50/86(58) 14/86(16) 
4 hours* 
+ive Control 	 -- 	 4 	88 	 -- 	 77/88(88) 	68/88(77) 26/88(30) 
-ive Control 	 -- 	 4 	47 	 -- 	 3/47(6) 	2/47(4) 	0/47(0) 
*= Hours post activation. The non-enucleated oocytes in activation control group (+ive) were activated at the same time. Both of the 
control groups were kept under paraffin oil in M2 medium in the dark at room temperature till treatments. 
morula/blastocyst stage is shown to be restricted to 16%, may be due to cell cycle 
stage effect or may be some cytoplasmic activity of MPF causing NEBD and PCC, 
leading to disturbance in the normal ploidy of the reconstructed embryos. 
8.3 The effect of interaction of different phases of donor 
cell cycle with cytoplast cell cycle phase on the 
development of the embryos reconstructed by nuclear 
transfer from 4-cell embryos. 
The present experiment was aimed to investigate the effect of interaction of 
different phases of 4-cell donor nuclei with different cell cycle phases of recipient 
cytoplasts on the development of embryos reconstructed by nuclear transfer. 
8.3 EXPERIMENTAL DESIGN 
To investigate the effect of interaction of different phases of donor nuclei 
with different cell cycle phases of recipient cytoplasts, the 2-cell embryos were 
recovered 44-48 hours post hCG injection from the mated females. The donor 
nuclei were synchronized for at least 9 hours using 10 .iM nocodazole in sM16. 
The embryos were released from synchronization by washing through several drops 
of M2 and sM 16 and cultured in microdrops of sM 16 medium under paraffin oil at 
37°C in the atmosphere of 5% CO2 in air. The 2-cell embryos after their recovery 
from the females were stored at low temperature of 4°C under paraffin oil in M2 till 
synchronization so that they could be used at preferred hours during day time and 
desirable cell cycle stage of 4-cell embryos be captured. In experiments where 4-
cells at GuS and S-phase of the cell cycle stage were required, the 2-cells were 
released in batches from the synchronization medium. The embryos started dividing 
30 minutes after their release from nocodazole. The embryos were reconstructed by 
using GuS 4-cell donor nuclei 75-90 minutes after their release. To reconstruct the 
embryos by using the S-phase of 4-cell donor nuclei, the 2-cell embryos were 
released from synchronization 4 hours prior to the reconstruction of embryos. On 
the other hand when the 4-cell donor nuclei at G2 or G2/M phase were required, the 
4-cell embryos were recovered 58 hours post hCG injection from the mated 
females. The 4-cell embryos were then synchronized by using 10 tM nocodazole 
for at least 6 hours to be used as 4-cell nuclear donor at G2/N4 stage of cell cycle. 
The embryos in these experiment were reconstructed by depositing the donor nuclei 
into perivitalline space of zona pellucida using micromanipulation procedures 
(section 3.4.4). The fusion method used was sendai mediated (section 3.4.4.3.1). 
By using mainly two approaches: (i) the embryos were reconstructed at the time of 
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enucleation i.e. at 0 hours of activation (Enucleation, fusion/activation) and (ii) they 
were reconstructed by using enucleated and pre-activated metaphase II oocytes i.e. 
3-4 hours post activation (Enucleation, activation/ fusion). Because of the limitation 
in the co-ordination of different stages of donor and recipient cell cycle, the embryos 
were reconstructed by using various combinations on each day. The different 
combinations were: the Gi and S-phases of donor nuclei with enucleated metaphase 
II recipient at 0 hours of activation, the donor nuclei at Gi or S-phase into pre-
activated metaphase II oocytes (3-4 hours post activation), the G2IM donor nuclei 
into enucleated metaphase H recipient (0 hours of activation) and G2IM donor nuclei 
into pre-activated enucleated oocytes (3-4 hours post activation). Two control 
groups were also made to compare the effect of activation stimuli and auto-activation 
of the oocyte with any other physical or chemical stimuli. The reconstructed 
embryos or recipient cytoplasts and activation control groups were activated by 
using strontium activation media containing 25 mM strontium chloride concentration 
in M16 (see Chapter 3). 
8.3.1.1- STATISTICAL ANALYSIS 
The analysis of the data was done using the method as stated earlier (see 
section 8.2.2) 
8.3.2 RESULTS 
The development after nuclear transfer in mouse is greatly affected (p< 
0.001) by the interaction of the cell cycle stages of donor nuclei and recipient cell 
cycle and the data is presented in table 8.2. The development of reconstructed 
embryos to blastocyst stage is shown to be greatly effected (p< 0.001) by the cell 
cycle stage of the donor nuclei. The development of embryos to blastocyst stage 
(41% and 46%) was better (p<0.00 1) when donor nuclei at G  or GuS phase were 
transferred into metaphase II at the time of enucleation and activation (0 hpa) and 
into pre-activated recipient cytoplasts (3-4 hpa) to morula/blastocyst respectively. It 
was shown as greatly affected when embryos were reconstructed by transferring 4-
cell S-phase and G2/N4 phase donor nuclei into metaphase II recipient (0 hpa) and 
into pre-activated recipient cytoplast (3-4 hpa). Though the development to 2-cell in 
embryos reconstructed by transferring S-phase donor nuclei into metaphase II 
recipient (0 hpa) and pre-activated (3-4 hpa) recipient cytoplasts is 26% and 21% 
but no development (0%) to morula or blastocyst was observed in former group as 
compared to the 7% development in later group. The same trend is shown in 
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Table: 8.2 DEVELOPMENT AFTER NUCLEAR TRANSFER OF RECONSTRUCTED EMBRYOS 
USING 4-CELL DONOR NUCLEI FROM DIFFERENT STAGES OF CELL CYCLE WITH 2 
CYTOPLAST RECIPIENTS. 
PROTOCOL NUCLEAR REPLICATES 	TOTAL 	FUSED! 2-CELL! (MORULAIBLAST)I 
USED DONOR TOTAL(%) FUSED(%) FUSED(%) 
Enuceation 4-Cell (GuS) 3 45 29/45(64) 17/29(59) 12/29(41) 
fusion/activation 4-Cell (S) 3 36 23/36(64) 6/23(26) 0/23(0) 
0 hours* 4-Cell (G2IM) 3 62 50/62(81) 2/50(4) 0150(0) 
Enucleation 4-Cell (G1!S) 5 53 39/53(74) 23/39(59) 18/39(46) 
activation => fusion 4-Cell (S) 3 44 29144(66) 6/29(21) 2/29(7) 
34 hours*  4-Cell (G2IM) 3 39 29/39(74) 24/29(83) 2/29(7) 
Act. Control -- 9 101 -- 80/101(79) 31/101(31) 
-lye Control 	 -- 	 9 	99 	 -- 	 3/99(3) 	1/99(1)** 
* hours post activation. **Developed upto morula. 
embryos reconstructed by using the G2JM stage donor nuclei with metaphase II 
oocytes (0 hpa) and pre-activated recipient cytoplast (3-4 hpa). 
8.3.3 CONCLUSIONS 
The development after nuclear transfer is greatly effected (p< 0.001) by the 
interaction of cell cycle phases of donor nuclei and recipient cytoplasts. The 
development to morula/blastocyst after nuclear transfer of donor nuclei at GI or 
GUS stage is high (p< 0.001) when embryos were reconstructed by using recipient 
cytoplasts with high level of MPF at the time of enucleation/fusion and activation 
and by using pre-activated recipient cytoplasts with basal level of MPF. When 
embryos were reconstructed by transferring donor nuclei at S-phase and G2IM 
phase of cell cycle into metaphase H recipient cytoplast, with high level of MPF, no 
embryo developed beyond 2-cell stage, may be due to aneuploidy in donor nuclei 
caused by the high level of MPF. On the other hand the development of the embryos 
reconstructed by transferring S-phase and G2I1\4 phase into pre-activated recipient 
cytoplasts where MIPF level supposed to be at basal level, is mainly restricted to 2-
cell and lower proportion reaches to morula/blastocyst stage. The reason may be due 
to some cytoplasmic activity of level of MPF which stays at its basal level for short 
period of time (see 7.2.2). The overall results of the experiment concludes that the 
development after nuclear transfer is effected by the cell cycle phase of the donor 
nuclei and its interaction with recipient cytoplasts. 
8.4 - The effect of delayed 
pronuclear formation and 
transfer 
activation protocol on the 
development after nuclear 
Is there any beneficial effect of exposing reconstituted embryos to high level 
of MPF? The present series of experiments aimed to answer this question. 
8.4.1- EXPERIMENTAL DESIGN 
8.4.1.1- The effect of delayed activation and Cytochalasin 
B exposure on the pronuclear formation of reconstructed 
embryos. 
To investigate the effect of delayed activation post fusion for different length 
of time and subsequent exposure to Cytochalasin B (The cytoskeleton inhibitor) on 
the pronuclear formation of reconstructed embryos, the oocytes recovered 14 hours 
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post hCG injections were enucleated and fused with 4-cell donor nuclei. The 
enucleationlfusion and delayed activation protocol was used in this experiment. The 
4-cell embryos recovered from Fl mated females, 58 hours post hCG injection were 
synchronized for 6 hours to use them at G2IM phase of cell cycle. In contrast the 2- 
cell embryos recovered from mated females, 44-48 hours post hCG injection 
were synchronized for at least 9 hours. They were released from synchronization 
and used as 4-cell S-phase donor to reconstructed the embryos. The embryos 
reconstructed by transferring 4-cell donor nuclei at S-phase and G2IM phase of cell 
cycle with enucleated Ivifi oocytes using micromanipulation procedures (see Chapter 
3) were activated 2, 4, and 6 hours post fusion were used. The embryos which 
were reconstructed by using 4-cell at S-phase of cell cycle were activated 2 hours 
post fusion only. The reconstructed embryos after their activation with 25 miVi 
Strontium Chloride in M16 were exposed to Cytochalasin B treatment (7.5 J.Lg/ml) 
in microdrops of sM16 for 6 hours at 37 °C and 5% CO2 in air in the incubator. At 
the end of the treatment the reconstructed embryos were washed, put on the slide 
and holded under the coverslip. The reconstructed embryos were fixed with 
Methanol: Acetic acid (3:1) for over night and stained with 2% Aceto Orcene. The 
data on the formation of pronuclei were obtained by scanning the slides under the 
microscope and were analyzed using method described in section 8.2.2. 
8.4.1.2- RESULTS 
The results of the experiment presented in table 8.3 shows highly significant 
difference (p<0.001) in the formation of 2 pronuclei. When the reconstructed 
embryos were activated 2 hours post fusion, all the embryos reconstructed by using 
4-cell S-phase donor nuclei underwent multiple pronuclei formation (> 2PN). 
Similarly, 95% of embryos reconstructed using 4-cell donor nuclei at G2/M stage of 
cell cycle showed more than 2 pronuclei. By delaying the time activation for 4 
hours, 80% of the embryos reconstructed using 4-cell at G2/M phase of cell cycle 
showed 2 pronuclei formation (Fig. 8.1) and 15% 1PN+IPB formation, while only 
3% were observed with multiple pronuclei. The proportion of embryos showing 
2PN increased to 91% when the reconstructed embryos were activated 6 hours post 
fusion. 
8.4.1.3 - CONCLUSIONS 
The exposure of reconstructed embryos to high level of MPF for 2 hours 
leads to the formation of multiple pronuclei. The shorter exposure of donor nucleus. 
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Fig. 8.1 Formation of two pronuclei 
The embryos reconstructed were activated 4 hours after fusion and then 
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Table: 8.3 THE EFFECT OF DELAYED ACTIVATION AND CYTOCHALASIN B EXPOSURE 
ON THE PRONUCLEAR FORMATION OF RECONSTRUCTED EMBRYOS. 
Treatment 	Donor 	Total 	Fused 	1PN+1PB 	2 Pronuclei 	> 2PN 
Nuclei (%) (%) (%) (%) 
Enucleation 
fusion => activation 	4-cell (S) 	27 	 21/27(78) 	0/21(0) 	0/21(0) 	21/21(100) 
(delayed activation)* 4-cell (G2/M) 	25 19/25(76) 0/19(0) 1/19(5) 18/19(95) 
Enucleation 
fusion 	activation 	4-cell (G2IM) 	97 	 74/97(76) 	11/74(15) 	59/74(80) 2/74(3) 
(delayed activation)** 
Enucleation 
fusion ==> activation 	4-cell (G2/M) 	33 	 23/33(70) 	2/23(9) 	 21/23(91) 0/23(0) 
(delayed activation)*** 
*The  reconstructed embryos were activated 2 hours post fusion. * * The reconstructed embryos were activated 4 hours post fusion. 
***The  reconstructed embryos were activated 6 hours post fusion. 
to high level of MPF may not be helpful in complete PCC which resulted into more 
than 2PN formation. It is obvious from the results that when the donor nuclei at 
G2IM stage of cell cycle were exposed for 4 hours to high level of MPF, only 3% 
showed > 2PN formation 
8.4.2- Effect of delayed activation protocol on the 
development of embryos reconstructed by transferring 2-
cell donor nuclei at G2IM stage of cell cycle into Mu 
cytoplasts. 
The present experiment was conducted to investigate the effect of delayed 
activation and Cytochalasin B exposure on the development of embryos 
reconstructed by transferring 2-cell donor nuclei at G2IM stage of cell cycle into MIII 
cytoplast. 
8.4.2.1- Experimental Design 
To study the effect of delayed activation and subsequent exposure to 
Cytochalasin B on the development of reconstructed embryos, the oocytes 
recovered 14 hours post hCG injection from the Fl females were enucleated using 
micromanipulation techniques (section 3.4.4). The embryos were reconstructed by 
transferring 2-cell donor nuclei at G2/N1 of cell cycle. For this purpose the 2-cell 
embryos were recovered from the mated Fl females 44 hours post hCG and mating. 
The embryos were exposed to 10 pM nocodazole till their use for nuclear transfer. 
The embryos were reconstructed by depositing donor nuclei with small amount of 
Sendai virus inside the perivitalline space of the zona pellucida of the enucleated MIT 
oocyte using micromanipulation techniques in the micromanipulation chamber. The 
reconstituted embryos were then washed and cultured in the microdrops of sM16 in 
the incubator at 37°C and 5% CO 2 in air. After 4 hours, the reconstructed embryos 
were activated by using 25 mM Strontium Chloride in M16 (see Appendix) for 1 
hour. The embryos were washed through several changes in M2 and sM16 and 
transferred to microdrops of sM16 containing Cytochalasin B (7.5 .igIm1) in a 
separate dish and cultured for further 4 hour. Two control groups were also made to 
compare the effect of activation stimuli and auto-activation of the oocyte with any 
other physical or chemical stimuli. At the end of Cytochalasin B treatment, the 
reconstructed embryos were washed through several changes of M2 and sMl6 and 
cultured for further development. The observations on the developmental pathway 
were recorded and the data was analyzed as described in section 8.2.2 
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8.4.2.2- RESULTS. 
The reconstructed embryos after their release from Cytochalasin B treatment 
extruded their extra polar body and 86% showed 1 pronucleus (Table: 8.4) . The 
pronounced effect of delayed activation protocol was observed as 82% embryos 
developed to 2-cell and 68% reached morulalblastocyst development. When 
development to morula/blastocyst was compared with activation control group, the 
development was better (p< 0.01) with delayed activation protocol. 
8.4.2.3 - CONCLUSIONS 
The exposure of donor nuclei to high level of MPF for 4 hours is beneficial 
in the development of embryos reconstructed by using the 2-cell donor nuclei at 
G2JM stage. The high level of MPF could be involved in the PCC and also the 
reprogramming of the donor nucleus. The extrusion of extra polar body may 
provides embryos with diploid genome and correct ploidy is maintained. 
8.4.3- Effect of delayed activation protocol on the 
development of embryos reconstructed by transferring 4-
cell donor nuclei at different stages of cell cycle into MI! 
cytoplasts. 
This experiment was aimed to study the effect of delayed activation protocol 
on the development of embryos reconstructed by transferring 4-cell donor nuclei at 
Gi or GUS, S, and G2JM stage of cell cycle into M11 cytoplasts. 
8.4.3.1 - EXPERIMENTAL DESIGN 
To investigate the effect of delayed activation on the development of 
reconstructed embryos, the oocytes recovered 14 hours post hCG injection were 
denuded from cumulus and enucleated using micromanipulation technique. In 
contrast, the 2-cell embryos were recovered from the mated females 44-48 hours 
post hCG injections. They were synchronized with 10 pM of Nocodazole for at 
least 9 hours. The embryos were released in groups from synchronization by 
washing through many drops of M2 and sM16. The embryos started dividing to 4-
cell 60 minutes after their release from synchronization and were used as Gi or 
GUS donor to reconstruct the embryos 75 minutes after their release. When the 4-
cell at S-phase donor nuclei were required, the embryos were reconstructed 4 hours 
post release. In contrast, when 4-cell donor nuclei at G2IM stage of cell cycle were 
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Table: 8.4 DEVELOPMENT AFTER NUCLEAR TRANSFER OF EMBRYOS RECONSTRUCTED 
BY TRANSFERRING 2-CELL (G2/M) DONOR NUCLEI INTOENUCLEATED METAPHASE II 
OOCYTES FOLLOWING ENUCLEATION/FUSION AND DELAYED ACTIVATION 
PROTOCOL. 
Treatments 	Donor 	Replicates 	Total 	Fused 
(recipient) Nuclei Total (%) 
Enucleation 
fusion = activation 2-Cell (G2IM) 	3 	 34 	22/34(65) 
(delayed activation)* 
-i-lye Control** 	 -- 	 2 	 38 	 -- 
-ive Control*** 	 -- 	 2 	 22 	 - - 
PN/ 	2-cell! 	Morula/ 
Fused(%) 	fused(%) Blast.(%) 
19/22(86) 18/22(82) 	15/22(68) 
33/38(87) 30/38(79) 	12/38(32) 
0/22(0) 	0/22(0) 	0/22(0) 
*The  reconstructed embryos were activated 4 hours post fusion of the couplets. **The  activation control group (+ive) received same 
activation stimulus at the same time. The control group (-ive) received no activation stimulus and cultured at the same time. Both of 
the control groups were kept under paraffin oil in M2 medium in the dark at room temperature till treatments. 
required, the 4-cell were recovered from the mated females 58 hours post hCG 
injections and synchronized with 10 !IM  of Nocodazole for 5 hours. The embryos 
were reconstructed by transferring donor nuclei inside the perivitalline space of zona 
pellucida of the cytoplasts with small amount of Sendai virus in the 
micromanipulation chamber using micromanipulation techniques (section 3.4.4). 
Most of the fusion occurred inside the micromanipulation chamber. The 
reconstructed embryos were then washed with several drops of M2 and sM16 to 
remove the effect of drugs and cultured in microdrops of sM16 in the incubator at 
37°C and 5% CO2 in air for 4 hours. The reconstructed embryos were then 
activated using 25 mM Strontium Chloride in M16 for 1 hour. Two control groups 
were also included to compare the effect of activation stimuli and auto-activation of 
oocytes with any physical stimuli. The reconstructed embryos after their activation 
were washed and cultured in microdrops of sM 16 containing Cytochalasin B (7.5 
pg/m1) for further 4 hours. At the end of Cytochalasin B treatment, the 
reconstructed embryos were washed and cultured in the microdrops of sM16 for 
development. The observations recorded on the developmental pathway and the data 
was analyzed using method described in section 8.2.2. 
8.4.3.2.- RESULTS 
The development after nuclear transfer is shown (Table: 8.5) to be greatly 
effected by the donor cell cycle stage when development to 2-cell was compared. 
When the embryos were reconstructed using 4-cell at S-phase of cell cycle, no 
embryo developed even to 2-cell stage due to donor nuclei exposure to cytoplasmic 
environment with high level of MPF. In contrast, when the embryos were 
reconstructed using donor nuclei from Gi or GuS and G2/M stage of cell cycle, the 
development to 2-cell is shown to be 50% and 56% respectively. The development 
to morula/blastocyst in the embryos reconstructed by using donor nuclei at G2/M 
stage of cell cycle with delayed activation protocol is 38% which is indistinguishable 
from the development of embryos reconstructed by using donor nuclei at Gi or 
GuS stage of cell cycle was used (38% vs. 42%). 
8.4.3.3.- CONCLUSIONS 
The exposure of donor nuclei to high level of MPF for 4 hours is beneficial 
in the development of embryos reconstructed by using the 4-cell donor nuclei at 
G2IM stage. The high level of MPF could be involved in the PCC and also the 
reprogramming of the donor nucleus. The results of the experiments demonstrates 
that the development after nuclear transfer by using delayed activation protocol is. 
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Table: 8.5 DEVELOPMENT AFTER NUCLEAR TRANSFER OF RECONSTRUCTED EMBRYOS 
USING 4-CELL DONOR NUCLEI FROM DIFFERENT STAGES OF CELL CYCLE WITH 













fusion 	activation 4-Cell 	(GuS) 3 30 26/30(87) 13/26(50) 11/26(42) 
(delayed activation)* 
4-Cell 	(S) 3 34 27/34(79) 0/27(0) 0/27(0) 
4-Cell (G2/M) 4 49 32/49(65) 18/32(56) 12/32(38) 
Act. Control** -- 3 72 - - 56/72(78) 21/72(29) 
-ive 	Control*** -- 3 30 - - 2/30(7) 0/30(0) 
*The  reconstructed embryos were activated 4 hours post fusion of the couplets. **The  activation control group (+ive) received same 
activation stimulus at the same time. *** The control group (-ive) received no activation stimulus and cultured at the same time. Both of 
the control groups were kept under paraffin oil in M2 medium in the dark at room temperature till treatments. 
only obtained by using donor nuclei at Gi or GUS and G2/M stage of cell cycle. In 
contrast no development is expected when S-phase donor nuclei are used to 
reconstruct the embryos because of high level of MPF which leads to chromosomes 
abnormalities 
8.5 - DISCUSSION 
The results of the present findings indicates the role of controlling cell cycle 
stage of donor nuclei and recipient cytoplasm for successful development of 
embryos reconstructed by nuclear transfer. The experiments were conducted to 
study the effect of interaction of donor nuclei and recipient cytoplasm on the 
development of embryos reconstructed by nuclear transfer. After activation of 
recipient cytoplasm, the cytoplasmic environment varies in relation to their MPF 
level. Freshly ovulated MU oocytes contain high levels of MPF activity and causes 
NEBD and PCC of the donor nuclei if reconstructed at this point (Czolowska et al., 
1984; Szollosi et al., 1986a, b. and Szollosi et al., 1988) . In contrast, NEBD and 
FCC is not observed in the embryos reconstructed after the disappearance of the 
cytoplasmic activity of MPF. The present experiments were performed by 
reconstructing the embryos at the time of activation (0 hpa) of MIII cytoplasts and 
using pre-activated cytoplasts (3-4 hpa). Moreover, the experiments were also 
performed using the protocol of delayed activation. The results of present series of 
experiments confirmed the earlier reports on the effect of interaction of donor nuclei 
and recipient cytoplasm on the development of reconstructed embryos. 
In this study, when the embryos were reconstructed by transferring 2-cell 
donor nuclei at G2 stage of the cell cycle into different cytoplasmic environments, 
the development to morula/blastocyst remained restricted mainly to pre-activated 
cytoplasts. The lower development in embryos reconstructed at the time of 
enucleation/ fusion! activation (0 hpa) at the same time may be due to the partial 
exposure of high level of MPF which was unable to cause proper chromatin 
condensation necessary for reprogramming of the donor nuclei. This idea is 
supported by the results of previous studies with amphibians (DiBerardino, 1988) 
and mammals (Collas and Robl, 1991; Collas et al., 1992a, b) which demonstrated 
that the exposure of donor nucleus to an cytoplasmic environment resulting 
chromatin condensation are helpful for nuclear reprogramming and have beneficial 
effects on the development of embryos reconstructed by nuclear transfer. 
The higher proportions of development to momla/ blastocyst stage is 
observed when the embryos were reconstructed by transferring 4-cell donor nuclei 
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from GI stage of cell cycle into IVifi cytoplasts (41%) and into pre-activated 
cytoplasts (46%). Present results confirmed the earlier findings (Collas et al., 1992; 
Cheong et al., 1993) which demonstrated development to blastocysts by 
transferring GI donor nuclei into MIII cytoplasts. The results (Table 8.2) 
development (46%) of embryos reconstructed by transferring G 1 donor nuclei into 
pre-activated cytoplasts after the disappearance of MPF are in line with the study of 
Campbell et al., (1993) which demonstrated that the normal ploidy in embryos 
reconstructed from all stages of cell cycle is expected, if reconstructed after the 
disappearance of MPF in the cytoplasts. The lower rate of development in embryos 
reconstructed by using G2 and S-phase donor nuclei in these experiments by using 
pre-activated cytoplasts demonstrated some cytoplasmic activity of MPF still present 
at the time of reconstruction of embryos, it stays for a very short time at basal level 
(referred to Chapter 6 fig: 6.2), causing damaging effect on the chromosome by 
pulverization (S-Phase donor) and re-replication of previously replicated 
chromosomes (G2 donor). 
In present study the experiments conducted to prolong the exposure of 
donor nuclei to cytoplasmic environment with high level of MPF using method of 
delayed activation enhances the developmental potential of reconstructed embryos. 
The embryos reconstructed by using 2-cell donor nuclei at G2 stage of cell cycle 
with delayed activation protocol showed considerably higher (68%) proportion of 
development to morula/blastocyst (Table: 8.4) than fusion and activation at the same 
time (Table: 8.1). The exposure of donor nuclei to MIII cytoplasts before activation 
provides cytoplasmic environment with high level of MPF. Since these experiments 
were completed, a benefit in delaying activation has also been described after 
transfer of cumulus cell nuclei to MIT oocytes (Wakayama et al., 1998). The 
mechanism of this effect is not understood. 
The effect of prolonged exposure to cytoplasmic environment in non-
activated MIII cytoplasts for different period of time on the pronuclear formation 
was studied in embryos reconstructed by G2 donor nuclei which suggested 
minimum exposure of 4 hours. The shorter exposure resulted in the formation of 
multiple pronuclei indicated duration time was not good enough for complete 
formation of the metaphase plate necessary for the formation of 2PN. The 
experiments conducted to prolong the exposure of 4-cell donor nuclei from different 
stages of the cell cycle to cytoplasmic environment enhances the developmental 
potential of reconstructed embryos. The development of embryos reconstructed 
using G2 donor nuclei was found to be comparable to the embryos reconstructed 
using GI donor suggested the beneficial effects of exposing to cytoplasmic 
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environment with high level of MPF for reprogramming. No development in 
embryos reconstructed by using 4-cell donor nuclei at S-phase stage of cell cycle 
and prolong exposure to non-activated cytoplasmic environment of M11 cytoplasts is 
hypothesised due to high level of MPF causing PCC which led to chromatin 
pulverisation. The report of previous studies (Rao and Johnson, 1974; Haneen and 
Rohme, 1982) showed the chromatin pulverisation of PCC by passaging of 8-cell 
nucleus through Ivifi cytoplasm. In this study the reconstructed embryos were 
exposed to Cytochalasin B for 4-6 hours. The embryos reconstructed by using 
G2I1\4 donor nuclei into Mil cytoplast environment when exposed to Cytochalasin 
B for 4 hours, 80% showed 2PN formation. This proportion increased to 91% by 
increasing the Cytochalasin B exposure to 6 hours. These reconstructed embryos 
when further cultured after washing, showed cone formation immediately and 
extrude a polar body showing only 1PN in the embryos. This extrusion of polar 
body in this case may be the extrusion of 1PN, leaving embryo with diploid 
chromosome and hence development from the G2 donor nuclei was achieved. 
In conclusion, the result of present study confirm that development after 
nuclear transfer is affected by the cell cycle stage of the donor nucleus and recipient 
cytoplasm and their interactions. Provided the cytoplasmic environment is suitable, 
the donor nuclei at early and late phases of cell cycle support development to morula 
and blastocyst stage. The observation of greater development with donor nuclei in 
G2 and G1 phases suggests that there may be differences in chromatin structure 




All experiments presented in this thesis were carried out on mouse. The 
mouse is the most commonly used laboratory mammal. Due to its small size and high 
fecundity it is relatively cheap to breed, buy and maintain. Recent major advances in 
technique of nuclear transplantation allow manipulation of genetic constitution of 
mouse eggs or embryos by the removal or addition of pronuclei or nuclei. Such 
procedures have made possible the investigation of a number of important areas in 
development: the developmental contribution of maternal and paternal pronuclei; 
nuclear-cytoplasmic interactions; the developmental potential of nuclei transferred to 
eggs from later stage embryos, and the feasibility of 'cloning'; production of 
transgenic animals and chimaeras; reproduction in mammals by parthenogenesis. 
The results presented in this thesis emphasize the importance of cytoplasmic 
environment responsible for reprogramming of the transferred nucleus and 
confirmed the importance of cell cycle co-ordination in the development of 
reconstructed embryos. The results demonstrate the importance of controlling donor 
and recipient cell cycle stages for appropriate co-ordination to enhance development 
in the embryo reconstructed by nuclear transfer. 
The results presented in table 8.2 demonstrated the significant effect of 
interaction of cell cycle stage of donor nuclei and recipient cytoplasts. When the 
embryos were reconstructed using donor nuclei from different stages of the cell cycle 
in the presence of high MPF activity, the Gl donor proved to be the best donor. 
These results confirmed the earlier finding of donor cell cycle stage effect (Collas et 
at., 1992a). Inappropriate co-ordination of cell cycle stages may lead to aneuploidy 
or chromosomal damage. The lower development of embryos reconstructed by 
transferring S-phase and G2 phase donor nuclei into pre-activated cytoplasts could 
be related to the unexpected cytoplasmic activity of MPF (see section 6.2.2) which 
reached its basal level around 4 hours post activation, but still caused NEBD and 
Table 9.1: Different protocols for nuclear transplantation and their success rates. 
Source 	Donor 	 Nuclear Transplantation Procedures 	 Morula (%) Blastocyst (%) 
Kayyoplast 
Table 5.5 GuS (4-cell) Enucleation/Activation (Sr 1 hr =6-DMAP 3 hr) =Fusion (4 hpa) 
Table 5.5 S (4-cell) EnucleationlActivation (Sr 1 hr =6-DMAP 3 hr) =Fusion (4 hpa) 
Table 5.5 G2 (4-cell) Enucleation/Activation (Sr 1 hr =6-DMAP 3 hr) =Fusion (4 hpa) 
Table 5.7 GuS (4-cell) Enucleation/Activation (Sr 1 hr =6-DMAP 3 hr) 	Fusion (4 hpa) 
Table 5.7 GuS (4-cell) Enucleation/Activation (Strontium 1 hr) =Fusion (4 hpa) 
Table 8.1 G2 (2-cell) Enucleation! Fusion /Activation (Sr 1 hr) (0 hpa) 
Table 8.2 G2 (2-cell) EnucleationlActivation(Sr 1 hr) [Fusion (3-4 hpa) 
Table 8.2 G 1/S (4-cell) Enucleationl Fusion /Activation (Sr 1' hr) (0 hpa) 
Table 8.2 S (4-cell) Enucleation! Fusion /Activation (Sr 1 hr) (0 hpa) 
Table 8.2 G2J1\4 (4-cell) Enucleationl Fusion /Activation (Sr 1 hr) (0 hpa) 
	
33/57 (85) 	31/39(79)  
19/47(40) 	11/47(23) 
23/49(47) 	13/49(27) 
41/45(91) 	35/45 (78) 
21/36 (58) 	21/36(58) 
2/87 (2) (Mor./Blast.) 
14/86 (16) (Mor.IBlast.) 
12/29 (41) (MoriBlast.) 
0/23 (0) (Mor./Blast.) 
0150 (0) (MorJB last.) 
Table 8.2 GuS (4-cell) Enucleation/ Activation (Sr 1 hr) =Fusion / (3-4 hpa) 
Table 8.2 S (4-cell) Enucleation/ Activation (Sr 1 hr) =Fusion / (3-4 hpa) 
Table 8.2 G2IM (4-cell) Enucleation/ Activation (Sr 1 hr) =Fusion / (3-4 hpa) 
Table 8.4 G2IM (2-cell) Enucleation! Fusion = 	Activation (Sr 1 hr) (3-4 hpf) 
Table 8.5 GUS (4-cell) Enucleation! Fusion = 	Activation (Sr 1 hr) (3-4 hpf) 
Table 8.5 S (4-cell) Enucleation! Fusion =' Activation (Sr 1 hr) (34 hpf) 
Table 8.5 G2I1\4 (4-cell) Enucleationl Fusion = 	Activation (Sr 1 hr) (3-4 hpf) 
Wakayama* GO/G1(cumulus) Enucleation! Fusion! Activation (Sr 6hr) (0 hpa) 
Wakayama* G0/G1(cumulus) Enucleation! Fusion = Activation (Sr 6hr) (1-3 hpf) 
Wakayama* 	GO/G1(cumulus) 	Enucleation! Fusion = Activation (Sr 6hr) (3-6 hpf) 
*Wakayama et al., (Nature 394, 369-374, 1998) 
18/39 (46) (Mor.IBlast.) 
2/29 (7) (Mor.IBlast.) 
2/29 (7) (Mor.fBlast.) 
15/22 (68) (Mor.fBlast.) 
11/26 (42) (Mor./Blast.) 
0/27 (0) (Mor.fBlast.) 
12/32 (38) (Mor.fBlast.) 
61/153 (17) (Blastocyst) 
277/474 (58) (Blastocyst) 
101/151 (67) (Blastocyst) 
NEBD & PCC in 41% ± 4.22 and 10.25% ± 3.7 donor nuclei respectively. 
However, it is suggested that experiments should be performed to evaluate the level 
of Hi kinase activity to map the level of MPF. It is further suggested that further 
experiments using prolonged exposure to strontium containing medium should be 
performed to properly activate the metaphase II cytoplasts as demonstrated by Bos-
Mikich et al., 1995, Wakayama et al., (1998). 
Different nuclear transfer procedures were employed to study the cell cycle 
co-ordination in nuclear transfer, experiment and the results are summarized in table 
9.1. Direct comparison of different activation timings have been made with 4-cell 
nuclei at three different stages of the cell cycle (table 9.2) 
Summary of effect of different activation protocols on 
development to morula/blastocyst (%) after nuclear transfer 
from 4-cell embryos 
Nuclear Donor Pre-activation * Simultaneously" * Delayed activation* **  
GuS 	 46 	 41 	 42 
S-phase 	 7 	 0 	 0 
G2/M 	 7 	 0 	 38 
*Enucleation/activation => fusion (4 hpa). "' Enucleation /fusion/activation at the same time. 
***Enucleationlfusion 	activation (4 hpf). 
Several different combinations give similar development to morula/blastocyst stage. 
Similar development with donor nuclei in GUS was obtained with all three recipient 
cell cycle stages. By contrast, very poor development was obtained with donor 
nuclei in S-phase. Development from nuclei in G2/1\4 was high only after delayed 
activation. Several factors probably contribute to these differences. In recent years 
greater development was obtained when oocytes were used as recipient cytoplasts 
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(Cheong et al., 1994) rather than enucleated zygote ( McGrath and Solter, 1984). 
This difference may reflect an influence of reprogramming factor present in the 
oocytes at Mil, but absent in the zygote after pronuclear formation. Factors able to 
reprogramme transferred nuclei may also be used in pronuclear formation and so no 
longer be available during nuclear transfer to an enucleated zygote. 
The cytoplasmic environment appears to be conditioning the chromatin 
during the process of condensation and making it amenable for reprogramming. 
During the condensation process in mitosis most of the nuclear proteins, except for 
histones, are removed from the nucleus (Nagi, 1985; Albert et at., 1989). 
Cytoplasmic proteins now have free access to chromosomes and may be passively 
trapped by the telophase nucleus as the nuclear envelope reforms (Swanson and 
McNeil, 1987). Similar events occurring during the completion of a meiotic 
maturation in activated oocytes may be necessary for reprogramming. Formation of a 
mature pronucleus may also require the active transport of proteins via the nuclear 
envelope: those supplied by an oocyte, and those which appear as new after egg 
activation (Dreyer, 1987; Howlett et al., 1988). It is not yet confirmed whether the 
cytoplasmic activity of MPF or some other cytoplasmic factors played their role in 
the reprogramming of the transferred nucleus. The results presented in table 5.5 
confirms that in the absence of high level of MPF and by maintaining the integrity of 
the nuclear envelope, the universal recipients support development of the 
reconstructed embryos from any stage of cell cycle to blastocyst stage. Under these 
circumstances some reprogramming factors must pass through the nuclear 
membrane. The reprogramming of the donor nuclear gene expression is an important 
step in enhancing the developmental potential of reconstructed embryos (Kono, 
1997). It was suggested that the birth of lambs using donor cultured cell at GO stage 
is the result of effective reprogramming (Campbell et al., 1996). However, further 
studies are suggested to identify the nature of this reprogramming factor. 
In experiments where the embryos were reconstructed using delayed 
activation protocol, the reconstructed embryos were exposed for 4 hours to 
Cytochalasin B. The embryos reconstructed using G2 donor nuclei when released 
from the Cytochalasin B exposure extruded a pronuclear like polar body and then 
began development. It is suggested that experiments should be conducted to evaluate 
the karyotype of these early embryos to confirm the ploidy. However, no polar body 
extrusion was observed in embryos reconstructed by using donor nuclei from G 1 
and S-phase of cell cycle. The present results contrast with earlier studies of Kono et 
al., (1992) and Cheong et at., (1993) who reported the extrusion of polar body like 
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structure containing DNA derived from the transferred nucleus. The difference might 
be due to the use of Cytochalasin B in this experiment. The extrusion of one of the 
pronuclear like structures in embryos reconstructed using G2 donors demonstrates 
that perhaps there is presence of some cytoplasmic mechanism which sense one of 
the pronuclear as polar body and extrudes it. The results confirms the earlier findings 
that window of opportunity exists from G2 through mitosis (Kwon and Kono, 
1996) to Gi. The state of universal recipient (Campbell et at., 1993) in mouse was 
difficult to achieve as level of MPF was at basal level for a very short period (see 
section 6.2.2). 
The results presented in table 5.5, 5.7 demonstrate the use of 6-DMAP in 
preparation of cytoplasts as universal recipients and by using this activation protocol 
it has been possible for the first time to obtain similar development with 4-cell 
blastomeres with donor nuclei at any stage of the cell cycle. The key to success in 
these experiments was the maintenance of nuclear envelope which helped in the 
maintenance of normal ploidy in reconstructed embryos. However, it is suggested 
that further experiments should be planned to evaluate the effectiveness of this 
activation protocol (chapter 5) on development to term. 
The rate of higher development with G 1 donor nuclei reported in 5.5 and 5.7 
could be related to the criteria used to select the donor at GI stage. The criteria 
introduced during the experiments presented in chapter 5 was the number of nucleoli. 
Donor nuclei after mitosis containing more than 6 nucleoli were considered to be at 
GI stage of cell cycle. The second reason for higher rate of development might be 
that the reconstructed embryos were fused immediately using electrofusion 
technique. However, it is suggested that this might be a useful criterion and an 
experiment should be conducted to assess development after transfer of nuclei with 
different number of nucleoli. 
The results presented in chapter 7 demonstrated that initiation of DNA 
replication, in 3rd and 4th cell cycle as investigated by pulse labelling technique for 
detecting the PCNA localization, starts 60 mm. after release from synchronization. 
The lower development of embryos reconstructed by using donor in Gi stage might 
be due to the fact that Gi duration is very short and the proportion of development as 
reported in chapter 8 and earlier is the proportion which was actually in G 1. The 
timing of GI duration is contradictory with that reported by Otaegui (1995, Ph.D. 
Thesis). The reason might be the difference in the use of techniques for the detection 
of the start of DNA replication in 3rd cell cycle. The BrdU technique reported in this 
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thesis is based on the rapid pulse labeling technique of (Nomura et al., 1993) which 
required only 5-8 mm. for BrdU incorporation. In contrast, the original technique 
involved incubation of at least 45 minutes. 
It is suggested that the further studies might be focused to use the donor 
nuclei from established culture cell lines after inducing them into different stage of 
the cell cycle including quiescent (GO). The birth of mice following nuclear transfer 
from cumulus cells (Wakayama et al., 1998) also suggests that also as a second 
approach nuclei should be transferred from a variety of differentiated cells. 
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APPENDIX 1 
Different Media and Stock Solutions 
The composition of different media and their preparation from different 
stock solutions used in the different experiments are detailed below. Moreover, 
the appendix consisted of the details of stock solutions of chemical 
compounds/drugs and antibodies. 
1.1 - Culture media M16, pM16 and sM16. 
Table A 1.1 - Composition of M16, pM16 and sM16 
Compound 	MW 	 gllitre (mM) 
M16 	pM16 	sM16 
NaC1 	 58.450 5.533 (94.66) 4.700 (80.40) 4.700 (80.40) 
KCI 74.557 0.356 (4.78) 0.356 (4.78) 0.356 (4.78) 
CaC12 7 HO 	147.200 0.252 (1.71) 0.252 (1.71) 0.252 (1.71) 
KH2PO4 	136.091 0.162 (1.19) 0.162 (1.19) 0.162 (1.19) 
M9SO4 7 HO 	246.500 0.293 (1.19) 0.293 (1.19) 0.293 (1.19) 
NaHCO3 	84.020 2.101 (25.00) 2.101 (25.00) 2.101 (25.00) 
Sodium pyruvate 	110.000 0.036 (0.33) 0.040 (0.36) 0.040 (0.36) 
Glucose 	179.860 1.000 (5.56) 0.350 (2.78) 0.350 (1.95) 
EDTA 372.200 0 0.037 (0.1) 0.037 (0.1) 
Sodium lactate 	112.100 4.349 (23 28) 4.349 (23 28) 4.349 (23 28) 
(60% syrup) 
L-Glutamine 0.000 0.000 0.146 
Bovine serum albumin (BSA) 4.000 4.000 4.000 
Penicillin G (K salt) 
(final conc. 100 units/ml) 0.060 0.060 0.060 
Streptomycin sulphate 
(final conc. 50.tg/mI) 0.050 0.050 0.050 
Phenol Red 0.010 0.010 0.010 
MEM non-essential amino acid solution lOOx 0.000 10.0 ml (v/v) 
MEM amino acids solution 50x 20.0 ml (v/v) 
Water (Molecular water) up to 1 litre up to I litre up to 1 litre. 
Osmolarity: M16 = 280; pM16 = 265; sM16 =260 mOsmoles. 
The compounds used in the preparation of those media, unless otherwise 
mentioned, were of cell culture tested and from Sigma (Poole, Dorset, UK). 
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Procedure - The media were prepared from the stock solutions mentioned in 
appendix 1.3. Various amounts of stock solutions were used depending upon the 
required volume of media. The stock D was always introduced in the end. All the 
stocks and BSA were dissolved in small amount of water in the volumetric flask 
then the volume was made up to desired volume. The required volume 
supplemented with BSA was then filter-sterilized into small appendorfs and 
stored at 4°C. 
1.2 - Manipulation media M2. 
Table A 1.2. - Composition of M2. 
Compound 	mlvi 	MW 	g/litre 
NaCl 	 94.66 58.450 5.533 
KC1 	 4.78 74.557 0.356 
CaC12 7 H20 	 1.71 147.200 0.252 
KH2PO4 	 1.19 136.091 0.162 
M9SO4 7 H20 	1.19 246.500 0.293 
NaHCO3 	 4.15 84.020 0.349 
HEPES 	 20.85 238.300 4.969 
Sodium lactate 	23.28 112.100 4.349 of 60% syrup 
Sodium pyruvate 0.33 110.000 0.036 
Glucose 	,- 	5.56 179.860 1.000 
L-Glutamine 0.000 0.146 
Bovine serum albumin (BSA) 4.000 
Penicillin G (K salt) final conc. 100 units/ml 0.060 
Streptomycin sulphate (final conc. 50.tg/ml) 0.050 
MEM non-essential amino acid solution lOOx 10.0 ml (v/v) 
MEM amino acids solution 50x 20.0 ml (vlv) 
Phenol Red 0.010 
Water (Molecular water) up to 1 litre. 
Osmolarity M2 = 280 mOsmoles. 
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(Sterile, endotoxin tested MEM non-essential amino acid solution (Cat no. 
M7145 SIGMA) and MEM amino acids solution without L-Glutamine (Gibco, 
BRL Cat no. 11130-036) were used in preparing the sM16 medium 
1.3- Preparation of M2, sM16 and activation media from stocks. 
Table A 1.3 - Composition of stock solutions 
Stock Mg free A Components g/lOOml g/lOOml 
(For M2) (For sM16) 
(10 x concentration) NaCl 5.533 4.700 
KC1 0.356 0.356 
KH2PO4 0.162 0.162 
Sodium lactate 4.349 4.349 
(60% syrup) 
Glucose 1.000 0.350 
Penicillin G 0.060 0.060 
Streptomycin sulphate 0.050 0.050 
EDTA 0.00 0.037 
Stock B Component g/lOOml g/lOOml 
(For M2) (For sM16) 
(10 x concentration) NaHCO3 0.349 2.101 
Phenol Red 0.010 0.010 
Stock C 	 Component 	g/lOml 	g/lOml 
(For M2) (For sM16) 
(100 x concentration) 	Sodium pyruvate 	0.036 	 0.040 
Stock D 	 Component 	g/lOml 	gIlOml 
(For M2) (For sM16) 
(100 x concentration) 	CaC12 7 H20 	0.252 	 0.252 
Stock E 	 Component 	g/lOml 	g/lOml 
(For M2) (For sM16) 
(10 x concentration) 	HEPES 	 4.969 	 0.000 
Phenol Red 	0.010 	 0.000 
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Stock Mg 	 Component gIlOml 	g/lOml 
(For M2) (For sM16) 
(100 x concentration) 	M9SO4 7 H20 0.293 	0.293 
Stock Glutamine 	Component g/lOml 	g/lOml 
(For M2) (For sM16) 
(100 x concentration) 	L-Glutamine 0.146 	0.146 
Stock Sr 	 Component g/lOml (For Activation Media) 
(100 x concentration) 	SrC12 6 H20 0.452 
Storage - At 4°C Stocks A Mg-, D, E, Mg and Sr were kept up to 3 months at 
4°C, but stocks B and C were change every three weeks and stock glutaniine 
was prepared freshly all the times. 
Table A 1.4 - Procedure to prepare M2, sM16 and calcium magnesium free 
M16 plus strontium from stocks. 
Stock 	 M2 	sM16 	CaMg free Ml6+Sr 
Mg free A 10.0 ml 5.0 ml 2.50 ml 
B 1.6m1 5.0 ml 2.50m1 
C 1.0 ml 0.5 ml 0.25 ml 
D 1.0 ml 0.5 ml 0.0 ml 
E 8.4 ml 0.0 ml 0.0 ml 
Mg 1.0 nil 0.5 ml 0.0 ml 
L-Glutamine 1.0 ml 0.5 ml 0.0 ml 
Non-essential a.a. 0.0 ml 0.5 ml 0.0 	ml 
Min.Essential a.a. 0.0 ml 1.0 ml 0.0 	ml 
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Sr 	 0.0 ml 	0.0 ml 	3.67 ml 
Water 	UptolOOml Upto5Oml 
	
Up to 25 ml 
A 1.5 - Phosphate Buffered Saline (PBS). 
Calcium-magnesium free PBS was prepared by dissolving pre-
formulated tablets (Flow Laboratories, Rickmansworth, Hertfordshire, UK) in 
distilled water into 500 ml bottles. PBS was then sterilized by autoclaving and 
stored at room temperature. 
A 1.6 - Acidic Tyrode solution for removing zona pellucida. 
A fresh 100 ml solution was prepared every two months and kept at 
room temperature. The pH was adjusted with Analar HC1. It was sterilized by 
filtration. Its composition in g/100 ml was: 
NaCl 0.800 
KC1 0.020 
CaCl2 2H20 0.024 
MgCL2 6H20 0.010 
Glucose 0.100 
Polyvinylpyrrolidone (PVP) 0.400 
The PVP was added to increase the viscosity and reduce embryo 
stickiness. 
A 1.7 - Hank's Balanced Salt solution (HBSS). 
This solution was used as diluent through the production of Sendai virus. 
For some of the procedures glucose was omitted in its composition, in those 
cases it was denominated Hank's balanced salt solution without glucose 
(HBSSG-). The whole composition was: 0.14 g/l of CaC12; 0.40 g/l of KC1; 
0.06 g/l of KH2PO4 ; 0.0977 g/l of Mg504 ; 8.00 g/l of NaCl; 0.048 g/l 
Na2HPO4; 1.00 g/l of glucose and 0.01 g/l of phenol red. 
A 1.8 - Chemical stocks 
1.8.1 - Anti -bromodeoxyuridine antibody 
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Mouse anti-bromodeoxyuridine (anti-BrdU) monoclonal antibody 
conjugated to fluorescein (Boehringer, cat no. 1202, Lewes, East Sussex, UK.) 
was diluted to 50 J.Lg/ml in PBS supplemented with 0.1% BSA. Fifty tl aliquots 
were made and kept at - 20°C. 
1.8.2 - Anti- proliferating cell nuclear antigen 
The anti-PCNAIcyclin (Immuno concepts Cat: No. 2037) was diluted 
with PBS containing FCS (9.9 ml PBS + 100 p.M FCS) with the ratio of 1:10 
i.e. 450 p.1 of above diluent and 50 p1 of anti-PCNA. 
1.8.3 - Bromodeoxyuridine 
Bromodeoxyuridine (BrdU) (5-bromo-2' deoxyuridine 5' -triphosphate, 
Sigma code No. B-063 1; Poole, Dorset, UK) was dissolved in water at 1 mg /ml 
concentration. Aliquots of 10 mM were made and kept at - 20°C. 
1.8.4 - Cytochalasin B 
Cytochalasin B, from Helminthosporium dematioideum (C 29 H37 N05 ; 
Sigma code No. C-6762; Poole, Dorset, UK.) was dissolved in dimethyl 
suiphoxide at 5mg/5m1 and stored at - 20 °C. The stock solution was used 
several times after freezing and thawing without any apparent lost of potency. 
The aliquots containing 10 p.g/10 p.1 were made and stored at 4°C. The working 
solution of 10 p.g/ml was made by adding one ml of medium in the aliquot. 
1.8.5 6-Dimethylaminopurine (DMAP) 
A stock solution of 6-dimethylaminopurine (N 6,N6-Dimethyladenine 
(C7H9N5);Sigma code No. D-2629; Poole, Dorset, UK.) (Sigma) was prepared 
by dissolving with the molecular water and the aliquots were made containing 
2.5 m1V1120 p.1 concentration. The aliquots were stored at -20°C. This solution 
was diluted with M16 or strontium activation media depending upon the type of 
treatment and the final concentration of 2.5mM/mi or 2.0 mM was achieved. 
1.8.6 - Hoechst dye. 
Hoechst no. 33342, bisbenzimide (2'- [4-Ethoxyphenyl] -5- [4-methyl-i-
piperazinylJ-2,5'-bi-IH-benzimidazole; Sigma code no B-2261; Poole, Dorset, 
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UK.) was dissolved in distilled water at 1mg/mi . A working concentration of 
1.0 jig/ml was used to stain the chromosomes for enucleation purposes. 
1.8.7 - Hyaluronidase 
Hyaluronidase, Type P1-S from bovine testes lyophilized powder 
containing approx. 90% protein ; balance primarily buffer salts. 
(Hyaluronoglucosaminidase; Hyaluronate 4-glycanohydrolase ; Sigma code no. 
H-3884; Poole, Dorset, UK.) was used. The stock solution was prepared by 
dissolving 30 mg/i ml of distilled water. The aliquots of 10 p1 were made and 
stored at -20 °C. A working concentration of 300 jig/nil of M2 was used in all 
the experiments to denuded the oocytes. 
1.8.8 lonomycin 
The stock solution of ionomycin calcium salt from streptomyces 
conglobatus (C 4 H7009Ca); Sigma product no. 10634 Poole, Dorset, UK) was 
prepared by dissolving 1mg of ionomycin calcium salt with 1338.5 jil of DMSO 
to the concentration of lmMJlml. The aliquots were made with the concentration 
of 5mIVII10pJ by dissolving the stock solution with molecular water and stored at 
-20°C. The ionomycin activation medias having concentration of 5jiM was 
prepared by adding one milliliter of M2 medium in the aliquots. 
1.8.9 - Nocodazole 
Nocodazole, (methyl (5- [2-thienylcarbonyl]- 1 H-benzimidazol-2-yl) 
carbamate; Sigma code no. M-2759; Poole, Dorset, UK.) was dissolved in 
dimethyl suiphoxide at 2 mg/ml and kept at 4 °C. The stock solution was used 
several times without any apparent lost of potency. To get 10 mM concentration 
of nocodazole 1.5 pI/ml was used in the experiments. 
1.8.10 	Taxol (Paclitaxel) 
Taxol is a trade mark of Paclitaxel. Paclitaxel, (C 47H51N0 14 ); Sigma 
product no. T1912; Poole, Dorset, UK.)was dissolved in water at 1 mg/1.17 ml 
of water to give rise concentration of lnilV[/ij.tl. The stock solution was aliquoted 
1.8.11 - Texas Red 
The Texas red (Vector Lab. Cat: No. TI-3000) was diluted with PBS 
containing 1% FCS with the ratio of 1:20. 
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